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Abstract 
Background: Rheumatoid Arthritis (RA) is associated with increased risk of 
cardiovascular disease (CVD). Physical inactivity is a modifiable risk factors of 
CVD and frequently associated with impaired functional status and health 
related quality of life. 
Objectives: This single blind randomised controlled trial investigated the impact 
of a pedometer-supported walking and education programme (Walk for RA–
WARA) on PA, sedentary time, PA self-efficacy, disease activity, functional 
capacity, quality of life and cardiovascular (CV) risk in people with RA. 
Methods: Seventy-six individuals, aged 56 (±15) years and within 5 years from RA 
diagnosis were randomly assigned to either the WARA intervention group (six 
weekly group education sessions and two booster sessions at 3 and 6 months) or 
the control group (single session). Demographic data were recorded and Body 
Mass Index (BMI), Waist-Hip ratio (WHR), Waist-Height ratio (WHtR), and blood 
pressure were measured. The primary outcomes were objectively measured PA 
profiles, daily step counts and time spent sedentary, using an activPALTM and 
self-reported using international physical activity questionnaire (IPAQ). 
Functional status was assessed with six-minute walk test (6MWT), health 
assessment questionnaire (HAQ), and hand grip strength. Rheumatoid arthritis 
quality of life (RAQoL) and PA Self-efficacy were evaluated. Blood samples were 
taken and the 10-year risk of CVD scores were calculated, using the Scottish 
Intercollegiate Guidelines Network (ASSIGN). Data were analysed descriptively 
and mixed generalised linear models (GLM) were used incorporating restricted 
maximum likelihood (REML) and post-hoc analyses. Interviews were undertaken 
with 10 people from the intervention and data were analysed thematically using 
the framework approach and NVivo 11 software. 
Results: The intervention group showed a significantly greater increase than the 
control group in steps/day at 3 months (by 3413 (1835-4990) steps/day, mean 
(95%CI)) (P<0.001), and 6 months (3599 (2135-5062) steps/day) (P<0.001) and a 
significant reduction in IPAQ weekday (P=0.014) and weekend sitting time 
(P=0.046). There were significant improvements in 6MWT (P<0.001), PA self-
efficacy (P=0.008), systolic blood pressure (P=0.002) and ASSIGN scores 
(P<0.001) in the intervention group. Participants found education sessions, 
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booster sessions, hand-outs, pedometer, PA diaries were important factors in 
increasing their step counts. In addition, they stated that WARA programme was 
enjoyable and helpful in terms of raising their knowledge regarding their 
condition. They also reported they felt much healthier and their mood had 
improved.  
Conclusions: The 6-month WARA intervention was effective in promoting PA, PA 
self-efficacy, physical function, and reducing the 10-year risk of CVD. The WARA 
programme may be a useful adjunct to current clinical practice in rheumatology.  
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1 Introduction 
1.1 Problem statement  
Rheumatoid Arthritis (RA) is a chronic auto-immune disease of unknown 
aetiology. It affects 0.5-1% of the UK population, and is most prevalent among 
people aged 40–60 years (Cooney et al., 2011, Panel., 2004). The risk of 
developing RA is two to three times higher among women than men (Henchoz et 
al., 2012, Plasqui, 2008, Sokka et al., 2008). Despite, the aetiology of RA being 
unknown, there are many factors implicated in the development of the disease, 
and the interaction of genetics, the immune system and environment factors 
may contribute to the development of RA (Aho and Heliovaara, 2004, Sugiyama 
et al., 2010).  
RA is characterized by inflammation of the joints resulting in progressive 
musculoskeletal damage and also extra articular manifestation such as 
pericarditis, neuropathy, ophthalmological manifestation and glomerulonephritis 
(John et al.,2011; Plasqui.,2008; Metsios et al.,2007; Turesson et al., 2003; 
Riemsa et al.,2003). The pathological process of RA may lead to a severe degree 
of articular destruction, loss of function, accelerated loss of muscle mass, 
restricted mobility and deformities (Cooney et al., 2011, Metsios et al., 2008). 
As a consequence of RA, people may suffer from severe joint pain, swelling, 
stiffness, muscle weakness, loss of bone density and general functional 
limitation in performing daily physical tasks (Avina-Zubieta et al., 2008, Cooney 
et al., 2011, Esbensen et al., 2015). 
Several disease-modifying antirheumatic drugs (DMARDs), such as methotrexate, 
sulfasalazine, leflunomide, hydroxychloroquine and azathioprine and biological 
drugs, such as infliximab, adalimumab and rituximab, have been shown to be 
effective in the control of disease activity, in minimising structural damage and 
in promoting longer life (Inui and Koike, 2016). Some recommend a ‘treat-to-
target’ (T2T) approach for RA, in order to achieve remission, or at least low 
disease activity (Smolen et al., 2016). Although modern technology may be used 
to help diagnose RA earlier, and new approaches using anti-rheumatic treatment 
regimens have improved the outcome of the disease, those with RA still suffer 
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from progressive, long term disability (Avina-Zubieta et al., 2008, Cooney et al., 
2011).  
It is well established that RA is associated with increased morbidity and 
mortality compared with general population (Pieringer and Pichler, 2011). 
People with RA have an increased risk of cardiovascular (CV) mortality of up to 
50% (Choy et al., 2014, Kerola et al., 2013, Metsios et al., 2008, Siebert et al., 
2016). Specifically, RA is associated with increased risk of cardiovascular disease 
(CVD) such as myocardial infarction, ischemic heart disease and heart failure; 
(Houri Levi et al., 2016, Kerola et al., 2013, Metsios et al., 2008, Pieringer and 
Pichler, 2011). However, increased risk of CVD among people with RA is not fully 
explained by traditional cardiovascular risk factors (Cooney et al., 2011, Houri 
Levi et al., 2016, Kerola et al., 2013, Zegkos et al., 2016). Clinical 
epidemiological observations suggest that low grade inflammation plays an 
important role in accelerating atherosclerosis and CVD (Avina-Zubieta et al., 
2008, Cooney et al., 2011, Kremers et al., 2008, Sattar et al., 2003).  
Metsios et al. (2008) reported a significantly greater CV risk profile among 
physically inactive people with RA (as determined by higher systolic pressure, 
elevated total cholesterol and low-density lipoprotein levels) compared with 
physically active RA people. People with RA may have inactive lifestyles for a 
number of reasons, including joint pain and stiffness, psychological disturbances 
or even fear of aggravating their disease, that could raise the CV risk profile 
(Zegkos et al., 2016).  
RA guidelines emphasise the role of regular physical activity (PA) which is 
associated with improved health outcomes both physical and mental, and 
reduced the risk of all-cause mortality by 30% (Knittle et al., 2015, Sokka et al., 
2008). It has been identified that over two-thirds of people with RA in the UK 
are physically inactive in comparison with the healthy population (Cooney et al., 
2011, Esbensen et al., 2015). PA plays an important role in the management of 
the disease, as it has a fundamental role in maintaining muscle strength, 
endurance, range of motion, decreasing inflammation and pain, and improving 
function and a sense of well-being (Baillet et al., 2012, Hakkinen et al., 2001, 
Plasqui, 2008, Prioreschi et al., 2013).  
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Behavioural interventions and patient education are fundamental components in 
the management of chronic disease and several studies strongly 
recommend their use in lifestyle interventions (Greaves et al., 2011, John et al., 
2011a, Knittle et al., 2015). Changing patient behaviour is one of the important 
challenges of healthcare (Michie et al., 2012). Systemic reviews and meta-
analyses have indicated that behavioural interventions show a significant 
positive effect on self-efficacy for PA, which is associated with a change in 
PA behaviour (John et al., 2011a, Olander et al., 2013).  
Systematic reviews by Olander et al. (2013) and Michie et al. (2012) showed 
behavioural change techniques, including self-monitoring and goal setting, are 
effective in increasing self-efficacy for PA, and that interventions which aim to 
increase PA should also promote social support. Any educational and lifestyle 
modification programme to increase knowledge should provide an explanation of 
the relevance of CVD, modification of lifestyle and encouragement of long-term 
relevant behavioural modification (Knittle et al., 2015, Olander et al., 2013). It 
is uncertain; however, whether behavioural change interventions can promote 
PA among people with RA, and further study of this is recommended (Cramp et 
al., 2013, Larkin et al., 2015a).  
John et al. (2011a) and Riemsma et al. (2004) evaluated the effectiveness of 
education programmes to manage RA, based on a systematic review of the 
evidence from randomised controlled trials. It concluded that any successful 
education programmes for people with RA, with the aim of promoting PA, would 
need to be designed in the format of group education, as this improves the 
participants’ compliance and adherence to programmes. 
In particular, it has been suggested that healthy lifestyle education programmes 
such as those aimed at increasing PA and reducing sedentary behaviour for 
people with RA should be provided during the early stage of the disease to 
maximise the potential for appropriate behaviours to be implemented and 
maintained (National Institute for Health and Care Excellence, 2015, Riemsma et 
al., 2003). There is a lack of education programme in routine clinical settings 
regarding lifestyle modification for people with RA (Zegkos et al., 2016). Thus, 
the outcomes that emerge from this study may help in developing new 
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approaches to patient education programme regarding PA and improve the 
health outcomes of people with RA. 
1.2 The purpose of the study 
The overall aim of this single blind randomised control trial (RCT) study was to 
investigate the effectiveness of a six-month, community based, pedometer 
supported, walking programme, along with an education programme 
incorporating behavioural change techniques (Walk for Rheumatoid Arthritis – 
WARA) on objectively measured physical activity (step count) and sedentary 
time, disease activity, functional capacity, quality of life, self-efficacy for PA 
and cardiovascular risk of people within the first five years of being diagnosed 
with RA.  
1.3 Objectives of the study 
This study had three objectives: 
To examine the effectiveness of a six-month community based, pedometer 
supported, walking programme, to increase PA and reduce sedentary time in 
people with RA within the first five years of diagnosis and to compare the results 
with a group of people (control) receiving usual care.  
To investigate the effectiveness of the programme in terms of cardiovascular 
risk, disease activity, quality of life, functional capacity and self-efficacy for 
physical activity. 
To explore the relationship between changes in physical activity, time spent 
sedentary and disease activity, quality of life, functional capacity, self-efficacy 
for physical activity and cardiovascular risk. 
1.4 Overview of the study 
The single blind RCT was approved by the West of Scotland Research Ethics 
Committee and was conducted in accordance with declaration of Helsinki 
between November 2014 and March 2016. The participants were recruited from 
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rheumatology clinics at Gartnavel General Hospital, Stobhill Hospital and 
Glasgow Royal Infirmary in Glasgow, UK.  
Participants who were randomised to the Walk for Rheumatoid Arthritis (WARA) 
intervention, received six weekly, one-hour small group interactive education 
sessions with plus two booster sessions at 3 and 6 months combined with 
pedometer based walking programme. The education sessions were delivered by 
an experienced physiotherapist. The control group received a one-hour group 
education session. 
The primary outcome measure was the changes in daily step count and sedentary 
time from baseline to six months (end of the intervention) which was obtained 
using an activPALTM worn for 7 consecutive days. The outcome measures (at 
baseline, 3, 6 months and one year) were self-reported questionnaires and 
physiological assessments (see Chapter 4). The principle investigator who 
performed all assessments was blind to the group allocation. To explore 
participant views regarding the WARA intervention at the end of the programme 
(6 months) 10 participants from the intervention group took part in a semi 
structured telephone interview. 
1.5 Thesis layout 
Chapter Two reviews the current literature on the prevalence and 
epidemiological trends in RA, its clinical features and extra articular 
manifestations, the risk factors for RA, the diagnostic criteria and course of RA, 
the epidemiology of CVD in RA, the risk factors of CVD in RA, its possible 
mechanisms and the pattern of CVD in people with RA. It also reviews PA, the 
benefits of PA, PA in RA, the definition of sedentary behaviour and the 
consequences of being sedentary in the general population and in those with RA. 
Chapter Three presents a definition of complex interventions discusses physical 
activity interventions as lifestyle interventions, the theoretical underpinning of 
the integral behavioural change, the behavioural change techniques (BCTs) and 
their effectiveness in changing the behaviour of people with RA in terms of 
physical activity. It also presents the content and mode of delivery of the WARA 
intervention. 
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Chapter Four presents a rationale for the chosen outcome measures in the form 
of a literature review, including discussion of the reliability and validity of the 
outcome measures.  
Chapter Five describes the materials and method used in the study, including 
the study design, ethical approval, study setting, patient recruitment and 
selection method, method of allocating participants to the intervention and 
control groups. It also discusses, the sample and sample size, control group 
intervention, piloting of the study, data management, the quantitative data 
collection tools and processes, and the qualitative data collection (telephone 
interview). Additionally, it presents the methods of data analysis (quantitative 
and qualitative) applied. 
Chapter Six presents the results of the study and offers comparisons between 
the intervention and control groups at baseline, three and six months, in terms 
of PA, CVD risk, quality of life, functional capacity and participants’ self-efficacy 
for PA. It includes the results of PA and sedentary behaviour of both groups at 
one year (6 months follow up).  
Chapter Seven presents the facilitators and barriers of the WARA intervention 
including all of the identified themes and subthemes. It includes a summary of 
the results and integrates the findings of both studies (quantitative and 
qualitative). 
Chapter Eight is the discussion chapter where the results of the study are 
discussed in relation to previous literature. It discusses the strengths and 
limitations of the study. 
Chapter Nine offers a summary of the study, considers the implications for 
future research, and offers recommendations for clinical practice. It also 
presents the conclusions of the study and detail of the current study makes a 
novel and original contribution to the existing evidence base in this field.  
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2 Literature Review 
This chapter describes the current literature related to rheumatoid arthritis 
(RA), cardiovascular disease (CVD), physical activity (PA), and sedentary 
behaviour providing the background and justification for the study. The section 
will begin with a description of the key features of RA and CV risk factors 
associated with RA. Also, it will explain PA guidelines and sedentary behaviour, 
and specifically discuss the role of PA on quality of life, functional capacity, 
disease activity and the risk of CVD in people with RA. The literature in relation 
to the outcome measures applied in this study will be presented in Chapter 4.  
2.1  Rheumatoid arthritis (RA) 
2.1.1  Epidemiology and prevalence  
Several epidemiological studies demonstrate that the incidence and prevalence 
of RA across the world shows considerable geographical variation (Alamanos and 
Drosos, 2005, Tobon et al., 2010). The estimated incidence of RA in North 
Europe and North America ranges from 20 to 50 cases per 100,000 of the 
population; in Southern Europe, this is 9 to 24 cases per 100,000 of the 
population (Tobon et al., 2010). The prevalence is about 0.5-1.1% in Northern 
Europe and North America, with a lower prevalence at around 0.3-0.7% in 
Southern Europe (Tobon et al., 2010). In developing countries, the prevalence is 
0.1-0.5%; however, no data was available about the number of cases/population 
(Alamanos and Drosos, 2005, Silman and Pearson, 2002, Tobon et al., 2010). In 
the large population-based UK Biobank cohort study the prevalence of reported 
RA was higher among participants from South Asia 1.35% compared to black 
participants 0.90% and Chinese 0.50% (Siebert et al., 2016). 
RA is the most common form of chronic joint inflammation. It is more prevalent 
among women, for example, the rates are two to three times higher in women 
than in men in the UK, where RA affects 0.5-1% of the population (Rodriguez et 
al., 2009). Rodriguez et al. (2009) reported that the RA incidence in the UK was 
0.15 per 1000 person-years; this was slightly lower than in previous reports from 
North American and northern European populations, where it was 0.20–0.50 per 
1000 person-years. 
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In addition, RA occurs at any age, however the prevalence of disease for both 
genders increases with age and the peak incidence of RA is between 50-60 years 
of age (Alamanos and Drosos, 2005, Tobon et al., 2010).  
It revealed that people with RA have shortened life expectancy by 3-10 years, 
with most people dying from CVD, infections, or haematological, gastrointestinal 
and pulmonary complications (Cooney et al., 2011, Dougados et al., 2014, John 
et al., 2011a, Sattar et al., 2003). CVD accounts for 50% of excess mortality in 
RA (Cooney et al., 2011, John et al., 2011a, Choy et al., 2014). It has been 
demonstrated that the RA mortality rate is relatively constant for both male and 
female at 2.4/100 person-years and 2.5/100 person-years respectively. The 
wider mortality gap between people with RA and those without RA may be due 
to improvement in survival among the general population (Gonzalez et al., 
2007).  
2.1.2 Time trends in the epidemiology of rheumatoid arthritis  
A number of epidemiological studies have documented that after 1960s the 
incidence and prevalence of RA decreased (Alamanos and Drosos, 2005, Tobon et 
al., 2010, Turesson et al., 2003). The average annual incidence of RA in 
Rochester, Minnesota during the period 1950 through to 1974 was 28.1 per 
100,000 for males and of 65.7 per 100,000 for females. A population study 
undertaken by Doran et al. (2002) using part of the cohort of Rochester, 
Minnesota demonstrated that there was a decrease in the incidence of RA from 
61.2/100,000 in 1955 to 32.7/100,000 in 1994. In 1975, prevalence rates were 
5.8 per 1000 for males and 13.4 for females (Linos et al., 1980). However, 
Symmons et al. (2002) reported that, from the 1950s the prevalence of RA in 
women in the UK may have fallen, but not among men. These changes may be 
due to changes in study methodology and case ascertainment criteria as some 
data collection was carried out before 1987/American College of Rheumatology 
(ACR) classification criteria, which added more precise diagnostic criteria, were 
published (Arnett et al., 1988). 
In 1956, RA was sub classified into definite RA that required at least 5 criteria 
out of 11 and 6 weeks of joint symptoms, or probable RA which required at least 
3 criteria and 4 weeks of joints symptoms. In 1958, classic RA was added (which 
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required patients to have 7 out of 11 criteria), and the duration of joint 
symptoms in probable RA was increased from 4 weeks to 6 weeks. However, data 
from the last decade indicates that the incidence of RA may be rising again after 
four decades of decline (Gonzalez et al., 2007, Tobon et al., 2010). In a 
population based the US, it was reported that the estimated incidence of RA 
appeared to increase more in women compared to men during the period of 
1995-2007. The incidence of RA appeared to increase by 2.5% per year from 1995 
to 2007 in women (95% CI: 0.3%, 4.7% per year, P=0.02), but not in men where 
the incidence declined 0.5% per year (95% CI: −3.6%, 2.7%; P=0.74) (Myasoedova 
et al., 2010). 
2.1.3 Pathophysiology of rheumatoid arthritis 
RA is a chronic inflammatory autoimmune disease, primarily affecting the 
synovium of the joint, and is characterized by disabling, symmetrical, 
polyarthritis and erosive synovitis (Cojocaru et al., 2010, Gibofsky, 2012). RA 
usually affects smaller, distal joints, which leads to progressive destruction of 
joint margins and articular cartilage. Joint pain, swelling and morning stiffness 
are the dominant features (Cooney et al., 2011), see Figure 2-1. RA also affects 
a number of organs, such as the heart, lung and eyes (Cojocaru et al., 2010).  
 
Figure 2-1 Joint affected by rheumatoid arthritis.  
http://www.drugs.com/health-guide/rheumatoid-arthritis.html, 09/05/2016 09:30 pm 
The synovium is the central area of pathology in a number of inflammatory joint 
diseases, including RA (Smith, 2011). The synovium is a soft tissue lining the 
joints, tendon sheaths and bursae. It consists of two parts, the surface layer is 
the intima and the underlying tissue is the sub intima (Smith, 2011). 
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The pathophysiology of RA is a complex phenomenon consisting of inflammation, 
abnormal production of certain inflammatory mediators such as cytokines and 
chemokines of numerous types, tumor necrosis factor alpha (TNF-α), interleukin-
1 (IL-1), IL-6, IL-8, transforming growth factor beta (TGF-β), fibroblast growth 
factor (FGF) and platelet-derived growth factor (PDGF) (Gibofsky, 2012, Siebert 
et al., 2015). RA is distinguished by inflammation of the synovium, elevated pro 
inflammatory cytokines such as; tumour necrosis factor alpha (TNF-α), 
interleukin 1b and C reactive protein about 3 to 100 times. Proliferation of 
synovium occurs and gives rise to destruction of several tissues, which include 
cartilage, tendon, bone, blood vessels and ligament (Gibofsky, 2012, Siebert et 
al., 2015), see Figure 2-2. A hyperplastic synovium with cartilage damage is the 
main manifestation in RA (Smith, 2011).  
In people with RA the intimal lining layer is usually markedly thickened, due to a 
number of processes, with macrophage influx from the vascular compartment, 
under cytokine and cell adhesion molecule control, being the dominant process 
(Cooney et al., 2011). The circulating level of cytokines reflects the level of 
inflammation and activity of disease, it also plays an important role in systemic 
effects of the disease such as vascular and rheumatoid cachexia (Cooney et al., 
2011, Smith, 2011). The rise of circulating inflammatory cytokines leads to 
damage of tendon and collagen and results in disorganisation of the tendon 
structure and gradual loss of elasticity and stiffness, particularly if the individual 
does not perform exercise regularly (Cooney et al., 2011). 
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Figure 2-2 The mechanism of inflammation associated pathogenesis in rheumatoid arthritis 
and osteoporosis 
http://pubs.rsc.org/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/Im
ageService/Articleimage/2010/FO/c0fo00103a/c0fo00103a-f6.gif, 08/05/2016 11 am 
Bone erosion affects 80% of people with RA (Smith, 2011). Synovial cytokines 
enhance osteoclast invasion and differentiation of the periosteal surface 
adjacent to articular cartilage. Deep resorption pits result from destroyed 
mineralized tissue due to effects of acidic enzymatic machinery of osteoclasts; 
the pits then become filled with inflammatory tissue. Also, inflammation of bone 
marrow happens as result of breach of cortical bone and synovial access to bone 
marrow (Freemont, 1996, Smith, 2011), see Figure 2-3.  
 
Figure 2-3 Anterior Posterior radiographic views of normal and rheumatoid arthritis hand 
http://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/media/medical/hw/h9991
226.jpg, 09/05/2016 08pm 
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In addition, RA is associated with increased overall morbidity and mortality 
compared with the general population particularly due to CVD (Agca et al., 
2016, Houri Levi et al., 2016, Metsios et al., 2014). The following section 
explains the current evidence in terms of the risk of CVD in people with RA. 
2.1.4 Diagnostic criteria for rheumatoid arthritis  
The classification of RA is dependent on several criteria to facilitate the 
definition of cases in clinical and epidemiological research. The recent criteria 
were developed by the American College of Rheumatology (ACR) in 1987 and the 
European League Against Rheumatism (EULAR) 2010 (Aletaha et al., 2010). The 
subsets of RA are based on the presence or absence of rheumatoid factor (RF) 
and anti-cyclic citrullinated peptide antibodies (ACPA) which can precede the 
clinical manifestation of RA by many years. The presence of ACPA is positive for 
RA (Alamanos and Drosos, 2005, Sugiyama et al., 2010). RF is an autoantibody 
that binds the Fc region of the immunoglobulin G molecule (IgG) and serves as a 
diagnostic and prognostic marker (Aletaha et al., 2010, Pratt et al., 2009). The 
production of RF results from a response to an antigen/antibody complex such as 
in immunisation and infections. However, it has been demonstrated that 5% of 
healthy subjects have positive RF, but RF is retained as a criterion for RA 
(Aletaha et al., 2010, Pratt et al., 2009). RA patients with positive RF have a 
higher frequency of extra articular manifestations than those with negative RF 
(Cojocaru et al., 2010). 
The criteria for the classification of Rheumatoid Arthritis (RA) 1987 American 
College of Rheumatology and the revised criteria from 2010 European League 
Against Rheumatism are shown in Table 2-1. The new criteria focus on diagnosis 
of RA at an early stage, rather than at a late stage and rely on features, such as 
persistent and/or erosive disease, rather than late stage features (Aletaha et 
al., 2010).  
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Table 2-1 Criteria for the classification of rheumatoid arthritis 1987 and the revised criteria 
2010 
 
 1987 Criteria 2010 Criteria 
Criteria Description Score Description Score 
Morning 
Stiffness 
In and around joints for 
at least 1 hour 
1 Clinical 
synovitis/swelling in 
at least 1 joint not 
explained by another 
disease 
NA 
Joint 
involvement 
Physician observed soft 
tissue swelling or fluid 
in 3 of 14 possible 
joints 
1 1 large joint 
2-10 large joints 
1-3 small joints (with 
or without large joint) 
4-10 small joints (with 
or without large joint) 
> 10 joints (at least 1 
small) 
0 
1 
2 
 
3 
 
5 
Arthritis of 
hand joints 
At least 1 swollen hand 
or wrist area 
1 NA NA 
Symmetric 
arthritis 
Simultaneous bilateral 
involvement 
1 NA NA 
Rheumatoid 
nodules 
Subcutaneous nodules 
over body 
prominences, extensor 
surfaces, or in juxtra-
articular regions 
observed by physician 
1 NA NA 
Serology  Positive RF serum test 1 Negative RF and 
negative ACPA 
Low-positive RF or 
ACPA 
High-positive RF or 
ACPA 
0 
 
2 
 
3 
Radiographic 
changes 
Erosions-or unequivocal 
bony decalcification in 
or adjacent to the 
involved joints, but not 
consistent with 
osteoarthritis 
1 NA 
 
NA 
Acute-phase 
reactants 
CRP or ESR NA Normal CRP and ESR 
Abnormal CRP or ESR 
0 
1 
Duration of 
symptoms 
First 4 criteria must be 
present for at least 6 
weeks  
NA < 6 weeks 
>6 weeks 
0 
1 
Criteria score 
required 
 > 4/7  >6/10 
Adapted from Aletaha et al. (2010), Symmons et al. (2002).Arnett et al. (1988). ACPA= Anti 
Circullinated Protein Antibody, CRP =C Reactive Protein, ESR= Erythrocyte Sedimentation Rate, 
NA =Not Applicable, RF= Rheumatoid Factor. 
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2.1.5 Risk factors for rheumatoid arthritis  
The epidemiological data on the risk factors of RA suggest that the variation in 
incidence and prevalence of RA reflects the complexity of predisposing factors 
(Rodriguez et al., 2009). The specific cause of RA is yet unknown, however the 
occurrence and expression of RA predisposition may be due to the interaction of 
genetic and environmental factors (Alamanos and Drosos, 2005, Tobon et al., 
2010). The environmental factor of infections, smoking, pollutants and dietary 
factors also play a role (Alamanos and Drosos, 2005, Sugiyama et al., 2010). 
However, the impact of these factors in developing and expression of the 
disease are not yet proven (Alamanos and Drosos, 2005). The following sections 
describe the risk factors that may influence the development of RA or the course 
and severity of the condition.  
1 Genetic Factors 
Epidemiological evidence suggests that genetic factors play an important role in 
the risk of RA (Tobon et al., 2010). In recent years, further evidence of the 
impact and nature of the genetic factors involved in RA has become available, 
although the relationship between the genetic factors and risk of developing RA, 
as well as the severity of the disease, is still uncertain (Alamanos and Drosos, 
2005, Tobon et al., 2010). Studies reported that genetic factors account for 50-
60% of the risk of developing RA and that the main gene associated with RA is 
the human leukocyte antigen (HLA)- class II alleles and particularly with sub 
types HLA-DRB104 (HLA-DR4) which accounts for one third of the genetic 
susceptibility to RA (Aho and Heliovaara, 2004, Scott et al., 2013). The main 
genetic factors associated with development of RA are HLA-DRBI and protein 
tyrosine phosphatase, non-receptor type 22 (PTPN22) (Tobon et al., 2010). 
Genetic predisposition is suggested as homozygous twins are at a higher risk of 
developing RA due to a shared epitope (epitope is the antibody binding site on 
an antigen) (Aho and Heliovaara, 2004, Combe, 2009). Family and twin studies 
found the risks for developing RA in relatives of affected individuals to be 
approximately 50-60% (Alamanos and Drosos, 2005, Pratt et al., 2013, Silman and 
Pearson, 2002).  
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2 Gender and Age  
RA is more common in females than males. The female to male ratio reported in 
studies varies from about 2:1 to 3:1; however the underlying reasons is unknown 
(Kvien et al., 2006, Scott et al., 2013). The higher risk of developing RA among 
females suggests the role of hormonal factors in disease susceptibility. Late 
menarche, 15 years and older, was found to be associated with an increased risk 
of RA (Pedersen et al., 2006). Pregnancy in RA is associated with remission of 
the disease, while in the post-partum period RA may flare up (Aho and 
Heliovaara, 2004, Silman and Pearson, 2002, Tobon et al., 2010). 
There is an increased risk of developing RA in the post-partum period with an 
odds ratio (OR) of 5.6 (95% CI 1.8-17.6) (Alamanos and Drosos, 2005, Scott et al., 
2013). A few studies suggest that the use of oral contraceptives and hormonal 
replacement therapy (HRT) after menopause may be associated with a reduced 
risk of developing RA. However, the role of hormones whether in occurrence of 
RA or as a protective mechanism remain uncertain (Alamanos and Drosos, 2005, 
Tobon et al., 2010). 
3 Socioeconomic Factors 
Socioeconomic status; occupation, level of education, marital status and social 
group are associated with the course and outcome of the disease more than with 
the risk of developing RA (Ahlstrand et al., 2012, Combe, 2009). Low 
socioeconomic status has been associated with rheumatoid factor (RF) positive 
and poor outcomes of the disease in both genders (Pedersen et al., 2006, Scott 
et al., 2011).  
4 Ethnicity 
Several studies reported a difference in susceptibility, clinical expression and 
occurrence of the disease between ethnic and racial groups, which may be 
related to differences in the interactions and distributions of genetic and 
environmental factors including life style (Alamanos and Drosos, 2005, Tobon et 
al., 2010). The risk of RA is high in Native Americans compared with Europeans 
(Molokhia and McKeigue, 2000). In addition, lower prevalence of RA has been 
identified among those from Mediterranean countries, South Asia, China and 
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Japan (Aho and Heliovaara, 2004, Gibofsky, 2012). Migrant studies demonstrated 
low occurrence of RA in migrant populations of African origin living in UK and 
they concluded that the genetic factors were important in predisposing 
individuals to the disease (Silman and Pearson, 2002). However, the role of 
genetic factors in disease susceptibility and severity is not fully explained, the 
variation of the incidence and prevalence of RA in different ethnic is only 
explained partly by genetic variation in the HLA region (Aho and Heliovaara, 
2004, Alamanos and Drosos, 2005, Scott et al., 2013). 
5 Lifestyle factors  
Lifestyle factors such as smoking, alcohol consumption, diet and obesity have 
been found to be associated with an increased risk of RA. The following lifestyle 
factors may influence the development or the course and severity of RA.  
a Smoking 
Smoking is considered to be the main environmental factor associated with RA. 
It has been shown in different cohort studies that smoking unequivocally 
increases the risk of seropositive RA (Scott et al., 2011). The risk of RA increases 
among current smokers, compared to non-smokers, and is also directly related 
to the number of packs smoked per year (Boyer et al., 2011, Hoovestol and 
Mikuls, 2011). Smoking influences the course and the risk of developing RA, and 
is also associated with severity and outcome of RA (Combe, 2009).  
Cigarette smoking duration has a role in disease progression through its 
relationship with rheumatoid factor and radiographic erosion and nodule 
(Combe, 2009). Gene-environment interaction studies reveal an increased risk of 
RA with HLA DR4 alleles susceptibility, in smokers, and those exposed to some 
form of bronchial stress such as Silica (Aho and Heliovaara, 2004, McInnes and 
Schett, 2011). 
b Alcohol  
The association between alcohol and severity of RA is still unclear (Frampton, 
2011). Studies revealed that consumption of alcohol may be protective against 
RA (Hoovestol and Mikuls, 2011, Scott et al., 2011). The risk of developing RA is 
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reduced by half in individuals who drink relatively small amount of alcohol (five 
or less alcoholic drinks/week) compared to those with no alcohol consumption 
(Hoovestol and Mikuls, 2011, Kallberg et al., 2009). In addition, Lu et al. (2014) 
reported that functional status improved with moderate alcohol consumption. 
Conversely, some studies reported no association between the consumption of 
alcohol and presence of RA (Huidekoper et al., 2013). A systematic review by 
Scott et al. (2013) demonstrated that ACPA-positive RA but not ACPA-negative 
RA was inversely associated with alcohol intake. 
c Dietary factors 
Epidemiological studies suggest that lifelong consumption of fish, cooked 
vegetables and olive oil has a protective effect against RA (Tobon et al., 2010). 
Studies indicated that the Mediterranean diet reduces the risk of RA (Aho and 
Heliovaara, 2004, Alamanos and Drosos, 2005). Omega 3 long chain 
polyunsaturated fatty acids from fish and oleic acid from olive oil produce anti-
inflammatory effects that were attributed to their protective role. These 
observations could explain the possible relation between diet and RA, and also 
partly explain the geographical variation of disease occurrence and severity (van 
Breukelen-van der Stoep et al., 2013). 
In addition, low risk of RA has been associated to a high intake of vitamins D and 
C, while vitamin K associated with decreases severity of inflammation in RA 
(Tobon et al., 2010). Retrospective studies found that antioxidant micronutrients 
play an important role in protecting against RA (Aho and Heliovaara, 2004, 
Hoovestol and Mikuls, 2011). An observational study reported that coffee intake 
was associated with higher risk of developing RA (Pedersen et al., 2006).  
d Obesity  
Obesity is associated with increased risk of developing RA and this risk is higher 
in those with morbid obesity (BMI more than 30) (Crowson et al., 2013, Scott et 
al., 2011). The risk of developing anti-citrullinated protein antibodies (ACPAs) at 
age 55 years and younger was (hazard ratio 1.45, 1.03-2.03) for overweight 
women and (1.65, 1.34-2.05) for obese women (P≤ 0.001) (Lu et al., 2014).  
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6 Environmental factors 
Genetic and environment interaction plays an important role in the development 
of RA (Pratt et al., 2009, Scott et al., 2011, Hoovestol and Mikuls, 2011). The 
following environmental factors may also influence the development or the 
course and severity of RA.  
a Pollutants 
There is a reported increased risk of RA among women living within 50 meters of 
a road, in comparison to those living 200 meters or more away from the road 
(Gabriel and Michaud, 2009). Exposure to traffic pollution may therefore be an 
environmental risk of developing RA (Shapira et al., 2010).  
b Early environmental factors and birth weight 
Early environmental factors could influence the risk of developing RA, for 
example, birth weight greater than 4.54 kg has been associated with a two-fold 
increase risk of developing RA (Scott et al., 2011). Breast-feeding and infections 
in infancy were found to be protective against RA (Scott et al., 2011, Tobon et 
al., 2010). In addition, breast feeding duration was found to be inversely related 
to RA risk (Scott et al., 2011). The meta-analysis of Chen et al. (2015) suggests 
that breastfeeding is associated with a lower risk of RA, regardless of whether 
the duration is shorter or longer than 12 months. 
c Infectious agents 
Infectious agents have been identified as risk factors of RA; however the 
underlying mechanism is unknown (McInnes and Schett, 2011). Immune complex 
formation in periods of infection may play a role in the induction of Rheumatoid 
Factor (RF). In addition, recent evidence suggests that gastrointestinal 
microbiomes influence the development of autoimmunity and emergence of RA 
(Alamanos and Drosos, 2005, McInnes and Schett, 2011). Epstein-Barr virus, 
borrelia, burgdorferi, rubella, parvovirus, and some bacteria, such as proteus 
and mycoplasma are infectious agents that have been implicated in RA disease 
development (Gibofsky, 2012, Silman and Pearson, 2002, Tobon et al., 2010). 
Porphyromonas gingivalis is a bacterial pathogen causing periodontal disease and 
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it has been reported that periodontal disease is more common in people with RA 
(Hoovestol and Mikuls, 2011, Scott et al., 2011).  
2.1.6 Clinical features of rheumatoid arthritis  
The most common symptoms of RA are symmetric swelling of the small joints 
associated with pain and/or morning stiffness of more than 30 minutes (Combe, 
2009, Knittle et al., 2011). Typically RA presents with joint pain and stiffness in 
multiple joints with the proximal interphalangeal joints, metacarpo-phalangeal 
joints and wrists most commonly involved (Wasserman, 2011). In addition, 
patients may suffer from fatigue; psychological stress and disability, which 
affect their ability to perform their normal activities of daily living (ADL) and 
work (Ahlstrand et al., 2012, Combe, 2009). Other presentations include 
polymyalgia like onset (polymyalgia is an inflammatory condition that causes 
pain and stiffness; it mostly affects the shoulders and neck),low grade fever, 
weight loss and malaise which can be associated with extra-articular 
manifestations (Young and Huizinga, 2009) such as pulmonary fibrosis, vasculitis, 
Sjögren's syndrome, and pulmonary nodules (Cojocaru et al., 2010). 
2.1.7 Differential diagnosis of rheumatoid arthritis 
There is a wide spectrum of disease characterized by joint swelling, and it is 
often difficult to distinguish early RA from other arthritis related conditions such 
as SLE (Systemic Lupus Erythematous) and psoriatic arthritis. A detailed history 
which includes joint assessments, laboratory and imaging findings are required 
to reach a diagnosis of RA (Aletaha et al., 2010, Pratt et al., 2009), Figure 2-4 
shown the classification of arthritis. 
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Figure 2-4 Classification of arthritis 
http://doctorsgates.blogspot.co.uk/2010/12/classification-of-inflammatory.html, 14/02/2017 08:18 
pm 
2.1.8 The course of rheumatoid arthritis 
The clinical course of RA is characterized by the remission and flare-up of 
disease. The follow-up of patients with radiological and laboratory investigations 
can indicate the disease process and also help to predict the outcome of the 
disease. Adequate treatment and early diagnosis may alter the disease (Combe, 
2009, Young and Huizinga, 2009). Identification and treatment of RA at an 
earlier stage can affect the disease course and the outcomes. It prevents the 
development of joint erosions or retards the progression of erosive disease 
(Heidari, 2011). In addition, the Scottish early RA study reported that those 
newly diagnosed with RA showed significant improvements in disease activity, 
functional ability and quality of life after treatment (Dale et al., 2016). 
However, people with RA may experience high rates of psychiatric morbidity 
such as anxiety and depression and also employment rates reduced after 
diagnosis (Dale et al., 2016). Thus, RA affects people in many domains of life 
such as physical, psychological and social, therefore early diagnosis and 
management of RA needs to include these aspects (Al-Fadl et al., 2014). 
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2.2 Cardiovascular risk in rheumatoid arthritis 
Studies have reported that the risk of heart failure, myocardial infarction and CV 
death among people with RA is 2-3 fold greater than the general population 
(Boyer et al., 2011). The high levels of CVD are not fully explained by traditional 
CV risk factors (Houri Levi et al., 2016, Kaplan, 2006, Kremers et al., 2008) and 
further studies have been recommended in order to develop an accurate 
estimation of CV risk in people with RA (Liao and Solomon, 2013). A large 
population-based cohort study using data from the UK Biobank found that 
participants who reported RA were more likely to have CVD than non-RA 
participants (OR 1.52, 95% CI 1.39 to 1.67) (Siebert et al., 2016).  
Studies have revealed strong positive associations between high BMI 
measurements and CVD risk factors, such as diastolic hypertension and 
hypercholesterolemia in RA patients (Summers et al., 2008, Paniagua et al., 
2008). Conversely, a low BMI in people with RA is an important indicator of the 
high risk of CVD mortality in people with RA, possibly due to high systemic 
inflammatory activity among people with low BMI (Kremers et al., 2008). This 
finding supports the hypothesis which states that inflammation is the key to CV 
mortality among people with RA (Escalante et al., 2005, Zegkos et al., 2016). 
van Halm et al. (2009) compared the prevalence of CVD among 294 people with 
RA with normal fasting glucose levels from a CARRE´ study with 194 individuals 
with type II diabetes mellitus (DM) and 258 people without diabetes (control) in 
the Hoorn study. The results demonstrated that the mean WHR was lower in 
individuals with RA 0.88 (SD± 0.08) compared with the non-diabetic controls 0.89 
(SD± 0.08). It is also significantly higher in the diabetic population 0.95 (SD± 
0.08) compared to those with RA. The odds ratio (OR) risk of developing CVD 
among individuals with RA is three times higher than that for non-diabetics and 
2.5 times that of individuals with Type II DM (van Halm et al., 2009). 
The European League Against Rheumatism taskforce recommended screening 
and identification of CVD for all people with RA at least once every 5 years. It 
also recommended a CVD prediction model such as Systematic Coronary Risk 
Evaluation and Framingham (Agca et al., 2016). EULAR attempted to adjust the 
prediction models for RA by a 1.5 multiplication factor when certain RA disease 
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characteristics were present (if two of the three criteria are fulfilled: (1) RA 
disease duration >10 years, (2) presence of RF or ACPA and (3) presence of 
severe extra-articular manifestations) (Agca et al., 2016). However, several 
studies found that the EULAR recommendations were ineffective. The CV risk 
score in RA seems to be underestimated even after the correction is applied 
(Corrales et al., 2014, Karpouzas G., 2013).  
It has been reported that despite an increased incidence of CVD among people 
with RA, health providers fail to identify CVD risk (Bartels et al., 2016). Further 
prospective studies have been recommended in order to evaluate the impact of 
traditional risk factors on the CV risk in RA, and also to identify the most 
appropriate management of CVD among RA sufferers (Zegkos et al., 2016). 
A cohort of 603 people with RA with a mean age of 58 years, of which 73% were 
female, were followed up for 15 years. During that time period, 176 patients 
died from CVD. Multivariable Cox regression analyses, controlled for 
cardiovascular risk factors and comorbidities, were used to estimate the risk of 
CV death, which was found to be significantly higher among people with RA 
vasculitis (HR 2.41, 95% CI 1.00-5.81) and RA lung disease (HR 2.32, 95% CI 1.11-
4.84) (Maradit-Kremers et al., 2005). 
People with RA sometimes manifest with CVD even before they fulfil the criteria 
for RA (Kremers et al., 2008). They are at double the risk of sudden death 
compared to the general population. Therefore, asymptomatic people with RA, 
who are at high risk may be potentially benefit from primary prevention (Cooney 
et al., 2011, Kaplan, 2006). Kremers et al. (2008) reported that CV risk is high in 
people with newly diagnosed RA; and one aim of management should be to 
detect and prevent CV disease as early as possible. However, Innala et al. (2011) 
reported that the CV events in early RA could explain by modifiable risk factors 
(explained below). Risk factors can be defined as any factors that increase the 
likelihood of developing a disease or injury, and can be modifiable or non-
modifiable (World Heart Federation, 2017a). The following are the modifiable 
and non-modifiable risk factors that could influence the risk of developing CVD 
in general population as well as RA. 
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2.2.1 Modifiable risks factors for cardiovascular disease 
Modifiable risk factors are defined as factors that increase the risk of morbidity 
and mortality where the means to reduce them are known and can be controlled 
(World Health Organization, 2009). Physical inactivity, sedentary behaviour, 
smoking and diets rich in saturated fats, are examples of modifiable risk factors 
that need to be mitigated by preventive action (Maruthur et al., 2009, World 
Heart Federation, 2017a). The seven risk factors are discussed below.  
1 Low levels of physical activity 
Reduced physical activity is the key risk factor for a chronic condition such as 
CVD, and other conditions such as diabetes and dyslipidemia, and it is one of the 
top 10 leading risk factors for mortality worldwide (World Health Organization, 
2015). Efforts to promote PA have led to significant improvement in health 
outcomes and have reduced relative risk of CVD by 20-35 % in the general 
population (Kokkinos, 2012, Warburton et al., 2006). Regular PA can reduce the 
risks of morbidity and mortality associated with numerous conditions such as 
CVD, hypertension and DM and also may help to improve joints and maintain 
muscle strength in the general population (UK physical activity guidelines, 2011). 
Adherence to a regular PA is associated with a low risk of sudden cardiac death 
(Chiuve et al., 2011, Greenland et al., 2010).  
2 Unhealthy diet 
High dietary intake of saturated fat, salt, and low intake of fruit and vegetables 
are linked to cardiovascular risk, with a strong relationship between the quality 
of diet and the risk of CVD in the general population (Dehghan et al., 2012, 
World Health Organization, 2014). A diet rich with fruit and vegetable reduced 
the risk of recurrent CVD events in people aged 55 years or over who were 
diagnosed with CVD (Dehghan et al., 2012). There is an association between the 
Mediterranean diet (high fruit, vegetables, legumes and cereals consumption, 
less red meat, more ﬁsh and olive oil or vegetable oil) and a reduction in the risk 
of CVD in the general population (Agca et al., 2016). Although there is a lack of 
evidence regarding the role of diet on CVD in RA, a healthy diet is recommended 
as part of a healthy lifestyle (Agca et al., 2016).  
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3 Smoking  
As early as the 1950s studies reported that there is strong association between 
cigarette smoke exposure and heart disease. Consuming more than 20 cigarettes 
daily leads to a 2- to 3-fold increase in heart disease (Rea et al., 2002). Smoking 
is considered one of the modifiable risk factors that increase the risk of CVD in 
the general population (Liao and Solomon, 2013), in both women and men 
(Huxley and Woodward, 2011). Although the evidence suggests that smoking 
increases the risk of CVD in the general population, the effect of smoking in 
those with RA remains uncertain. A meta-analysis data of 4 studies out of 10 
found an association between smoking and CV risk in people with RA (RR 1.50, 
95% CI 1.15, 1.84), indicating a 50% increased risk of a CV event in smokers with 
RA compared to non-smoking RA patients (Baghdadi et al., 2015). However, the 
causal link between smoking and CV events in RA has not yet been identified. 
4 Obesity  
Obesity is associated with elevated vascular risk in population studies. Those 
with a body mass index (BMI) >30kg/m2 (van Halm et al., 2009) or low 
BMI<20kg/m2 are at increased risk of developing heart disease compared with 
health individuals (del Rincon et al., 2001, Kremers et al., 2008). Also, a high 
waist-to-hip ratio (WHR) could increase the risk of CVD in people with RA (van 
Halm et al., 2009). Abnormal body fat composition can lead to increased levels 
of CRP in RA adipose tissue; this is considered to be a source of inflammatory 
cytokines that induce the hepatic production of CRP (Liao and Solomon, 2013).  
A review by Baghdadi et al. (2015) reported a 16% higher incidence of CV 
morbidity in obese RA people compared to non-obese RA people. In addition, 
obesity is a major predicator of CV events and type II diabetes mellitus (DM) in 
non-RA patients. However, people with RA and with a low BMI are also at risk of 
CVD due to loss of body cell mass, known as rheumatoid cachexia which is 
frequently accompanied by inflammatory disease activity, excess production of 
cytokines and increased risk of CVD (Boyer et al., 2011, Zegkos et al., 2016). 
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5 Hypertension 
Hypertension is defined as an average systolic blood pressure (SBP) ≥140 mmHg, 
an average diastolic blood pressure(DBP) ≥90 mmHg, or taking medication for 
elevated blood pressure (Centers for Disease Control and prevention, 2016a). In 
the Framingham Heart Study, even high-normal blood pressure (which was 
defined as a SBP of 130-139 mmHg, DBP of 85-89 mmHg, or both or taking 
medication for elevated blood pressure levels) increased the risk of CVD 2-fold, 
compared with healthy individuals (Kannel, 2009). Hypertension contributes to 
the increases risk of CVD in the general population as well as in RA (Liao and 
Solomon, 2013). Individuals with RA and hypertension (RR of 2.24, 95% CI 1.42- 
3.06) are at two times greater risk of CVD than non-hypertensive individuals 
(Baghdadi et al., 2015, Innala et al., 2011). Siebert et al. (2016) reported 
participants with RA were more likely to have hypertension than people without 
RA (OR 1.19, 95% CI 1.21-1.27). 
6 Metabolic syndrome 
Metabolic syndrome is characterized by a group of medical conditions that 
contribute to the risk for both heart disease and type II DM. In the Kuopio 
ischemic heart disease risk factor study, people with metabolic syndrome had 
significantly higher rates of CVD, coronary, and all-cause mortality (Grundy et 
al., 2005, Lakka et al., 2002). There is an increased prevalence of metabolic 
syndrome in people with long term RA of about 43% more than the general 
population (Pamuk et al., 2006) and greater insulin resistance among RA people 
who carotid plaques (La Montagna et al., 2007). It has been reported that the 
use of some medications such as antihypertensive drugs and glucocorticoids, 
were correlated with glucose metabolism effect in people with RA (Dessein et 
al., 2006). 
7 Diabetes  
Diabetes mellitus (DM) is defined as fasting plasma glucose >7 mmol/L or 
treatment with hypoglycaemic agents (Howard et al., 2002). People with 
diabetes are 2-8 times more likely to experience CV events than age-matched 
and ethnically matched individuals without diabetes (Howard et al., 2002). The 
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risk of CV events was increased among people with RA who have type II DM (RR 
1.94, 95% CI 1.58-2.30) (Baghdadi et al., 2015). 
2.2.2 Non modifiable risk factors for cardiovascular disease  
Non-modifiable risk factors can be defined as factors that increase the risk of 
mortality and morbidity from disease; however, they cannot be changed or 
controlled (World Heart Federation, 2017a). The non- modifiable risk factors for 
CVD are discussed below. 
1 Age 
The risk of developing heart disease increases with age in RA (Kaplan, 2010). 
Men aged over 45 years and women greater than 55 years are at risk of 
developing CVD in general population (del Rincon et al., 2001, Kremers et al., 
2008). 
2 Gender 
There is an increased risk of developing CVD among men compared to pre-
menopausal women in general population. However, women tend to develop 
CVD later in life than men (Peters et al., 2016). This is likely to be due to sex-
specific biological factors, such as hormones and fat distribution, as well as 
behavioural, social and cultural factors related to risk behaviours, and gender 
disparities in access and usage of health services (Peters et al., 2016). 
3 Family history of early heart disease 
A family history of heart disease is considered one of the risk factors in 
increasing the risk of developing CVD in the general population (del Rincon et 
al., 2001, Kremers et al., 2008). A first-degree family history of CVD or stroke 
before the age of 55 years for men or 65 years for women increases the risk of 
CVD in the general population (World Heart Federation, 2017b). 
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4 Race 
It has been noted that the risk of CVD is higher among African Americans 
diagnosed with RA (29.7%) than other connective tissue disease (CTD) (14.7%) 
(Alenghat, 2016). 
The clinical manifestation of atherosclerosis is mainly CVD and coronary heart 
disease. The following are possible mechanisms that may explain the high 
prevalence of atherosclerosis in people with RA.   
2.2.3 Possible mechanisms of atherosclerosis in rheumatoid 
arthritis 
1 Chronic systemic inflammation on vascular endothelium  
Inflammation in RA centres around the synovium which may play an indirect role 
through spill of inflammation mediators into the systemic circulation which can 
then interact with endothelial cells, altering their function and leading to 
atherosclerosis (Cooney et al., 2011). Inflammation in RA is associated with high 
concentrations of interleukin IL-1, IL-6 and tumor necrosis factor alpha (TNFα), 
two of the central cytokines resulting in high C reactive protein (CRP). The 
effects of these cytokines on endothelial cells may enhance the atherosclerotic 
process; increase their permeability, facilitating migration of inflammatory cells 
to vessel walls and up regulating inflammatory response to express adhesion 
molecules (del Rincon et al., 2001, Metsios et al., 2009, Pieringer and Pichler, 
2011).  
2 Atherogenic side effects of some anti-rheumatic medications  
In addition, to the inflammatory phenomena, some anti-rheumatic treatment 
may play a role in predisposing individuals to atherosclerosis. For example, 
disease modifying anti-inflammatory drugs (DMARDs) such as Methotrexate (MTX) 
could lead to high plasma homocysteine (hyperhomocysteinemia) (van Ede et 
al., 2002), which is associated with atherothrombosis (Boers, 2000). However,  
studies by Nurmohamed (2009), Westlake et al. (2010) & Marks and Edwards 
(2012) demonstrate that MTX use is associated with a reduced risk of CVD 
morbidity and mortality in people with RA and may also reduce atherosclerosis. 
Glucocorticoids affect glucose metabolism and could contributed to the higher 
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prevalence of metabolic disorder in people with RA (Boyer et al., 2011). EULAR 
guidelines recommend the prescribing the lowest dose of glucocorticoids for the 
shortest duration (Peters et al., 2010). 
However, the questionnaires in standard monitoring of people with RA (QUEST-
RA) undertaken by Naranjo et al. (2008), which analysed data from 15 countries 
and 4363 participants demonstrated that even long-term use of medication such 
as sulfasalazine, leflunomide, and methotrexate is associated with a lower risk 
of CV disease among people with RA. The risk of CVD was reduced in people with 
RA treated with TNFα blocking agents, while controlling inflammation and 
decreasing risk of plaque formation (Solomon et al., 2013). However, the 
beneficial effects of the use of biological drugs such as anti-TNF-α therapy 
should be administered with caution in people who have been diagnosed with 
moderate or severe heart failure, as it could worsen the condition (Listing et al., 
2008). 
In addition, non-steroidal anti-inflammatory (NSAIDS) and cyclo-oxygenase 
inhibitors (COXIBS) are associated with a twofold increased risk of CV risk 
(especially myocardial infarction) (Nurmohamed, 2009, van Breukelen-van der 
Stoep et al., 2013).  
Nevertheless, the findings of studies investigating the association between CV 
events and corticosteroid use are contradictory, since some studies have been 
unable to demonstrate an association between steroid use and CV mortality 
among people with RA (del Rincon et al., 2001). A systematic review carried out 
by Ruyssen-Witrand et al. (2011) included 1138 screened reports and 37 items of 
literature assessing the risk of CV in low dose corticosteroid (LDCs) to treat RA. 
LDCs were associated with major CV events in four studies out of six.  
2.2.4 Pattern of CVD in patients with rheumatoid arthritis 
Studies have suggested that the rate of myocardial infarction and stroke is 
doubled and the rate of sudden death increased in people with RA (Gonzalez et 
al., 2007, Kremers et al., 2008, Liao et al., 2015). The prevalence of ischemic 
heart disease (IHD) was higher among people with RA in comparison to healthy 
control (Gonzalez et al., 2007, Kremers et al., 2008, Liao et al., 2015).  
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In addition, the absolute risk of CV events such as myocardial infarction and 
heart failure among people with RA was found to be 49.5 per 1000 person-years 
and among non-RA was 31.7 per 1000 person-years in populations which were 
age and sex matched (Kremers et al., 2008). It has been reported that the CVD 
events in people with RA is higher in young adults and those without known have 
prior CVD events (Solomon et al., 2006). 
People with RA who are physically inactive have a worse CVD profile than people 
with RA who are physically active (Metsios et al., 2009). European league against 
Rheumatism.(2009) recommended healthy lifestyle with promotion of PA among 
people with RA in order to reduce the risk of CVD and improve the health 
outcomes (Zegkos et al., 2016). The following section discusses physical activity, 
guidelines, benefits and its effects generally and in people with RA.  
2.3 Physical activity (PA) 
2.3.1 Definition of physical activity  
Physical activity is defined as “any type of bodily movement produced by 
muscles that results in energy expenditure”(World Health Organization, 2015). 
Housework, gardening, walking, climbing stairs are examples of PA (Public 
Health England, 2016, Miles and British Nutrition Foundation, 2007). PA includes 
all body movement produced by skeletal muscles to improve functional ability, 
retain quality of life or slow deterioration of health (Plasqui, 2008). Exercise is a 
specific form of PA in that it is planned, structural and repetitive bodily 
movement, performed with the intention of acquiring fitness, such as swimming, 
and yoga (World Health Organization, 2015).  
2.3.2 The benefits of physical activity in the general population 
and in people with rheumatoid arthritis 
1 The benefits of physical activity in the general population 
There is good evidence to show that PA plays an important role in improving 
health outcomes and reducing morbidity and mortality in the general population 
(Warburton et al., 2006). The UK physical activity guidelines (2011) demonstrate 
that PA is the key determinant for preventing and reducing the consequences of 
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non-communicable diseases. PA is important for reducing and preventing a 
number of conditions such as hypertension, diabetes, coronary heart disease, 
depression, hip fracture, cancers and all-cause mortality (Hamilton et al., 2008, 
Macera et al., 2003). Regular PA plays an important role in reducing the risk of 
hip fractures by up to 68%, depression 30%, CVD 35% and all causes of mortality 
30% (Public Health England, 2016). PA is an essential component of a healthy 
life, and it also has a role in improving mental health and mood (Hamilton et al., 
2008).  
PA is characterized and described in terms of frequency, intensity and duration. 
Frequency is defined as the number of times an activity is performed in a given 
time frame (Hamilton et al., 2008, Macera et al., 2003). Duration refers to total 
amount of time which the activity is performed either accumulative or 
continuously over specified of time. Intensity is defined as that energy 
expenditure during specific activity and usually is measured in metabolic 
equivalents (METs) (Khoja et al., 2016). A study involving 77,782 participants 
followed up healthy women for 24 years in relation to their lifestyle including 
moderate, vigorous and low levels of PA, and showed that 1790 died from CVD 
and 4527 died from cancer; 47% to 62% of the deaths were correlated with being 
overweight, physically inactive and having an unhealthy diet (van Dam et al., 
2008).  
Moreau et al. (2001) demonstrated that over a 24-week walking programme, 
women who increased their step count by 4330 steps/day above baseline 
reduced their systolic blood pressure (SBP) by 11mmHg and body mass reduced 
by 1.3 kg. A study carried out by Teh et al. (2015) on healthy individuals found 
that SBP levels were negatively associated with PA levels (P = 0.032) but not 
diastolic blood pressure (DBP) levels. However, no dose response was found 
between PA and blood pressure. A reduction in SBP and DBP was seen at 12 
weeks and 12 months in men in the intervention group in an RCT conducted 
by  Hunt et al. (2014). The participants of Hunt et al.' study took part in a 
walking programme delivered as part of a healthy lifestyle programme at 
professional football clubs.  
A RCT by Baker et al. (2008a), involved 16 healthy men and 63 women, the mean 
age was 49.2 years ± 8.8. The intervention group received a PA consultation and 
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a 12-week pedometer-based walking programme with no programme for the 
control group. The results demonstrated an increased step count in the 
intervention group from baseline (6802 ± 3212) to (9977 ± 4669) steps/day 
(46.7%) at 12 weeks (P<0 .001) and time spent in leisure walking (P=0.02). In 
addition, the weekday and weekend sedentary times were reduced, as measure 
by the self-reported method international physical activity questionnaires 
(IPAQ). However, no changes were noted in health outcome measures in either 
group. This could be due to intensity of walking being too low, or the duration of 
study (12 weeks) being insufficient for physiological changes to take place.  
It revealed that PA plays an important role in improving CV profile. In studies by 
Loprinzi and Ramulu (2013) and Healy et al. (2015), a significant association was 
found between light-intensity PA, low inflammatory markers and blood glucose 
in adults with diabetes mellitus. A cross-sectional study of Teh et al. (2015) 
reported a significant dose response between blood glucose and PA (P= 0.04). 
Also, a large cohort study carried out in the United States among more than 
70,000 healthy women aged 40-65 years reported that brisk walking and more 
vigorous exercise were associated with a 25% reduction in diabetes incidence (Hu 
et al., 1999).  
2 The benefits of physical activity in people with rheumatoid arthritis 
An increase in PA may be beneficial to those with RA, as previous evidence has 
revealed that people with RA are less active than the general population 
(Cooney et al., 2011, Esbensen et al., 2015). Increasing PA in those with RA may 
help with symptoms such as muscle weakness, poor mobility and physical 
function, without damaging the joints or exacerbating rheumatoid disease 
activity (Cooney et al., 2011). People with RA who are physically active have 
improved RA symptoms such as pain and fatigue, which conversely are 
considered the primary barriers to PA in RA sufferers (Veldhuijzen van Zanten et 
al., 2015). 
A study by Khoja et al. (2016) on RA reported that very light, light and moderate 
intensity PA was significant associated with lower functional disability, SBP, DBP, 
and BMI, and improved insulin sensitivity and HDL (P < 0.05). A study done by 
Stavropoulos-Kalinoglou et al. (2013) reported that CVD was reduced in RA 
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cohorts who participated in programmes of 6 months of high intensity exercise. 
Another study showed a reduction in risk of CVD by 20-30% among women and 
men who engaged in high levels of leisure time PA, while moderate leisure time 
PA decreased CVD risk by 10-20% (Li and Siegrist, 2012). A review of RCTs by 
Metsios et al. (2009) demonstrated a reduced risk of developing CVD and 
improved functional capacity in RA cohorts who were physically active. Thus, 
physical activity may play a role in reducing CVD in people with RA; however, 
walking is a simple and inexpensive PA. There is a lack of studies that examine 
the effect of walking on CVD risk, therefore the WARA intervention was 
designed. 
The most important factors for maintaining health and improving physical 
function in people with RA are aerobic physical exercise and muscle strength 
training, along with psychosocial factors (Tierney et al., 2012). Exercise whether 
aerobic or strengthening has positive effect on RA disease progress, range of 
motion, muscle mass quality of life and functional capacity (Plasqui, 2008). The 
combination of increased PA and effective medication may help to inhibit 
disease progression, improve quality of life and health outcomes (Metsios et al., 
2011).  
The benefits of PA were identified from both quantitative and qualitative studies 
that reported improvements in joint function, pain relief, a feeling of 
independence and taking control (van Zanten et al., 2015).  
It was concluded that PA is important for improving arthritis symptoms and 
mental health, and reducing the risk of CVD. It was recommended that support 
was given to people with RA to overcome their PA barriers. Support from friends, 
family and health providers was found to be an important facilitator of PA, as 
was education about the importance and benefits of being physically active for 
people with RA (van Zanten et al., 2015). 
2.3.3 Physical activity guidelines 
According to the UK physical activity guidelines (2011), Public Health England 
(2016), Start active stay active (2011) it is recommended that adults (19 to 64 
years) and older adults (65 years and more), undertake 150 minutes of moderate 
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intensity PA per week (equivalent to 2½ hours of moderately intense PA of 10 
minutes bouts or more, which could be achieved with 30 minutes’ exercise 5 
days per week), for general health and to reduce the risk of cardio-metabolic 
disease. However, for older adults any amount of PA is better than none, and 
greater PA results in better physical and cognitive function. In addition, the 
physical activity guidelines recommended undertaking PA to improve muscle 
strength on at least two days of the week (UK physical activity guidelines, 2011). 
This is particularly important in the context of RA to help preserve muscle mass 
and function (Plasqui, 2008). 
For adults a target of 10,000 steps per day has been widely adopted as a 
reasonable estimate of an appropriate level of daily activity (Hardeman et al., 
2009). Studies reveal that 10,000 steps/day are associated with good health 
(Choi et al., 2007, Tudor-Locke and Bassett, 2004, Tudor-Locke and Rowe, 
2012). Moderate intensity walking is approximately 1000 steps in 10 minutes i.e. 
a cadence of 100 steps/ minute (Harris et al., 2013). However, 10,000 steps per 
day may not be possible for older adults and people who have chronic conditions 
(Tudor-Locke and Bassett, 2004), therefore, any amount of PA is better than 
none (UK physical activity guidelines, 2011). 
The 2015 update of the 2009 EULAR recommendations for CVD risk management 
(Nurmohamed, 2015)in inflammatory joint disease (IJD) recommended a healthy 
lifestyle for people with RA, with an emphasis on the benefits of a healthy diet, 
regular exercise and smoking cessation. To date, there is no evidence that 
exercise has any detrimental effects on people with RA and it should be 
encouraged in people with RA (Agca et al., 2016).  
2.4 Habitual physical activity in rheumatoid arthritis 
This section will present an overview of physical activity levels in people with 
RA. It will then present a critical appraisal of interventional studies aiming to 
increase PA in people with RA.  
Many studies have been carried out to examine the level of PA in people with RA 
either objective, subjective or both. Observational data reports that over two-
thirds of people with RA in the UK are physically inactive in comparison with the 
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healthy population (Cooney et al., 2011, Esbensen et al., 2015). It has been 
identified that RA has negative consequences on individual lives, both physically 
and psychologically, and exercise programmes for people with RA should include 
strengthening and stretching exercises, as well as exercises of moderate 
intensity (Cooney et al., 2011). When PA was encouraged in people with RA in 
the lowest quartile in terms of physical function, the highest physical 
improvements were noted (Feinglass et al., 2012).  
A cross-sectional study used data from two RA cohorts collected from two 
research studies carried out at the University of Pittsburgh between 2007 and 
2013. PA was measured using Sensewear Armband accelerometers (Khoja et al., 
2016). Ninety-eight participants mean age 58 ± 9 years with disease duration 
ranging from 6 to 22 years were included in the study, 85% of which were 
female. Sedentary behaviour was defined as activities that needed up to 1 
metabolic equivalents (METs); very light intensity represented activities that 
required between 1.1 and 1.9 METs, light intensity was activities between 2.0 
and 2.9 METs, whereas moderate intensity represented activities ≥3.0 METs. 
Watching TV, reading, or working at a computer were examples of sedentary 
behaviour; washing dishes, cleaning windows, or folding laundry were the 
examples of very light intensity; lawn-mowing, vacuuming, and slow walking 
were examples of light intensity; and swimming, brisk walking, or playing golf 
were examples of moderate intensity (Khoja et al., 2016). 
The results showed that 17% were physical active (as defined by ≥150 
minutes/week of moderate PA in 10-minute bouts), and that the mean sedentary 
time across the cohort was 9.8 hours/day. Participants spent on average 3.5 
hours/day engaged in very light PA, light PA 2.1 hours/day, and 35 minutes/day 
engaged in moderate PA. It concluded that people with RA were mainly active at 
light and very light intensities PA.  
In addition, a cross-sectional study was conducted by Paul et al. (2014) involving 
19 people with RA and 19 controls, matched in terms of age, sex and BMI. The 
mean age of RA group was 51 ± 12.5 years and the control group was 49.6 ± 12.5 
years, the disease duration was 13.6 ± 9.3 years. PA monitoring was undertaken 
for five days using an activPALTM device. It was demonstrated that people with 
RA exhibited significantly longer periods of sedentary behaviour than the control 
35 
 
group of community dwelling volunteers (P=0.029) with significantly lower levels 
of walking-related PA (6052 ± 1955 steps/day) compared with the control group 
(11,045 ± 4329 steps/day) (P< 0.001).  
A cross-sectional study was carried out with 47 individuals with RA and a mean 
age 56.5 ± 7.0 years. The mean disease duration was 14.3 ± 8.4. PA was 
objectively measured by the Sensewear for 10 consecutive days. It was found 
that the average steps/day were (7151 ± 2637) (Piva et al., 2010). The average 
number of steps/day in Piva et al.’s study was higher than Paul et al.’s study. 
Although both studies were similar in the disease duration and age of the 
participants, the difference in the step results in both studies may be related to 
the cohort sample as Piva et al. only recruited women and also although both 
studies measured PA objectively, the activPAlTM is more accurate and valid than 
the Sensewear in assessing PA (Mahendran et al., 2016).  
Furthermore, a case control study of 110 people with RA with disease duration 
9.3 ±7.6 years and 440 age and sex matched controls used a self-reported PA 
frequency questionnaire to assess the energy expenditure of participants 
(Henchoz et al., 2012). Sedentariness was defined as spending less than 10% of 
total energy expenditure in moderate or high PA. People with RA had lower 
energy expenditure (2392kcal/day) compared with controls (2494 kcal/day) 
(P=0.003), resulting from engaging in less moderate-intensity PA (P=0.015). 
Sedentariness was also associated with poor clinical scores in RA (Henchoz et al., 
2012). The result of Henchoz et al.’s study supported the findings of Khoja et al 
as discussed above. People with RA spend less time on moderate-intensity PA; 
however, the studies differed in their way of measuring PA as Khoja et al. 
assessed it with an objective measure and Henchoz et al used a subjective 
measure.  
Additionally, although there was a difference in the mean disease duration of 
Wikstrom et al.’s study (less than 6 years) and Henchoz et al.’s study (up to 16.9 
years) both studies measured PA subjectively and PA has been found to be lower 
in RA irrespective of the disease duration.  
A review aimed to examine the PA level, energy expenditure and aerobic 
capacity of people with RA (Munsterman et al., 2012). The review included 12 
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studies, 10 cross-sectional studies and 2 cohort studies. PA levels were assessed 
with self-reported questionnaires, either the Paffenbarger questionnaire, 
modified versions of the Paffenbarger Questionnaire, or the Short Questionnaire 
to Assess Health Enhancing PA (SQUASH). Aerobic capacity was measured with 
VO2Max and PA energy expenditure (PAEE) was also calculated. People with RA 
were less physically active compared with healthy people, and had significantly 
lower energy expenditure, lower aerobic capacity than the normative values and 
also they spent less time on vigorous PA than the healthy controls (Munsterman 
et al., 2012). Thus, people with RA were less physically active compared with 
the controls and promotion of PA in people with RA was recommended.  
Despite the differences in methodology, sample size, disease duration and the 
outcome measures, all studies found that, compared to healthy controls, people 
with RA had lower levels of PA, whether in terms of taking few steps, lower 
energy expenditure, lower aerobic capacity or spend less time on moderate and 
vigorous intensity PA. People with RA therefore do not meet the PA guidelines 
(≥150 minutes/week of moderate PA) (UK physical activity guidelines, 2011) and 
the 2015 update of the 2009 EULAR recommendations of regular exercise and 
healthy lifestyle (Agca et al., 2016). Therefore, promoting PA in people with RA 
is recommended in order to improve health outcomes and to reduce the risk of 
comorbidity, particularly CVD (Cooney et al., 2011). 
2.5 Physical activity/ Exercise interventions in 
rheumatoid arthritis 
The following section reviews and describes the evidence for physical activity/ 
exercise interventions in people with RA. The review focuses on studies where 
the intervention mainly promotes PA and aerobic exercise, particularly walking 
and strengthening exercises, and where the primary outcome measure is PA. 
This review was not concerned with other types of exercises such as balance or 
flexibility exercises, or studies where the primary outcome measures are not 
physical activity, for example interventions that aim to manage the symptoms of 
RA. This review was undertaken to identify the effectiveness of PA/exercise in 
people with RA and also to highlight the limitations and evidence gaps in this 
area. The information from this review helped to inform the design of the 
present study.  
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2.5.1 Search strategy 
A literature review provides the background and justification for the research 
and it allows a comparison of past research on PA/exercise for those with RA. In 
order to review literature regarding the effectiveness of PA programmes in 
people with RA on the primary outcome measure (PA behaviour), relevant 
research was identified by searching relevant databases for publications from 
2006 through to 2017. The main search covered the most recent papers; 
however older papers of interest were also included. Relevant papers were also 
identified by reviewing the reference lists (Figure 2-5).                                                
The key articles were obtained primarily from PubMed, Medline, Google Scholar, 
Cochrane Library, and Web Sciences. In order to ensure that relevant studies 
were not missed, the search terms remained broad. These were rheumatoid 
arthritis, physical activity, exercise, walking then these terms were combined 
with the Boolean operator AND “rheumatoid arthritis AND physical activity”, 
“rheumatoid arthritis AND exercise”, “rheumatoid arthritis AND walking”, 
“rheumatoid arthritis AND aerobic exercise”. 
2.5.2 Inclusion and exclusion criteria in the literature review 
To focus the literature review, only randomised clinical trials and controlled 
trials on PA-based interventions or exercise interventions were reviewed. Any 
studies that included balance or flexibility exercises were not included in this 
review. Full articles were retrieved for assessment to determine whether the 
abstract fulfilled the criteria, Figure 2-5 shows the prisma diagram. The 
following criteria were adopted for the exclusion of studies from this literature 
review: Any study involving people diagnosed with arthritis other than 
rheumatoid arthritis; however, if the study examined a mixed population where 
the data from the RA group was reported, it was not excluded. 
Publications in other languages than English 
Trials which were not randomised controlled trials or controlled trials  
Primary outcome other than physical activity/exercise 
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Inaccessible/unpublished studies  
 
Figure 2-5 Prisma diagram of the literature seach 
Adopted from: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 
6(7) (Moher et al., 2009) 
Table 2-2 summarises the 14 articles included in this review. The review of 
previous studies helped to understand the role of PA/exercise intervention in 
terms of the health outcomes, the gap in the research and also the safety of 
exercise in people with RA. In addition, in order to understand the key methods, 
the contradictory findings between studies, their limitations and 
recommendations were also examined. This helped to design the study and 
justify the findings of this thesis. The following information was extracted from 
each article and is included in Table 2-2: study citation, study population, age, 
disease duration, intervention, outcome measures, results and limitations of the 
studies. Although the main searching the databases for publications was from 
Initial search  
n= 1015 articles 
Full-text articles 
excluded, n = 76  
Reasons for exclusions: 
RCTs/controlled trials  
arthritis other than RA 
Primary outcome other 
than PA/exercise 
 
Final inclusion 
n=14 articles 
After duplicates 
removed n= 558 
articles 
Recorded screened 
(title /abstract) 
n= 558 PA/ exercise 
 
Full-text articles 
assessed for eligibility  
n= 90 PA/exercise 
articles and 5 relevant 
papers were identified 
in references lists 
Records excluded  
n = 468   
Reasons for exclusions: 
Publications in other 
languish than English 
Inaccessible/unpublished 
studies  
Studies other than RA 
Juvenile RA 
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2006 through to 2017, one study of interest from 2001 was included. The studies 
were published between 2001 and 2017.  
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Table 2-2 Physical activity / Exercise intervention studies in rheumatoid arthritis 
 
Author and 
design 
Participants Key methods Outcome measure Findings Limitations 
Hakkinen et 
al. (2001) 
RCT, 2yrs 
70 RA 
patients 
Mean age: 49 
± 10yrs 
DD: <2yrs 
62 completed 
the study 
IG: Strength training 
with elastic band 
2times/week also 
patients encouraged 
to perform PA such as 
walking, cycling, 
&swimming 2–3 times/ 
week for 30–45 
minutes. IG minimally 
supervised at-home 
CG: ROM (without 
resistance) 
2times/week  
Both groups 
completed diaries 
(bimonthly) 
Assessed at 0,6,12,18 
months 
Grip strength: 
dynamometer 
FC: HAQ 
DA: DA score 
Walk time: the number 
of seconds /30m 
 
Improved Muscle 
strength in both 
groups 
IG=15-59% 
CG=1-31% 
Improved DA, HAQ 
and walking speed in 
IG 
No negative effect 
of exercise 
The 
participants 
were low 
disease activity 
none of 
participants 
were treated 
with DMARDs 
van den Berg 
et al. (2006) 
RCT, 12 
months 
160 RA 
patients 
Mean age: IG 
49.5 ±12.9 yrs 
&CG 
49.8±13.9yrs 
DD: IG 7.6yrs 
& CG 5.5yrs 
152 
completed 
the study 
 
IG: Muscle 
strengthening, range 
of motion and cycling, 
5 times/week on 5 
days, also an online 
discussion forum 
&face-to-face group 
meetings were held 
every 3 months  
CG: Training delivered 
on a website without 
additional support 
Assessed at 0, 3, 6, 9 
and 12 months 
PA assessed with study 
questionnaire and with 
activity monitor 
(Actilog V3.0) 
Number of days 
participating in vigorous 
exercise for 20-minute 
HAQ, RAQoL &DAS28 
was collected 
 
Greater proportion 
of people in the IG 
were physically 
active than in the 
CG (38% v 22%) at 6 
months increasing 
the number of days 
(at least 3 days) 
participating in 
vigorous intensity PA 
for 20 minutes in IG 
There were no 
Using self-
reported 
questionnaires 
were 
developed 
specifically for 
the study and 
not validated 
for sensitivity 
to change and 
construct 
validity  
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significant 
differences between 
groups regarding 
HAQ, RAQoL or 
DAS28 
Neuberger et 
al. (2007) 
RCT, 12 
weeks 
310 RA 
patient 
Mean age: 
55.5yrs 
40-70yrs 
DD: not 
mentioned 
220 
completed 
the study 
IG: Class exercise, 
home exercise using a 
videotape (Warm-up, 
low-impact aerobics, 
strengthening, and 
cool-down exercises) 
CG: Usual care 
Assessed at 0, 6 & 12 
weeks 
Grip strength: portable 
sphygmomanometer  
Walk time: the number 
of seconds 50 feet 
& VO2max 
Improved 
Grip strength, walk 
time, self-efficacy,  
and Self-efficacy 
influenced exercise 
participation, no 
negative effect of 
exercise 
Convenience 
sample 
Mayoux-
Benhamou et 
al. (2008) 
RCT, 12 
months 
208 RA 
patients  
mean age: 
54.7 ± 13.1yrs 
DD: 12.7 ± 
9.8yrs 
189 
completed 
the study 
IG: Education 
programme (8 weekly 
sessions, totalling 5 
hours) including 
training on home-
based exercises and 
guidelines for leisure 
PA 
CG: Usual care 
Assessed at 0,6 &12 
months 
Baecke questionnaire 
was used to compare PA 
at the baseline and 
follow-up  
Increase adherence 
with PA (particularly 
leisure PA) at 6 
months programmes 
but not 12 months 
Most of the 
participants 
had a long 
disease 
duration and 
had received 
education 
before the 
programme  
de Jong et 
al. (2009) 
RCT,2yrs 
 150 RA 
patients 
Aged:20-70yrs 
DD: 6yrs 
118 
completed 
the study 
IG: Supervised high 
intensity exercise 
programme, 
1.25hrs/session 
CG: Physical therapy 
(usual care) 
Assessed at 0 ,6,12 &24 
months 
Muscle strength with 
dynamometer 
DAS44, disability 
questionnaires 
Participants in IG 
Increased muscle 
strength, physical 
fitness & function 
and reduce disease 
activity 
Participants in 
the IG more 
motivated with 
better 
experience 
with exercise 
and physical 
function   
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Flint-Wagner 
et al. (2009)  
RCT, 
16weeks 
24 RA 
patients 
Mean age: NA 
DD: NA 
24 completed 
the study 
IG: Supervised 
exercise programme 
3times/week 
CG: Usual care 
Assessed at 0, 8 and16 
weeks 
Muscle strength with 
dynamometer, VAS, 
HAQ & 50 feet walk 
time 
Muscle strength 
improved, hand grip 
however reduced in 
CG, improved 50 
feet walk time & 
HAQ & reduced in 
pain 
Small sample 
size 
Hurkmans et 
al. (2010) 
RCT, follow 
up study 24 
months 
152 RA 
patients 
Mean age: IG 
49.5 ±12.9yrs 
& CG 
49.8±13.9yrs 
DD: IG 7.6 & 
CG 5.5yrs 
110 
completed 
the study 
 
IG: Individual 
guidance on PA 
through the website, a 
bicycle ergometer and 
also group contact 
CG: Received general 
information regarding 
PA by Email and the 
website  
Assessed at 24 months 
The PA levels were 
investigated with two 
questionnaires HAQ &  
RAQoL was also 
assessed 
More participants 
met the public 
health 
recommendation of 
moderate-intensity 
PA in the IG than CG 
at 24 months (19% 
and 24% 
retrospectively, P< 
0.05), improved 
RAQoL in IG; no 
improvement in HAQ  
Self-reported 
questionnaires, 
which might 
lead to under 
or 
overestimation 
Selection bias 
in the study as 
only people 
who had access 
to the internet 
were selected 
Breedland et 
al. (2011) 
RCT, 9 weeks 
34 RA 
patients 
Mean age:48 
±11.3yrs  
DD: IG 9.7& 
CG 5.9yrs 
32 completed 
the study 
IG: Supervised aerobic 
(cyclic, jogging) & 
strength exercise plus 
education sessions 
(joint pain, fatigue, 
disease activity, sleep 
disturbance, self-
efficacy) 60 
minutes/weekly 
session 
CG: Usual care 
Assessed at 0,9,13 & 22 
follow-up) weeks 
VO2max, muscle 
strength, arthritis self-
efficacy scale 
Improvement of 
VO2max, physical 
training with self-
management 
education would 
increase physical 
performance, 
improved self-
efficacy 
Small sample 
size 
Brodin et al. 
(2008) 
228 RA 
patients 
IG: Individual coaching 
by a physiotherapist 
Assessed at regular 
medical check-ups 
There was a 
significant 
Convenience 
sample 
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RCT 12 
months’ data 
Sjoquist et 
al. (2011) 
RCT, 24 
months 
Mean age: IG 
55±14.0yrs 
&CG 
57±113.9yrs  
DD: IG 33±4.5 
&CG 34±4.4 
months 
157 
completed 
the study 
during the first year 
with telephone 
support monthly for 12 
months 
CG: Usual care 
Self-reported PA 
questionnaires, visual 
analogue scale to assess 
pain, HAQ & DAS28 
difference between 
groups in terms of 
PA after the one-
year intervention 
(54% versus 44%) (P< 
0.05), improvement 
in muscle strength  
No difference in 
VAS, HAQ&DAS28 at 
24 months in both 
groups 
Dogu et al. 
(2013) 
RCT, 6weeks 
 
52 female RA 
patients 
Aged:40-70yrs 
DD:6.51-
10.65yrs 
47 completed 
the study 
IG 1: Supervised 
isotonic exercise  
IG2: Supervised 
isometric exercise 
 
Assessed at 0 & 6 weeks 
Muscle strength with 
dynamometer 
VAS, DAS28, RAQoL 
Both isotonic and 
isometric increased 
muscle strength, 
quality of life and 
reduce pain & 
disease activity 
Short term 
study 
Stavropoulos-
Kalinoglou et 
al. (2013) 
RCT,6months 
40 RA 
patients 
Mean age: 
53.9±9.9yrs 
DD: 6.0 (4.0–
10.0)yrs 
36 completed 
the study  
 
IG: Individualised 
aerobic and resistance 
high intensity 
exercise, 3times/week 
plus walk on 
treadmill, cycle and 
resistance training 
leg, shoulder & chest 
press. 
CG: Advice on 
exercise benefits and 
lifestyle changes  
Assessed at 0,3 and 6 
months 
IPAQ, VO2max, DAS28, 
HAQ&CVD risk 
Improved IPAQ, 
VO2max, blood 
pressure, lipid 
profile, HAQ, DAS28 
& reduce CVD risk 
Convenience 
sample 
Knittle et al. 
(2015). 
78 RA 
patients 
IG: 5-week motivation 
and behaviour 
Assessed at 0,6 & 32 
weeks 
A significant 
interaction effect 
PA was 
assessed with 
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RCT, 32 
weeks 
Mean age: 
IG60.7 
±11.9yrs &CG 
64.7±11.5yrs 
DD: not 
mentioned 
67 completed 
the study 
programme combined 
with education 
session, one 
motivational interview 
and two self-
regulation coaching 
sessions 
CG: Single education 
session about PA 
exercise  
short questionnaire to 
assess health-enhancing 
PA and number of days 
participating in  
Self-efficacy assessed 
with an 18-item 
questionnaire from 
Badura, (2006); RA 
disease activity index 
and HAQ  
between the IG&CG 
A significant 
increase in leisure 
time PA in IG by 84 
minutes (P=0.022), 
also an increase in 
days/week of 30 
minutes PA 
(P=0.016) and self-
efficacy (P=0.001); 
no significant 
difference in HAQ or 
disease activity in 
either group 
self-reported 
questionnaires 
only  
Orlova et al. 
(2015) 
RCT,6 
months 
51 RA 
patients 
Aged:18-53yrs 
DD:2-
17months 
66.&% of IG1 
completed 
study  
57.1% of IG2 
completed 
study 
IG1: High-intensity 
dynamic exercises 
using gym apparatus 
at hospital. 
IG2: Muscle-
strengthening at 
hospital, therapeutic 
exercises (45 min) 
under the supervision 
of a trainer 
CG: At outpatient 
exercises 3 
times/week a week 
drug therapy 
Assessed at 0,6 
Average power of knee 
extension and ankle 
flexion, VAS, ESR, 
DAS28,HAQ 
Efficacy of the 
intensive gym 
exercises was higher 
than the therapeutic 
exercises  
Improved VAS, HAQ 
Young age 
participants, 
early stage of 
RA, 
participants 
with low 
disease activity  
Seneca et al. 
(2015) 
RCT,12 
weeks 
51 RA 
patients 
Aged:23-79yrs 
DD: ≤ 5yrs 
IG: Six-week 
supervised, 
progressive, high-
intensity exercise 
Assessed at 0, 6 &12 
weeks 
VO2max, DAS28, HAQ, 
muscle strength 
No significant 
differences between 
groups in terms of 
muscle strength, 
Small sample 
size with a 
number of 
dropout in 
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36 completed 
the study 
programme followed 
by a six-week self-
administered exercise 
programme 
CG: A 12-week self-
administered exercise 
programme. 
Both groups: Exercises 
3times/week  
 physical fitness, 
pain or HAQ, there 
was a significant 
differences in DAS28 
score 
remission and 
early disease, 
short term 
study 
IG= intervention group, CG= Control Group, RAQoL= Rheumatoid Arthritis Quality of Life, HAQ= Health Assessment Questionnaire, ROM=Range of Motion 
Exercise, yrs=years, m=meter, NA= Not Available, DD=Disease Duration, CRP= C - Reactive Protein, DA=Disease Activity, DAS= Disease Activity Score, 
VAS=Visual Analogy Scale, RCT= Randomised Clinical Trial, DMARD=Disease Modifying Anti-Rheumatic Drug.
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Generally, sample size varied across the studies. Some studies had a small 
sample size, such as Flint-Wagner et al. (2009) with only 24 RA participants, 
whereas Neuberger et al. (2007) RA cohort numbered 310.  
There were differences in population demographics. Some studies included 
younger participants, such as Orlova et al. (2015) where the participants were 
aged between 18 and 53 years old. The mean age of Hakkinen et al. (2001) study 
was 49 ± 10yrs, and in comparison other studies such as Seneca et al. (2015) 
included participants up to the age of 79 years.  
There was also a different in disease duration between studies. For example, 
Orlova et al. (2015) included participants in the early stage of RA, less than 2 
years from diagnosis, while others included participants with disease duration up 
to 22 years (Mayoux-Benhamou et al., 2008). Many different outcome measures 
have been used across the studies. For example, some studies measured PA with 
self-reported questionnaires developed specifically for the study, while others 
used standard questionnaires, making comparisons difficult. 
The majority of the studies found improvement in PA regardless of the duration 
of the intervention or the intensity of the exercise. The level of description of 
the interventions varied throughout the studies, especially in terms of describing 
the type of exercise included. However, they all agree that exercise (aerobic/ 
strengthening exercise) is effective for people with RA. 
Generally, all studies assessed the participants before and after the intervention 
and a few studies included follow-up after the period of the intervention (12 
months follow-up). However, these studies had high loss to follow-up; for 
example, in Sjoquist et al. (2011) the loss to follow-up was 31% and in Hurkmans 
et al. (2010) it was 28%. 
In general, the intervention was delivered face-to-face and in a few studies the 
intervention was delivered via the internet, as in van den Berg et al. (2006) and 
Hurkmans et al. (2010). 
The majority of the studies were non-blinded RCTs, either assessor or 
participants or both, and this may increase the risk of bias in the results. Most 
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studies made a comparison between the intervention and usual care, with a few 
studies having an attentional control programme for the control group, such as a 
self-administered exercise programme. In the majority of studies, the 
interventions/exercise programmes were done under supervision, and the 
programmes consisted of different types of exercise such as strengthening, 
stretching and aerobic exercises. Therefore, it is difficult to identify the 
particular type and intensity of exercise that helps to improve the PA outcome. 
And also the programmes were delivered to people with RA at different stages of 
disease and disability.   
Almost all of the studies that included strengthening exercises in their 
intervention showed an improvement in muscle strength and hand grip. A few 
studies reported improvement in disease activity; however these studies had a 
small sample size and included early RA patients (Seneca et al., 2015).  
A few studies demonstrated improvement in functional capacity (HAQ). They 
were studies where the examined cohort was in the early stage of RA and had 
low disease activity (Hakkinen et al., 2001) or the programme was supervised 
with intensive intervention and the participants were young, aged between 18 
and 53 years old (Orlova et al., 2015). It seems that PA programmes for people 
with early RA (less than 2 years’ duration) were more effective in improving 
functional capacity. 
Whilst there are a number of studies on the efficacy and effectiveness of 
exercise (resistance, stretching and strengthening exercises) among those with 
RA, and a number of internet-based interventions, there was a lack of group 
education sessions based on behaviour change theory and BCT. Although the 
effectiveness of walking has been revealed and recommended by PA guidelines, 
there is a lack of studies where the intervention was based mainly on a walking 
programme. 
From the 14 studies summarised in Table 2-2, seven studies aimed to promote PA 
in people with RA using mainly physical activity and aerobic exercise, 
particularly walking/strengthening exercises. These are discussed in detail in the 
following section.  
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2.5.3  Physical activity interventions in rheumatoid arthritis 
Physical activity includes all body movement that results in energy expenditure 
such as housework, gardening and walking (Plasqui, 2008). It is important to 
improve functional capacity and health and wellbeing in people with RA (Cooney 
et al., 2011). 
Exercise is a key modifiable factor which may be undertaken alone or in 
combination with other lifestyle changes, to help reduce the risk of a number of 
chronic diseases, such as CVD (From et al., 2013). There are many different 
types of exercise, such as aerobic including walking, strengthening or stretching 
exercises. The most appropriate PA for RA joints is aerobic exercise such as 
walking. It can enhance cartilage integrity and joint lubrication, increase range 
of motion and flexibility in people suffering from RA (Cooney et al., 2011, Pal et 
al., 2009). 
Walking is a perfect PA for the general population, as well as people with RA. It 
is popular, convenient for all ages, requires no specialist skills and has little risk 
of injury (Baxter et al., 2016, Kassavou et al., 2013, Ogilvie et al., 2007). 
Walking can prevent premature mortality and contributes to a healthy lifestyle 
as well as good quality of life in people with RA (Tudor-Locke and Rowe, 2012).  
A randomised control trial was carried out by Baxter et al. (2016) involving 33 RA 
patients and 22 control individuals. The intervention group had instructions on a 
walking route and had to complete the walking circuit three or four times per 
week, while the control group undertook a nutrition education session. The 
intervention group showed improvements in their self-efficacy for PA and 
wellbeing and experienced less pain symptoms compared with the control group; 
as such, it was recommended that walking appeared to be safe, feasible and 
acceptable for people with RA (Baxter et al., 2016).  
Additionally, strengthening exercises can improve the strength of connective 
tissues and increase tendon stiffness (Cooney et al., 2011, Pal et al., 2009). 
Metsios et al. (2008) reported that the combination of aerobic and strengthening 
exercises has been used in an RA exercise regimen to achieve effective 
outcomes. 
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Strengthening exercise is a type of physical exercise that requires the use of 
resistance to induce muscle contraction (Gois et al., 2014). While, stretching 
exercise involves slow and controlled movements through a range of muscle and 
joint motion in order to enhance and maintain range of motion (Page, 2012).  
The following sections discuss seven studies on PA/aerobic exercise in detail. An 
intervention targeting PA in people with RA was undertaken by Mayoux-
Benhamou et al. (2008). The study investigated the effect of education on the 
exercise habits of people with RA. The intervention consisted of an education 
programme (8 weekly sessions, totalling 5 hours) including training on home-
based exercises and guidelines for leisure PA. The content of the first 4 sessions 
was information about RA and its medical management. The other 4 sessions 
discussed the PA programme. These sessions aimed to enhance the positive 
attitudes and beliefs related to PA, and they were conducted by health 
professionals. Also, discussed in the sessions were individual physical and 
psychological barriers to PA, and instruction for the participants on how to 
incorporate moderate intensity PA into their daily lives. All of the 
participants received a booklet about the home-based exercise programme and 
leisure PA recommendations.  
Two hundred and eight participants were followed up after 6 and 12 
months. The adherence with leisure PA was defined by whether the leisure PA 
increased by 20% or more above their baseline. The Baecke questionnaire score 
was used to assess PA. The paper suggested that education programmes for 
people with RA may increase adherence with PA (particularly leisure PA) 
(Mayoux-Benhamou et al., 2008). 
A multicentre RCT investigated the effectiveness of an internet-based PA 
intervention for people with RA (van den Berg et al., 2006). A sample of 160 
participants was randomised into an intervention group (IG) (n=82) and a control 
group (CG) (n=78). The disease duration of the IG was 7.6 years and CG was 5.5 
years. The IG programme was an individual weekly schedule with feedback from 
a physiotherapist through a website PA programme. Both groups were eligible to 
participant in the study if they had a computer with Internet facilities and they 
were able to cycle on a bicycle ergometer.  
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The programme consisted of muscle strengthening exercise, range of motion 
exercises and cycling exercises, 5 times/week on 5 days. The exercises were 
performed in sitting, standing and lying positions in 3 sets of 10 repetitions per 
set; for some exercises, an elastic band was used. Also, there was an online 
discussion forum that enabled the participants to discuss the PA programme with 
other participants. Additionally, face-to-face group meetings were held every 3 
months for a year. The CG programme was training delivered on a website 
without additional support. The intervention (training group) was given 
individual guidance on PA through the website, a bicycle ergometer and also 
group contact. The control group received general information regarding PA by 
Email and the website. The participants were assessed at baseline, and at 3, 6, 9 
and 12 months. The PA level, the primary outcome measure, was measured with 
a questionnaire developed specifically for the study. The participants were 
asked regarding the days participating in moderate and vigorous intensity PA in 
order to identify the proportion of participants who were meeting the Dutch 
public health recommendations for PA. The secondary outcome measure was 
objectively measured PA, which involved an activity monitor (Actilog V3.0) worn 
around the ankle for 5 consecutive days, assessing the number of days spent 
participating in vigorous exercise for 20 minutes. 
Functional capacity was assessed with the HAQ, RA quality of life was assessed 
with RA quality of life questionnaire (RAQoL) and disease activity measured with 
the DAS28. The main finding was that a greater proportion of people in the IG 
were physically active people than in the CG (38% versus 22%) (P< 0.05) at 6 
months and 35% versus 11% respectively (P< 0.05) at 9 months. Significant 
differences in PA were observed between the IG and the CG with the IG 
increasing the number of days participating in vigorous intensity PA for 20 
minutes compared to the CG. There were no significant differences between 
groups regarding HAQ, quality of life or disease activity. However, the 
questionnaires were not validated for sensitivity to change and construct 
validity, which could lead to bias in the results. Also, the study did not utilise 
specific health behaviour change theory, despite including goal setting and 
social support (van den Berg et al., 2006).  
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The 24 months follow data of van den Berg et al. (2006) was reported by 
Hurkmans et al. (2010). Of 152 participants who completed the 1-year internet 
based PA intervention, 110 participants were available at follow-up study at 24 
months. The PA levels were investigated with two questions according to public 
health recommendations of PA 30 min for at least 5 days/week; or vigorous 
physical activity, 20 min for at least 3 days/week. The first question asked how 
many days/week people performed moderate PA, which was defined as PA that 
causes a small increase in heart rate or breathing, such as gardening or brisk 
walking, in the past 3 months. The second question was how many days/week 
they performed vigorous PA, which was defined as exercise causing a large 
increase in heart rate or breathing, such as running, in the past 3 months.   
Functional capacity was also assessed at 24 months with the HAQ and quality of 
life with the RAQoL questionnaire. The number of participants who met the 
public health recommendation of moderate-intensity PA was significantly higher 
in the intervention group at 24 months compared with the control (P< 0.05). 
Only RAQoL was significantly improved at 24 months in the intervention group; 
no improvement in functional capacity (HAQ) was noted in either group. The 
study concluded that both general and individual internet-based PA programmes 
were effective for increasing moderate PA intensity up to 12 months’ post-
intervention in people with RA. However, the study used self-reported 
questionnaires, which might lead to under or overestimation of PA levels, and 
there was no description of the behaviour change theory underpinning the 
development and delivery of the intervention, or if they used such theory. 
Therefore, it is difficult to explain and understand the success of the study. In 
addition, there was the potential for selection bias in the study as only people 
who had access to the internet were selected; those people may have higher 
levels of self-efficacy to perform exercise. As a result, those participants may 
have better self-management skills and therefore need less face-to-face contact 
(Hurkmans et al., 2010).   
A multicentre RCT was carried out in Sweden over 24 months. It involved 228 
participants, with an intervention group (n=94) and control group (n=134) with 
early RA (within 2 years of diagnosis) (Sjoquist et al., 2011). The intervention 
consisted of individual coaching by a physiotherapist during the first year in 
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order to adopt health-enhancing PA levels (defined as 30 minutes/day of 
moderate intensity PA more than 4 days/week) with telephone support monthly 
for 12 months. This was followed by no coaching during the subsequent year. 
The participants were assessed with self-reported PA questionnaires, visual 
analogue scale to assess pain, HAQ and DAS28. It was reported that 69% of the 
participants in the intervention group and 69% of those in the control group 
completed the study (2 years). There was a significant difference between 
groups in terms of PA at the baseline (the intervention group 47% versus the 
control group 51%) and after the one-year intervention (the intervention group 
54% versus the control group 44%) (P< 0.05). 
There was also an improvement in the intervention group in muscle strength, 
measured by the timed stand test (P< 0.001) and hand grip strength (P=0.03),12 
months data published by Brodin et al. (2008). Despite the observed different 
pattern in PA behaviour in both groups, there was no significant difference 
between groups in any measurement at the end of the second year of the study 
(Sjoquist et al., 2011). The sampling method used was convenience sampling, 
and the questionnaire used to assess PA was developed specifically for the study 
and validated. The programme may have been unable to cause long-term 
behaviour change because important behavioural elements that facilitate the 
maintenance of PA behaviour, such as enhancing self-efficacy, or behaviour 
theory such as SCT were not included. 
An RCT evaluated motivation and behaviour change in a 5-week programme of 
combined education sessions, one motivational interview and two self-regulation 
coaching sessions in people with RA (Knittle et al 2015). Seventy-eight 
participants were randomised into an intervention group (n=38) and a control 
group (n=40) (Knittle et al., 2015). In the first week, both groups received a 
small group education session led by a physiotherapist. The education session 
topic was the importance of PA for people with RA and the recommended 
guidelines for PA. Also, the participants were motivated to choose PA, to start 
with comfortable intensity and duration of activity and then to increase it 
gradually. The participants were provided with a list of exercises suitable for 
people with arthritis. The control group received no further intervention. The 
intervention received a workbook developed for study of exercise instructions. In 
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weeks 2 and 3, the intervention group received a one-to-one motivational 
interview carried out by a physiotherapist for 45 minutes, discussing PA long-
term goals and PA lifestyle. At the end of the interview, PA diaries were given 
out. In weeks 4 and 5, one-to-one sessions were carried out lasting 40 to 60 
minutes by a rheumatology nurse. In order to enhance the intervention, the 
participants were advised to follow the structure of the workbook and their PA 
diaries were reviewed. The participants received feedback on their progress, set 
a PA goal, engaged in action planning, identifying PA barriers and how to 
overcome them, all encouraged by social support.  
The main outcome was health-enhancing PA measured with a short 
questionnaire, and the number of days per week they were involved in leisure 
time PA for at least 30 minutes at moderate intensity PA was recorded. Self-
efficacy was assessed with an18-item questionnaire from Badura, (2006); disease 
activity was assessed with the RA disease activity index and functional capacity 
with the HAQ. All outcomes were assessed at 6 weeks and at follow-up, 32 weeks 
after the baseline. Over the 32 weeks of the study, there was a significant 
interaction effect between the intervention and control groups. In the 
intervention group there was a significant increase in leisure time PA by 84 
minutes (P=0.022), also an increase in days/week of 30 minutes PA (P=0.016) 
and self-efficacy (P=0.001); however, there was no significant difference in HAQ 
or disease activity in either group. Although the programme successfully 
increased PA in the target population, PA was assessed with self-reported 
questionnaires only and also the programme consisted of multiple components, 
so it is difficult to isolate the component that led to the change of PA behaviour 
(Knittle et al., 2015). 
An RCT carried out by Stavropoulos-Kalinoglou et al. (2013) included 40 RA 
patients with a mean age of 53.9±9.9 years. The disease duration ranged from 
4.0 to 10.0 years. The participants were randomly allocated to the intervention 
or control group. The intervention group had a programme consisting of 
individualised aerobic exercise. They were asked to perform 3-4 different 
exercises such as walking on a treadmill and cycling for 3-4 minutes; each 
session was 50-60 minutes including 10 minutes warm up and 5-10 minutes cool 
down. This programme was for the first 3 months and thereafter some resistance 
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training was added such as leg press, shoulder press, chest press and pull ups. 
They were required to complete three sets of 12–15 repetitions during each 
exercise session. The control group received advice on exercise benefits and 
lifestyle changes. The participants were assessed at baseline, 3 and 6 months. 
The outcome measures were PA assessed with self-reported questionnaire 
(IPAQ), and aerobic capacity assessed with VO2max. Disease activity was 
measured with DAS28, functional capacity with HAQ, blood pressure was 
measured and total and high density lipoprotein (HDL) cholesterol was 
evaluated. The 10-year CVD event probability was established using the Heart 
Score programme (http://www.heartscore.org) of the European Society of 
Cardiology. The results showed improved physical activity, aerobic capacity 
(VO2max) and also systolic and diastolic blood pressure. Additionally, lipid profile, 
HAQ, DAS28 & CVD risk were improved (Stavropoulos-Kalinoglou et al., 2013). 
However, the intervention was intensive, and the sample was small (40 
participants), 36 completed the study.  
Another study included 34 RA patients with a mean age of 48±11.3 years 
(Breedland et al., 2011). The mean disease duration was 7 years. The study was 
an RCT which aimed to evaluate the effect of group-based education and an 
exercise programme on physical aerobic capacity. The outcome assessor was 
blinded to the group allocation of the participants. The participants were 
randomly divided into a control group and an intervention group where the 
intervention consisted of a supervised physical exercise programme in order to 
improve aerobic capacity and muscle strength, plus an educational programme. 
The supervised aerobic exercise was muscle exercise circuit, cyclic and aqua 
jogging for 3 hours per week on 2 separate days. Strengthening exercises were 
done in a circuit which included leg press, leg extension, leg curl, rowing, chest 
press and abdominal trainer. Each training session consisted of 3 sets of 20 
contractions. The education sessions were lasted 60 minutes a week and covered 
joint pain, fatigue, disease activity, sleep disturbance and self-efficacy. 
The participants were assessed at baseline, 9, 13 & 22 weeks. Aerobic capacity 
was assessed with VO2 max, muscle strength was assessed by hand grip strength 
and the self-reported health status of the participants was assessed using the 
Dutch version of the Arthritis Impact Measurement Scales-2. The control group 
55 
 
 
was usual care. The results showed a significant improvement of aerobic 
capacity in the intervention group (12.1%) however the control group declined (- 
1.7%). Although there were significant changes within the groups in terms of 
muscle strength and health status, no difference was noted between groups 
regarding these outcomes (Breedland et al., 2011). However, the study sample 
was small and also the programme was supervised and intensive.  
Although the success of the aforementioned studies in increasing PA levels was 
evident, the PA outcome was measured by self-reported questionnaires. Only 
the study of van den Berg et al. (2006) used an objective measure (Actilog V3.0), 
and this was as a secondary outcome measure. However, the current study 
assessed PA using both objective and subjective methods, whilst also being built 
upon behaviour change theory and behaviour change techniques.  
There were differences in the duration of the interventions and programmes; 
some studies had programmes of 6 -12 months, and in these the loss during 
follow-up was lower, e.g. Stavropoulos-Kalinoglou et al. (2013) where loss during 
follow-up was 10% and van den Berg et al. (2006) were loss during follow-up was 
5%. However, in other studies with follow-up of 24 months, such as Hurkmans et 
al. (2010), loss during follow-up was 27.6%.  
The intervention in some studies was intensive and under supervision and these 
studies were able to improve the lipid profile and HAQ, and reduce CVD, as in  
Stavropoulos-Kalinoglou et al. (2013). However, no behavioural theory or 
behavioural change techniques were included. This means that it is difficult to 
understand the results and also it is unclear whether these studies were able to 
motivate people and maintain their PA levels after the intervention.  
Only the follow-up study of Hurkmans et al. (2010) reported improving the 
quality of life of people with RA at 24 months. This may be explained by the fact 
that the people who were motivated and physically active completed the 24-
month assessment or it may be related to other factors such as disease activity 
controlled by treatment or pain and fatigue further study is needed. None of the 
other studies showed any improvement in RAQoL. 
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2.5.4 Summary  
There is growing body of literature regarding physical activity/exercise in RA and 
this has been discussed in relation to aerobic, strengthening, stretching or 
combined exercises. The literature varied in methodology and quality and it has 
been summarised in Table 2-2. Overall, all of the studies were able to improve 
PA levels and also muscle strength if they included strengthening exercises. 
None of the studies reported injuries related to exercise or PA.  
Physical activity and exercise has been found to be beneficial for people with 
RA; however, there is a need for further research to evaluate: 
The effect of aerobic exercise, particularly walking, on RA. Walking is simple, 
inexpensive and feasible for all ages. 
To assess physical activity as a primary outcome measure with both subjective 
and objective measures. This will allow an assessment of the actual activity and 
the context of this activity.  
To assess the effectiveness of group education sessions based on behavioural 
change theory and behavioural change techniques on RA outcomes.  
To examine the effectiveness of a walking programme and education sessions on 
RA disease and comorbidities such as CVD risk.  
To improve research methodology used in studies of PA in RA in order to reduce 
the risk of bias. 
Therefore, the WARA intervention was designed based on the limitations and the 
gaps in the evidence in this area.  
To promote PA effectively, the evidence suggested the use of some devices such 
as pedometers. The following section presents the evidence for pedometer-
supported walking programmes in healthy people and those with RA. 
57 
 
 
2.6 Walking based pedometer support programme  
A pedometer is small device which may provide information about the number of 
steps taken, time spent walking and distance covered (Fitzsimons et al., 2008). 
Pedometers have been widely used in the assessment and promotion of PA in 
clinical studies (Mansi et al., 2013). Studies suggest that pedometers can 
promote walking effectively with a significant association between increase in 
PA and pedometer use (Fitzsimons et al., 2008, Pal et al., 2009). Studies have 
demonstrated that interventions using pedometers that provide feedback to 
users and assist in self-monitoring PA behaviour are one of the most effective 
approaches that can be used to increase PA (Baker et al., 2008a, Mansi et al., 
2013, Pal et al., 2009). Studies by Bravata et al. (2007) and Pal et al. (2009) 
concluded that the immediate feedback from a pedometer and the use of step 
goals, can lead to a significant improvement in PA levels among obese women.  
The study, Walking for Wellbeing in the West, demonstrated that pedometer 
based walking for 12 weeks with PA consultation is an effective way to increase 
walking and encourage and motivate people who do not meeting the current PA 
recommendation (Baker et al., 2008a). A systematic review demonstrated that 
the use of a pedometer can increase PA level by 27% and daily step count by 
2000-3000 steps (Tudor-Locke et al., 2011b).  
A pilot study by Stovitz et al. (2005) included 94 participants from a family 
medicine clinic and aimed to investigate the role of the pedometer in physician 
counselling that may help patients to increase their ambulatory activity. The 
participants were assigned to two groups; both groups received a brief physician 
endorsement of regular PA, education material on the benefits of a healthy 
lifestyle, three contacts with a health educator. However, the intervention 
group received a pedometer, were instructed how to use it and were asked to 
record their step count daily over the 9-weeks of the study. The mean step 
count in the intervention group increased from (6779 steps/day) at baseline to 
(8855 steps/day) at 9 weeks (pedometer step count was assessed for the 
intervention group only).   
A 16 week pedometer-based workplace intervention was carried out with 154 
employees at two work places (Baghianimoghaddam et al., 2016). The 
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participants were instructed to wear a pedometer and were told how to use the 
pedometer and the PA log. The participants submitted weekly logs to the 
researcher. Participants in the intervention workplace were encouraged to 
develop teams, and each team was motivated to complete at least 30 minutes of 
continuous, brisk walking every workday. They were given a map of walks 
around the campus and instructions on how to increase PA throughout the 
intervention phase. The instructions included increasing their step count by 500 
steps/week, and training to overcome their PA barriers. Furthermore, the 
participants were told about the role of social support. They were advised to use 
the staircase instead of the lift, to use their break times to walk, and to parking 
their cars farther away from the building. 
Pedometer-based and self-reported PA using the IPAQ from one work place 
(intervention) was compared with another work place (control group). A 
significant improvement was observed in step count from baseline to 16 weeks 
among the intervention group (8279 ± 2759 steps/day) compared with the 
control group (4118 ± 1136 steps/day). A significant increase in the leisure time 
PA was reported by women in the intervention group but not in the control group 
(Baghianimoghaddam et al., 2016). 
A systematic review was carried out of 14 RCTs examined the effect of PA 
intervention on objectively measured PA using accelerometers or pedometers in 
people with chronic musculoskeletal pain, such as osteoarthritis and low back 
pain (Oliveira et al., 2016). It found no significant difference between the 
intervention groups and those with no or minimal intervention in objectively-
measured PA in short-term (≤3 months), intermediate (>3 months and <12 
months), and long-term (≥12 months) (Oliveira et al., 2016). The sample size of 
the included trials ranged from 38 to 293 participants. Interventions to promote 
PA varied across the trials, and included a cognitive-behavioural PA intervention, 
a web-based PA intervention programme, a pedometer-based walking 
programme, general exercise group classes and therapeutic exercises. 
Education/advice was the type of comparator most commonly used, followed by 
self-management. Five trials used accelerometers to assess PA, 2 trials used 
pedometers and 1 trial used both. The PA measures used as outcomes were step 
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count, time spent in various intensities of PA, and total vector magnitude 
(counts) (Oliveira et al., 2016).  
The authors suggested that future research is warranted to clarify whether 
inactive people with chronic musculoskeletal pain respond better to PA 
interventions than more active people. The included studies had limitations such 
as combined study populations and also the use of a variety of outcome 
measures to asses PA e.g. pedometers or accelerometers. The authors 
recommended that future trials should investigate the long-term effects of PA 
interventions in people with chronic musculoskeletal pain. They also 
recommended that dropout rates and the blinding of the assessor should be 
considered in future studies (Oliveira et al., 2016). 
A weakness of the available literature is the use of different data-processing 
techniques, as well as the variability of outcomes reported. No behaviour 
theories were mentioned in any of the trials included and this could explain the 
reason for their failure to promote PA in the target population (Oliveira et al., 
2016). 
Although a number of studies evaluated pedometer-supported programmes in 
healthy individuals, only one study conducted by Katz  et al. (2015), published as 
an abstract, used a pedometer with people with RA. Ninety-six participants were 
included in the study; the mean age was 54 ±13 years, and 88% were female. 
The disease duration was 14 ±13 years (Katz  et al., 2015). The participants 
completed baseline questionnaires and received activity-monitoring devices 
which were used to gather baseline PA data over one week. After one week, the 
participants were randomised into an education group or a control group. The 
latter only received education regarding PA. 
The intervention group either received a pedometer and step diary, or 
pedometer, step diary, and step targets. The step target was based on the step 
count of the baseline value with the goal of increasing 10% every two weeks. The 
intervention groups received phone calls every two weeks to collect step diary 
information. The participants were assessed at week 10 (by phone) and week 21 
(in person). The study by Katz et al. showed a positive change in step count from 
the baseline to 21 weeks (2132 ± 2698 steps/day) by 92% ± 125 in the 
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intervention group, who used a pedometer and PA diary. When a step target was 
included in addition to the pedometer and diary, the step count increased by 
(1299 ± 2389 steps/day) (P=0.02) by 188% ± 506. In the control group, the step 
count increased by (-327 ± 2429 steps/day) (P=0.53) by 3% ± 56  (Katz  et al., 
2015). The result suggests that prescribing pedometers to people with RA can be 
effective in promoting PA and adding a step target is actually less beneficial 
than using a pedometer and PA diary (Katz  et al., 2015). No other study 
evaluated pedometer-supported programmes in people with RA. 
As a result of the increase in use of pedometers and through research aimed to 
motivate PA, Tudor-Locke et al. (2004) evaluated the popular health 
recommendation of 10,000 steps/day, as well as the available evidence 
regarding pedometer-based indices. It has been reported that 10,000 steps/day 
is a reasonable estimate of daily PA, providing health benefits among healthy 
individuals. However, there was some evidence to suggest that this value was 
not suitable for some groups, such as old people and people who have chronic 
conditions. In addition, there was concern about the use of 10,000 steps/day as 
a universal goal as it is considered low for children and also as a target against 
obesity. There was some evidence demonstrating the health benefits relating to 
incremental improvement in baseline value.  
People who were involved in daily physical activity which totalled less than 500 
steps/day were considered as having a sedentary lifestyle (Tudor-Locke et al., 
2004). While, people who performed more than 10,000 steps/day were classified 
as having an active lifestyle. Tudor-Locke et al. (2004) has classified pedometer-
determined PA in healthy adults, as shown in Table 2-3. 
Table 2-3 Classify pedometer-determined physical activity in healthy adult 
 
Steps/day Activity index 
<5000 Sedentary lifestyle 
5000-7499 Low active 
7500-9999 Somewhat active 
≥10,000 Active 
>12,500 Highly active 
Adapted from how many steps are enough (Tudor-Locke et al., 2004). 
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Based on the aforementioned evidence on the role of pedometers in self-
monitoring and feedback, showing that they encourage and motivate PA 
behaviour, the pedometer was chosen for self-monitoring of PA as part of the 
intervention in the current study. The pedometer-supported walking with a 
weekly goal will be discussed in (Section 3.8.2). 
2.7 Qualitative studies on facilitators and barriers of 
physical activity in rheumatoid arthritis 
Qualitative research methods include interviews and focus groups, and allow a 
wider interpretation and in-depth examination of the barriers and facilitators of 
PA in people with RA.  
A study by Withall et al. (2016) conducted focus groups with people with RA: 15 
females and 4 males with a mean age of 59.9 ± 10.3 years and mean disease 
duration of 44 ±34 months. They identified that group-based education as part of 
a PA programme supported by health care workers positively influenced the 
recruitment and adherence to the programme as it facilitated social support 
from other members of the group and motivated them. Withall et al found a PA 
programme which consisted of 5 education sessions over 12 weeks (4 group 
sessions and 1 individual session with guided exercise) was acceptable. The 
findings of the focus group suggested that the participants would have preferred 
a less intense programme with less contact and more flexibility. While, a 
programme of 6 months’ duration with twice-weekly education sessions for six 
weeks was considered to be a significant commitment for participants.  
People with RA have a fear that exercise may worsen their condition, and also 
that pain and RA disease activity are main barriers to PA in people with RA 
(Withall et al., 2016).The majority of people with early RA who participated in 
a focus group requested group education with information regarding RA, along 
with discussions and sharing thoughts with other people with RA (Withall et al., 
2016).Therefore, the education of people with RA regarding the benefits of PA 
on disease activity, functional capacity and cardiovascular health is 
recommended. 
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A qualitative study examined the experience of an exercise programme which 
aimed to maintain physical ability in people with RA. Semi-structured interviews 
were carried out with 16 physically active people with RA with a mean age of 50 
years and average disease duration of 21 years. It demonstrated that PA 
maintenance in people with RA was understood as meaning resisting disability 
and taking responsibility for their life, health and wellbeing (Loeppenthin et al., 
2014). 
A focus group conducted by Crowley and Kennedy (2009) involving 12 people 
with RA found that the factors that enhanced adherence to exercise include 
disease activity (remission), and environmental (social support) and personal 
factors (individual motivation). It reported that people with RA preferred the 
exercise sessions to take place on common ground (a comfortable place that is 
available to people with good transportation and facilities) and people with RA 
liked to receive exercise instructions. It identified pain and fatigue as barriers to 
exercise but also identified fear of falling and the psychological effects of RA as 
other barriers to PA (Crowley and Kennedy, 2009). 
Eight females with RA undertook semi structured interviews via telephone in 
order to examine the perceived barriers and attitudes to PA among women with 
RA. Fear for safety and fear of unknown and social support were the main 
barriers to PA. Walking 3-4 times/week was reported as an acceptable 
programme for people with RA (Baxter et al., 2015). 
Ten women and 5 men aged 23 to 73 years with RA disease duration from 4 -27 
years were interviewed with a semi-structured interview technique in their 
homes, in order to discover how people with RA describe their sedentary 
behaviour (Thomsen et al., 2015). Content analysis was used to analyse the 
data. People with RA mentioned that during a flare-up of the disease they spent 
a lot of time being sedentary and that also they cancelled social activities as a 
result of fatigue. They found a day of having pain isolating. They also said that 
RA forced them to sit, and that they had more sitting breaks between day-to-day 
activities. It was concluded that people with RA see pain and fatigue as barriers 
to their mobility, and that also personal and social factors lead them to spend 
more time sitting down (Thomsen et al., 2015). 
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A review of qualitative studies done by van Zanten et al. (2015) regarding the 
barriers, facilitators and benefits of PA in people with RA found 453 articles; 
however only 26 studies, quantitative and qualitative, fulfilled the 
inclusion criteria of the study. It was found that there was a lack of knowledge 
regarding the amount and type of exercise and PA suitable for people with RA. 
Also, there was a fear of PA aggravating their condition. Pain and fatigue were 
identified as the barriers to PA, plus a lack of advice from health care providers 
regarding PA. The most effective facilitators were identified as support from 
instructors and health care providers, and social support for PA. Conversely, the 
lack of this support was reported as a barrier.  
In addition, knowledge and awareness regarding CVD can influence a patient’s 
choice in adopting a healthy lifestyle behaviour including PA (Koniak-Griffin and 
Brecht, 2015). A study interviewed 10 people with RA, ranging from 23-81 years 
of age 70% of whom were female, in order to evaluate CVD preventive care (lipid 
testing and hypertension diagnosis) including promotion of healthy lifestyle 
(Bartels et al., 2013). Almost all of the participants were not aware of the 
increased risk of CVD in people with RA. In addition, the majority of the 
participants who were interviewed reported that they received no consistent 
CVD preventive care. It is recommended that rheumatologists should consider 
interventions to overcome the CVD preventive care gap in clinics. 
Thus, the majority of the studies suggested that physically active people with RA 
might not be different from inactive people with RA in terms of their perceived 
barriers to PA, but that PA interventions are able to help physically active 
people to manage or overcome these barriers more effectively than inactive 
people. 
Although the studies varied in their ways of collecting data (some used focus 
groups and others semi-structured interviews) fear of PA aggravating their 
condition, pain and fatigue seems to be the most common PA barrier of people 
with RA. In addition, group-based education sessions and social support 
appeared to be the most important facilitators of PA programmes in people with 
RA.  
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UK physical activity guidelines (2011), Start active stay active (2011) not only 
recommended an increase in PA, but also emphasise that adults should reduce 
the time spent being sedentary. The following is a discussion of sedentary 
behaviour in general and in people with RA. 
2.8 Sedentary behaviour  
2.8.1 Definition of sedentary behaviour  
Sedentary behaviour is defined as the amount of time spent sitting or lying down 
and includes behaviours such as viewing TV, other screen- time behaviour 
(computer, video), being a passenger in a car or other forms of transport (Ford 
and Caspersen, 2012, Khoja et al., 2016). 
Also, sedentary behaviour has been defined in terms of energy expenditure. 
“Sedentary behaviour is defined as any waking behaviour characterised by an 
energy expenditure of 1.5 METS or less, while in a sitting or reclining posture” 
(Sedentary Behaviour Research Network, 2012). 
2.8.2 Sedentary behaviour in rheumatoid arthritis 
Objectively measured sedentary behaviour in people with RA using activPAL™ 
found that people with RA had higher sedentary times than the control group by 
1 hour (P = 0.029) (Paul et al., 2014). Subjective measures of sedentary 
behaviour using a self-reported questionnaire also concluded that there was a 
higher sedentary time in those with RA than in the control (Henchoz et al., 
2012). Similarly, it reported that women with RA were spending more time 
sedentary than healthy controls (Tourinho et al., 2008). However, it is unclear 
how sedentarism was defined in these studies. 
2.8.3 Consequences of sedentary behaviour in general population 
as well as rheumatoid arthritis 
Sedentary behaviour has a negative impact on health and wellbeing (Mutrie et 
al., 2012). Evidence suggests that sedentary time is an independent risk factor 
for ill health (Mutrie et al., 2012, Thorp et al., 2011). 
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Sedentary behaviour might lead to suppression of lipoprotein lipase activity of 
skeletal muscle (LPL) due to loss of local contractile stimulation. LPL is the 
enzyme engaged in the uptake of free fatty acids and triglycerides into skeletal 
muscle and high density lipoprotein (HDL) (Hamilton et al., 2008). In addition, 
lack of local muscle contraction may reduce glucose uptake. Elevated levels of 
triglyceride, free fatty acids and glucose in circulation could lead to excess free 
radicals and trigger inflammation, endothelial dysfunction and increased 
sympathetic pathway activity that is conductive to the development of coronary 
heart disease and CV risk (O'Keefe et al., 2012).  
Dunstan et al. (2010) revealed that the length of time spent viewing television 
was correlated with increased risk of CVD as well as all-cause mortality. Their 
research examined 880 adults and followed them up over 58,087 person-years, 
and found 284 deaths (87 CVD deaths, 125 cancer deaths). They found that 1 
hour/day of time spent viewing television has a hazard ratio (HR; 1.11 95% CI 
1.03 -1.20) for CVD mortality, (1.09 95% CI 0.96 - 1.23) for cancer mortality and 
(1.18 95% CI 1.03- 1.35) for all-cause mortality (Dunstan et al., 2010). A review 
by Ford and Caspersen (2012) revealed that sedentary behaviour is significantly 
associated with increased risk of CVD, and also overweight/obesity, 
hypertension, diabetes, high cholesterol, metabolic syndrome (Healy et al., 
2008), and cancers such as ovarian, colon and endometrial in general population.  
A few studies investigated the consequences of sedentary behaviour in people 
with RA. Sixty-one individuals with RA, with a mean age of 54.9 years, were 
included in a cross-sectional study (Fenton et al., 2017). Fasted blood samples 
were taken and sedentary behaviour (sedentary time, sedentary bouts and 
sedentary breaks) and also level of PA were objectively assessed using GT3X 
accelerometers (Actigraph) for 7 consecutive days. The ten-year CVD risk was 
computed (Q-risk-score2), and functional disability was measured using self-
reported questionnaire. The participants spent about 8 to 9 hrs/day being 
sedentary and 4.5 hrs/day engaged in low levels of PA. There was a significant 
positive association between sedentary time and number of sedentary bouts/day 
≥20 min and CVD risk in people with RA. There was also a reverse association 
between low levels of PA (1.6 – 2.9 METS) and CVD risk in people with RA. 
However, this association was independent of engagement in moderate intensity 
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PA. Promoting low levels of PA and reducing sedentary bouts to <20 min were 
recommended in order to reduce CVD risk in people with RA. There was a non-
significant association between sedentary behaviour and functional disability 
(Fenton et al., 2017).  
One study objectively measured sedentary behaviour and PA using the 
Sensewear Armband (Khoja et al. (2016). They reported that people with RA 
spent 9.8 hours/day sedentary. A significant inverse association between very 
light, light and moderate PA and CVD risk in people with RA was identified. A 
higher time spent being sedentary was significantly associated with higher BMI, 
higher diastolic and systolic blood pressure, impaired insulin sensitivity, and 
lower HDL levels (P< 0.05). PA was not associated with LDL and triglycerides. 
Also, a higher functional disability (HAQ) and disease activity scores (DAS28) 
were associated with time spent being sedentary. 
However, there were inconsistences between both Khoja et al. (2016) and 
Fenton et al. (2017) in their definition of sedentary behaviour and light PA. 
Khoja et al. (2016) defined sedentary behaviour and LPA as activities requiring 
<1 MET, and 1 – 2.9 METS, respectively. Fenton et al.’s study defined sedentary 
behaviour as ≤1.5 MET. Thus Khoja et al.’s (2016) method might lead to an 
underestimation of sedentary time and an overestimation of LPA.  However, it 
seems that people with RA spend more time being sedentary than the healthy 
population.  
2.8.4 The consequences of interrupting sitting time  
A study carried out by Healy et al. (2008) recruited 168 people with diabetes and 
identified that interrupting the time spent sitting reduced the waist 
circumference (P = 0.026), BMI (P = 0.026), triglycerides (P = 0.029), and glucose 
(P = 0.025). Reducing and breaking up the time of adults sedentary behaviour 
plays an important role in lowering postprandial glucose, triglyceride and insulin 
level also it is beneficial to BMI, waist circumference among overweight and 
obese adults (Dunstan et al., 2012, Owen et al., 2010). A RCT with cross over 
design on previously sedentary adults by Mutrie et al. (2012) found that the 
reducing sitting time improved quality of life.  
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Seventeen prospective experimental studies that examined the effectiveness of 
breaking up prolonged sitting time on CV risk factors were reviewed, along with 
the effect of replacing sitting with light intensity PA and standing (Benatti and 
Ried-Larsen, 2015). It was found that breaking up sitting time had beneficial 
effects on cardio metabolic risk factors. The intensity and frequency of PA 
should be considered, particularly in people who have a sedentary lifestyle 
(Benatti and Ried-Larsen, 2015). However, no study has examined the 
effectiveness of breaking up sedentary time in people with RA.  
There is evidence that people with RA have an inactive lifestyle, which may be 
related to a number of reasons, including joint pain and stiffness, psychological 
disturbances or even fear of aggravating their disease. This inactive lifestyle 
could contribute to their CV risk profile. Therefore, the aim of this study was to 
increase (physical activity) step count, reduce sedentary behaviour in order to 
reduce the risk of CVD and improve the health outcomes in terms of disease 
activity, functional capacity, quality of life, and self-efficacy for PA. The 
following chapter describes the details of the current intervention (WARA), the 
theories underpinning the intervention and some explanation of the mechanism 
of action.  
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3 Walk for Rheumatoid Arthritis (WARA) 
intervention 
This chapter begins by defining complex interventions, lifestyle, an unhealthy 
lifestyle and health risks. Then, it reviews the theoretical underpinning of the 
behavioural changes upon which the WARA intervention was grounded, and the 
behavioural change techniques that were used in the WARA intervention. It 
presents the evidence of the effectiveness of the behavioural changes with 
regard to targeting physical activity behaviour. The chapter also considers the 
duration and mode of delivery of interventions in relation to physical activity in 
RA. Finally, the development and content of the Walk for Rheumatoid Arthritis 
(WARA) intervention are described, along with the rationale for the content of 
the booklet that was given to the participants. 
3.1 Definition of interventions and complex interventions 
An intervention is defined as a set of actions with a coherent objective, which is 
intended to produce identifiable outcomes (Olander et al., 2013). A complex 
intervention is an intervention that consists of a number of interacting 
components with several outcome measures (Campbell et al., 2000, Craig et al., 
2008). Programmes that focus on health promotion and disease prevention are 
complex interventions due to the complexity of health risk behaviours and also 
because they require several actions, in order to promote health behaviours or 
healthy lifestyles (Craig et al., 2008). 
3.2 Unhealthy lifestyles and health risks 
Lifestyle can be defined as the personal habits or the ways of living of 
individuals on a day to day basis. It takes into account physical, psychological, 
social or environmental factors, and is influenced by culture, family or social 
class (Ezzati et al., 2002, Trovato, 2012). Unhealthy lifestyles can predispose 
people to chronic conditions such as cardiovascular disease (CVD). There are 
many risk factors associated with CVD that can be treated or changed – these are 
called modifiable risk factors, (see section2.2.1). Physical inactivity, sedentary 
behaviour, and diets rich in saturated fats, are examples of modifiable risk 
factors which need addressed to promote a healthy lifestyle thus minimising, or 
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preventing, chronic conditions such as CVD. Lifestyle interventions address 
modifiable risk factors by tackling the behaviours requiring change, such as 
physical inactivity, within specific populations (Michie et al., 2012).  
The Medical Research Council's evaluation guidance states that the key elements 
of evaluating complex interventions and understanding how the intervention 
works are: identifying the appropriate theory; assessing feasibility and piloting 
the interventions; assessing the effectiveness of the interventions; and 
understanding the change process (Medical Research Council, 2006). These 
elements were considered when designing the WARA intervention. The following 
sections discuss the role of the theory underpinning behaviour change and 
behavioural change techniques (BCTs), and the BCTs that were chosen in the 
WARA intervention. Based on the evidence of BCTs that are effective in 
increasing PA behaviour, increased self-efficacy for PA and their role in changing 
PA behaviour and improving the outcomes, seven BCTs were used in the WARA 
intervention. These are further discussed in the following sections.  
3.3 Theoretical underpinning of behaviour change  
A number of theories have been identified in attempting to explain behavioural 
change, with each theory being focused, to a greater or lesser extent, on social 
factors (Bandura, 1977, Morris et al., 2012). Underpinning theories focus on 
individual choice and behaviour at different points of an individual’s life, or on 
the relationships between behaviour, individuals, society, and physical 
environments (Morris et al., 2012, Riemsma et al., 2004).  
Social Cognitive Theory (SCT) was developed by Bandura (1986) and is relevant 
for designing health education and health behaviour programmes (John et al., 
2011a). SCT is a behavioural health theory that explains behaviour in a triadic 
and reciprocal model, where the environment, an individual, and behaviour 
interact to determine motivation and behaviour, Figure 3-1 (John et al., 2011a, 
Glanz et al., 2002). The interaction is complicated, and all of these dimensions 
are important for behaviour change (Bandura, 2001, Glanz et al., 2002). 
However, SCT has been criticised as it does not provide a full explanation of how 
the environment, behaviour and cognition interact, and there are many 
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hypotheses regarding this interaction (Munro et al., 2007, Plotnikoff et al., 
2013).  
 
Figure 3-1 Overview of social cognitive theory  
Adapted from (Pajares, 2002)  
Increasing the knowledge and awareness of the participants in research studies, 
for example providing information to promote PA and a healthy diet, has been 
identified as influencing changes in behaviour as increasing knowledge has a 
significant influence on human actions and motivation (Romeike et al., 2016). 
Patient education is defined as “any set of planned educational activities 
designed to improve patient’s health behaviours and/or health status” (John et 
al., 2011b, Riemsma et al., 2004). Education sessions and the associated 
material allow participants to access information on e.g. PA and to interact with 
other study participants (Artinian et al., 2010, Glanz and Bishop, 2010). 
However, van Achterberg et al. (2011) stated that knowledge and simply 
providing materials were insufficient to promote healthy behaviours in patients; 
professionals should consider alternative comprehensive strategies by combining 
knowledge, awareness and facilitation techniques.  
A systematic review and meta-analysis by Young et al. (2014) concluded that SCT 
is a useful framework to explain PA behaviour. Another systematic review and 
meta-analysis by Plotnikoff et al. (2013) stated that few studies utilise SCT to 
explain objective PA behaviour, therefore more theoretically based studies are 
needed. Riemsma et al. (2004) and John et al. (2011a) concluded that any 
Behaviour 
Environmental 
Factors 
Personal  
Factors 
(Cognitive affective 
and biological 
events) 
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successful programmes for people with RA, with the aim of changing unhealthy 
lifestyles and reducing the risk of CVD, should be based on social cognitive 
theory. This is expected to enhance the results because it targets knowledge, 
self-efficacy and behaviour (John et al., 2011a). 
SCT assumes self-efficacy to be the core element of behaviour change (John et 
al., 2011a). Self-efficacy is defined as people’s beliefs in their ability to perform 
a specific task within a given context (Bandura, 2004, Ng and Lucianetti, 2016). 
Self-efficacy is related to SCT in that people with high self-efficacy will face up 
to failures or setbacks. They are more likely to set challenging goals for 
themselves and even if they face barriers or relapse they will not give up 
(Bandura, 1977, Munro et al., 2007, Plotnikoff et al., 2013). Increasing 
participants’ confidence in their ability to achieve their PA goal was found to be 
associated with motivating them towards the PA goal, overcoming perceived 
external barriers and improving outcome expectations (John et al., 2011a). Self-
efficacy is related to people’s experiences, either positive or negative, in terms 
of a particular task, and to other people’s performance on a particular task 
(Bandura, 1977). Self-efficacy can be built by setting small specific goals which 
together relate to larger goals (Bandura, 1977, Munro et al., 2007, Plotnikoff et 
al., 2013). 
The SCT theory also explains how people react according to their beliefs and 
according to the outcomes of their actions (Michie et al., 2008). For example, 
individual self-beliefs regarding exercise include people's beliefs about the 
outcomes of being physically active, and that enables them to undertake PA or 
exercise (Ezzati et al., 2002). Participants’ beliefs, impulses and habits result 
from associative learning and the psychological state of the individual leads to a 
certain behaviour. The fact that an individual believes in the importance of PA 
does not necessarily mean that this individual will be physically active (Bandura, 
1977).  
To successfully increase PA, several elements have to be considered, such as the 
practice of a specific behaviour, the role of cognition in motivation and the 
impact of the situations an individual is faced with (Flynn et al., 2009, Larkin et 
al., 2015a). The motivation of the individual to engage in PA and the strength of 
their belief in the health benefits to be gained from PA may be significant 
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factors in increasing self-efficacy (Crain et al., 2010). Additionally, increasing 
people’s knowledge regarding how PA influences their health is a fundamental 
factor that can motivate them and help to improve self-efficacy for PA (Larkin et 
al., 2016b). The intervention should aim to improve participants’ knowledge, 
increase their self-efficacy for PA, and improve their behavioural and clinical 
outcomes. In particular, lifestyle education programmes such as those aimed at 
increasing PA behaviour for people with RA should be provided during the early 
stage of the disease to maximise the potential for appropriate behaviours to be 
implemented and maintained (Riemsma et al., 2004). However, there is a lack of 
evidence regarding the role of self-efficacy in determining levels of PA in people 
with RA (Bauman et al., 2012, Neuberger et al., 2007). The WARA intervention 
was designed to increase awareness and knowledge regarding the benefits of PA, 
and to enhance participants’ self-efficacy for PA based on SCT in people with RA 
within 5 years of diagnosis. 
SCT has a number of aspects that should be considered when designing an 
effective intervention, for example the perception of the environment, a 
healthy lifestyle and the external factors surrounding the individual, such as 
social support. Also, the behavioural capability of the individual should be 
considered in terms of their knowledge and skill to perform a given behaviour, 
such as regulating their goals. Observing other people’s actions and the 
outcomes of other people’s behaviour during the intervention also plays an 
important role in motivating people towards their goal. It is important to not 
only promote the behaviour but also to minimize relapse and help participants to 
overcome barriers. People can be trained on how to solve the problems that 
they may face during and after the programme.  
Furthermore, to improve the outcomes, people should understand the benefits 
of adhering to the programme; self-initiated rewards and incentives are 
important to motivate them to progress further towards their goal. These factors 
can help people to increase their confidence to perform a behaviour and should 
be included in an effective intervention (Bandura, 2001, Glanz et al., 2002).  
Taking into account the aforementioned aspects of SCT concepts, the WARA 
intervention was designed. The WARA intervention was grounded in the 
constructs of social cognitive theory (SCT) through the education of the 
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participants regarding their condition (RA) and it focuses on PA, heart disease in 
RA and the benefits of being physically active. It also included a session on 
healthy diet. Table 3-1 shows the process of the application of SCT concepts in 
the WARA intervention.  
Table 3-1 Overview of the application of social cognitive theory of the WARA intervention 
 
Social Cognitive Theory 
Construct 
Process of the application 
Self-efficacy Verbal encouragement from physiotherapist 
during sessions or follow-up phone call 
Observational learning Interactive discussions of participant’s 
experience of RA and PA, practice of strength 
training at group sessions 
Social support Group sessions promoting physical activity, and 
also participants encouraged to seek support 
from other people (partner, family or friends) 
Self-control Weekly goal setting, self-monitoring via 
pedometer and PA diary, problem solving of 
their PA barriers 
Behavioural capability Knowledge and skill to perform PA through 
planning of weekly goal and how to overcome 
PA barriers, either in education session 
activities or during discussion with 
physiotherapist in monthly phone call 
Outcomes expectation Raise awareness and knowledge regarding RA, 
CVD and PA. The benefits of being physically 
active (joints, health in general and mood) 
Individual motivation  Verbal encouragement during phone calls with 
physiotherapist and from other participants in 
the sessions 
 
Recent evidence has demonstrated that interventions that include BCTs (goal 
setting, feedback on outcomes of behaviour, action planning, problem solving 
and social support) are more effective in enhancing self-efficacy for PA and 
promoting PA behaviour (Olander et al., 2013). In addition, John et al. (2011a) 
concluded that participants should be trained in BCTs such as goal setting and 
the self-monitoring of behaviours to improve the outcomes of the intervention. 
The following sections discuss the BCTs that were chosen and used in the WARA 
intervention based on the evidence of their effectiveness in increasing PA 
behaviour. 
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3.4 Behavioural change techniques 
A behaviour change technique (BCT) is defined as a technique in which there is a 
consistent set of activities organised to modify a particular behaviour (Cane et 
al., 2012, Michie et al., 2011b). A number of BCTs have been reported to 
promote positive lifestyle change, therefore in this study the most effective 
BCTs used in RCTs promoting PA were chosen. A review of 25 RCTs found that 
the most effective BCTs that influence PA in short-term interventions among 
inactive adults were feedback, behaviour practice and graded goals (Howlett et 
al., 2015). In addition, the intervention would be effective in the long term if it 
also included action planning, instructions on how to perform the behaviour and 
self-reward (Howlett et al., 2015). In another systematic review, action planning 
and providing instruction were found to be related to increasing self-efficacy 
and PA in healthy adults (Williams and French, 2011). Engagement with social 
support, goal-setting and self-monitoring and targeting healthy lifestyles, such 
as promoting PA and a healthy diet, increased the effectiveness of interventions 
designed to promote changes in diet and/or physical activity (Greaves et al., 
2011). 
Behavioural change interventions utilising goal setting, self-monitoring, and 
feedback on behaviours may increase self-efficacy for PA among people with RA 
(Smarr et al., 1997). Furthermore, a review concluded that self-monitoring and 
goal setting were the most employed technique in studies promoting PA in 
people with RA (Larkin et al., 2015b). Thus, goal setting, self-monitoring, 
feedback, action planning and social support are the BCTs that were mostly 
used, and they seem to be effective in promoting PA. The following sections 
discuss the BCTs used in the WARA intervention. 
3.4.1 Goal setting  
Goal setting is a motivational technique that involves setting a specific goal to 
enhance the performance of an individual (Lunenburg, 2011, McCarthy et al., 
2010) by making the individual focus their attention on their task and on 
developing new learning strategies (McCarthy et al., 2010). 
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Setting SMART goals (specific, measurable, achievable, realistic and time-bound) 
is the most effective tool to achieve the objective (Lunenburg, 2011, McCarthy 
et al., 2010). When setting a SMART goal the following should be considered: 
what the individual wants to achieve, and how they will achieve it; a plan of the 
steps to achieve the goal; a breakdown of the goal into smaller targets; a 
written document that helps the person feel that the goal is tangible and that it 
is necessary to commit to reaching within a specific time period (Lunenburg, 
2011, McCarthy et al., 2010). 
To increase the effectiveness of PA programmes in RA, the goal needs to be 
realistic (Withall et al., 2016). Setting appropriate goals and achieving those 
goals plays an important role in enhancing self-efficacy, which impacts on PA 
behaviour (Lunenburg, 2011). An increase in self-efficacy for PA is observed if it 
is specified how the goals are to be achieved (Olander et al., 2013). This 
increases the belief in personal capabilities and efficacy, and leads to higher 
motivation and less stress (Michie et al., 2011b, Williams and French, 2011). 
3.4.2 Self-monitoring of behaviour 
Self-monitoring involves the individual recording their own specific behaviour 
(Cane et al., 2012). Interventions that encourage participants to self-monitor 
their behaviours are more likely to achieve behaviour change (Michie et al., 
2011b, Williams and French, 2011). The use of a physical activity diary plays an 
important role in self-monitoring which then influences adherence (Conn et al., 
2011, Dalle Grave et al., 2011). 
3.4.3 Feedback on outcomes on behaviour 
Feedback on outcomes of behaviour increases decision-making by increasing 
participants’ understanding of the details of the target that has to be achieved, 
and can also improve the outcome. For example, unhealthy behaviour (physical 
inactivity) can lead to consequences in the future, therefore, decision-making is 
driven by long-term consequences rather than immediate outcomes (Brown, 
2006, Ivers et al., 2012). It can motivate participants to continue certain 
behaviours they have acquired or it may provide them with a direction for 
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adjusting their behaviour in order to achieve a targeted goal (Artinian et al., 
2010).  
3.4.4 Action planning  
Action plans describe what, where and how a goal will be achieved (Michie et 
al., 2011a). It has been found BCTs such as action planning are associated with a 
significant increase in self-efficacy for PA in obese adults (Olander et al., 2013) 
and play an important role in the improvement of individual self-efficacy and PA 
(Williams and French, 2011).The first step of an action plan is to identify a 
SMART goal or set of SMART goals to achieve (Lunenburg, 2011, McCarthy et al., 
2010). The behaviour goal should be reviewed regularly and according to the 
situation, further plans made for progression toward the SMART goal (National 
Institute for Health and Care Excellence, 2013, Niedermann et al., 2004). To 
apply action planning, it is important to provide instruction to the participants 
during the education sessions, to encourage them to plan how they will reach 
their step goal and to help individuals to achieve their behavioural goal 
(Niedermann et al., 2004, Riemsma et al., 2003). 
3.4.5 Problem solving 
Problem solving is a process with a sequence of activities that includes problem 
identification, generation of alternatives and selection of solutions (Ashford et 
al., 2010). Problem-solving affected by attitudes and beliefs, and the problem-
solving process includes how the individual attempts to handle the situation 
(Niedermann et al., 2004). For example, it is important to identify the barriers 
or obstacles to PA, such as poor weather, that might interfere with the 
implementation of walking plans. Barriers should be overcome by finding a 
solution that successfully copes with such problems, such as walking in a 
shopping centre in poor weather instead of at a park (Centers for Disease 
Control and Prevention., 2011). 
3.4.6 Relapse Prevention  
Relapse prevention aims to teach individuals how to anticipate and cope with a 
relapse (Hendershot et al., 2011). Relapse related to PA is defined as a return to 
physical inactivity (Williams and French, 2011). In relapse prevention training in 
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one study, the participants were taught about relapse and were able to practise 
skills to identify and cope with high-risk situations that might lead to relapse, 
such as the weather or personal problems (Hagobian and Phelan, 2013). To 
prevent relapse, programmes should increase the knowledge of patients 
regarding the benefits of PA, identifying motivational barriers that people could 
face, and enhancing their ability to plan strategies to overcome or avoid risky 
situations (Hagobian and Phelan, 2013). In addition, an effective strategy in 
preventing relapse involves supporting individuals by follow-up texts, emails, or 
telephone calls by the health provider (Wu et al., 2016, Burke et al., 2005).  
3.4.7 Social support 
Social support can increase PA behaviour (Olander et al., 2013). Social support 
could be provided by friends, relatives, colleagues or a group that share the 
same interests. People who receive more social support tend to have high levels 
of self-efficacy (Kim et al., 2008). A number of intervention studies revealed 
that social support helps to encourage, motivate and increase self-efficacy 
(Riemsma et al., 2003, van Achterberg et al., 2011). Providing an education 
programme in groups is a form of social support and may play a role in improving 
individual self-efficacy (Somers et al., 2012). Friendly contact between 
participants or with their other forms of social support can provide spiritual or 
material assistance to individuals when they are facing some difficulties in their 
PA task. Social support helps individuals to cope with stress, enhances their self-
confidence and improves their self-efficacy (Miller and Dimatteo, 2013, Wang et 
al., 2015). 
To implement the lifestyle intervention programme, the acceptability and 
adherence of participants to the programme is an important issue (Blekken et 
al., 2015). To achieve successful programme implementation, the mode of 
delivery, and the duration of the programme should be considered (Carroll et 
al., 2007). The following section discussed the relevant literature concerning the 
mode of delivery and duration of PA programmes, specifically in relation to RA. 
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3.5 Duration and mode of delivery of physical activity 
programmes for people with rheumatoid arthritis 
3.5.1 Programme duration  
The effectiveness of interventions vary considerably among studies, and is 
related to the purpose and the duration of the intervention. Different studies 
use different intervention durations: short-term (brief intervention), medium- 
and long-term intervention (extended intervention). Brief interventions may 
range from single education sessions to three sessions lasting up to 30 minutes 
(McQueen et al., 2011). An extended intervention consist of multiple education 
session(s) (National Institute for Health and Care Excellence, 2014). 
Education programmes designed to increase the knowledge of RA patients’ can 
be delivered as several sessions on consecutive days (Abourazzak et al., 2009), 
weekly sessions over several weeks such as 5 weekly sessions (Riemsma et al., 
2003) or 6 weekly sessions (Lovisi Neto et al., 2009). It has been found that a 
short-term group education session in RA is unlikely to maintain its effect over 
the long term (Riemsma et al., 2004). Although long-term interventions that last 
more than six weeks are more successful, they carry an inherent risk of attrition 
(Riemsma et al., 2004). The arthritis self-management programmes were shown 
to have a small but significant effect on increasing PA among osteoarthritis 
patients when the programmes were offered for less than 12 months. The effect 
of the intervention was reduced when the programme exceeded 12 months. 
A review of 11 randomised controlled trials of patient education in RA identified 
varied educational interventions that have been implemented. Although none of 
the short-term interventions showed a significant change in health status, 
improvements in the knowledge and compliance in short and long term of 
patient’s education were generally observed. However, only two studies of long 
term interventions showed improvement in health status. A future strategy to 
maintain short-term improvement over long intervals of time is recommended 
(Niedermann et al., 2004). 
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3.5.2 Mode of delivery of physical activity programmes in 
rheumatoid arthritis  
To change an inactive lifestyle to an active lifestyle, it is important to motivate 
and encourage people. Behavioural interventions may be delivered in different 
ways, through computer-mediated programmes and computer-based formats 
(Dunn et al., 1998, Portnoy et al., 2008), by SMS text messaging (Muller et al., 
2016, Shaw and Bosworth, 2012), face-to-face in small groups (Conn et al., 2011, 
Noordman et al., 2012, Riemsma et al., 2004) or individual face-to-face 
(Noordman et al., 2012). 
In order to encourage people to become habitually physically active over the 
long term, support should be offered at regular intervals (National Institute for 
Health and Care Excellence, 2014). Interventions delivered by face-to-face 
methods (mentored meetings, led walks, or educational sessions) significantly 
increase the levels of self-reported walking (Ogilvie et al., 2007). 
Interventions based on education sessions are the most popular strategy used in 
arthritis self-management programmes (Warsi et al., 2003). Benefiting from the 
social support of a peer group, participants have an increased desire to succeed 
due to a sense of commitment to the group. There is also increased adherence 
of participants to the programme and the number of withdrawals is reduced 
(Appel et al., 2003, Artinian et al., 2010, Wadden et al., 2005). 
In addition, incorporating telephone, text or email support from the group or the 
facilitator encourages participants to engage in the programme (Kozica et al., 
2015). Frequent contact with participants can provide many advantages, such as 
the establishment of trust between the participants and the provider (Appel et 
al., 2003, Artinian et al., 2010, Wadden et al., 2005). 
A systematic review was undertaken of 11 studies comparing PA interventions 
with a placebo, or no interventions in community-dwelling adults with 
symptomatic knee or hip osteoarthritis (2741 participants, mean age 62.2 years) 
(Williamson et al., 2015). Randomised controlled trials published between 1997 
and 2013 were considered in the review. The programmes were delivered face-
to-face and involved supervised exercise with the majority of the trials 
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incorporated an arthritis self-management programme, targeting self-efficacy 
and coping skills of the patients. No specific effective mode of delivery was 
noted possibly due to the small number of RCTs included in this review 
(Williamson et al., 2015).  
A Cochrane systematic review by Riemsma et al. (2004) aimed to determine the 
effectiveness of patient education on health status in RA. This review compared 
the results of various kinds of studies including those which provided information 
only (9 studies; 687 patients), counselling (5 studies; 430 patients) and 
behavioural intervention versus control groups (24 studies; 2,493 patients). 
It concluded that any successful education programmes for people with RA, 
needs to be designed in the format of group education, as this improves 
participants’ compliance and adherence to programmes and enhances 
motivation for behaviour change. Although this review is more than 10 years old, 
the more recent review of John et al. (2011a) supports these findings concluding 
that participants should be trained in BCTs such as goal setting and the self-
monitoring of behaviours. The intervention should aim to improve participants’ 
knowledge, increase their self-efficacy for PA, and improve their behavioural 
and clinical outcomes.  
3.6 Ongoing support (booster sessions) 
Booster sessions, are defined as additional sessions after the main sessions have 
ended, in order to reinforce any progress that had been made since the 
preliminary sessions have been conducted (Stuart-Shor et al., 2012). Booster 
sessions help people to maintain recently adapted behaviour such as increased 
PA levels acquired following the programme sessions that may help to avoid a 
relapse (Goyder et al., 2014). The evidence suggests that several group-based 
sessions with follow-up (booster) sessions are more effective than a single 
session (Evans, 2011).  
A study conducted by Abbott et al. (2015) aimed to investigate whether 
booster sessions of exercise therapy over a year could improve outcomes by 
comparing a programme consisting of exercise therapy with booster sessions to 
one without booster sessions. The intervention consisted of aerobic, 
strengthening, stretching exercise and neuromuscular control exercises. All 
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participants were provided twelve 45-minute sessions of exercise therapy, 
supervised and progressed by a physical therapist. Booster sessions were defined 
as sessions of supervised therapy provided at intervals of time after the 
consecutive sessions, with intervening periods of no supervised therapy. The 
participants received 8 consecutive sessions in the initial 9 weeks with 4 booster 
sessions (2 booster sessions at 5 months, 1 booster session at 8 months, and 1 
booster session at 11 months). It was reported that a 3-month interval between 
the booster sessions was selected due to the fact that the benefits from the 
exercise programmes may decline within this period. The results showed a 
significant improvement in the physical function of participants who received 
exercise therapy with booster sessions, compared to participants who received 
exercise therapy alone. However, although they were successful in improving 
physical function no theory or BCTs was described.  
An RCT was carried out on people with osteoarthritis. The participants were 
randomly allocated to a group that received 12 weeks of physiotherapist- 
supervised exercise with two booster sessions (230 minutes) over 24 weeks, or to 
a group that received 12 weeks of physiotherapist-supervised exercise with no 
booster sessions (control). All of the participants were asked to perform their 
home exercises 4 times/week. No significance difference was found between 
groups in terms of pain. It was concluded that two booster sessions did not 
influence the outcomes or programme adherence (Bennell et al., 2014). The low 
number of booster sessions over 24 weeks, and also the fact that the programme 
did not explicitly incorporate BCTS and was not constructed on the behaviour 
theory could explain the reason for the failure.  
An assessor blinded RCT targeted PA in people with osteoarthritis was 
undertaken where participants were randomised into an intervention group that 
received 18 sessions of behavioural activity over 12 weeks and then 7 booster 
sessions over a year, and a control group that received 18 sessions of usual care 
over 12 weeks without booster sessions (Pisters et al., 2010). There was a 
significant difference between groups. The behavioural activity group had higher 
adherence to the programme and met more of the recommendations of PA than 
the usual care group (Pisters et al., 2010).  
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3.7 Summary  
The evidence suggests that the effectiveness of programmes aimed at increasing 
PA is increased if they are delivered in face-to-face sessions, with booster 
sessions in small groups, and with theory based interventions combined with 
behavioural change techniques.  
The Walk for Rheumatoid Arthritis (WARA) intervention is a lifestyle intervention 
that has been designed to target PA behaviours. It aims to increase PA and 
encourage a healthy diet, to improve health outcomes and reduce CVD risk in 
people who have been diagnosed with RA within the last five years. The WARA 
intervention was designed with group education sessions and provides 
participants with written information in the form of a WARA booklet. 
3.8 Description of the WARA intervention 
The WARA intervention consisted of a physical activity component and an 
educational component. The PA component focused on a pedometer supported 
walking programme and strength exercises based on the UK physical activity 
guidelines (2011). The educational component consisted of six weekly sessions in 
small groups of up to six people and two booster sessions (at three and six 
months); the following sections explain the intervention structure and the 
contents of the WARA intervention. 
3.8.1 Structure of the WARA Intervention 
During the first six weeks’ participants attended a one-hour session. During this 
education session, a number of topics were considered, and were discussed 
interactively with the participants, Table 3-3.  
After the six weeks of education sessions, the physiotherapist contacted the 
participants at the end of weeks 7, 9 and 11 (i.e. when their step target 
increased by 1000 steps or changed from three to five days) to the end of the 
intervention (6 months). Contact was made either by phone or email according 
to individual preference and the physiotherapist discussed the participant’s step 
counts for the past month and their step goals for the following month, also any 
PA barriers they faced and how they planned to overcome them. Participants 
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were told to make contact with the physiotherapist if they had any further 
questions or problems.  
The WARA intervention also involved two group booster sessions, after 3 and 6 
months. The aim of the booster sessions was to encourage participants' 
maintenance of, and motivation towards, their PA by providing support to the 
participants, to evaluate their own barriers to PA and to encourage them to 
continue to use their pedometers and to record their steps in their PA diary. The 
participants were encouraged to plan how to deal with anticipated obstacles.  
3.8.2 Content of the WARA intervention 
The programme consisted of two components; a physical activity component and 
an educational component. The PA component focused on walking and strength 
exercises based on the UK physical activity guidelines. The WARA programme 
was based on SCT and BCTs.  
1 Physical Activity Component  
A pedometer (DIGI WALKER SW-200, Japan) was given to each individual in the 
intervention group at the first education session. Participants were instructed to 
wear the pedometer on the waist band above the hip during all waking hours and 
daily PA. The only exceptions were when they were immersed in water (bathing 
or swimming) or in bed at night. They were also instructed to reset the 
pedometer to zero at the beginning of each day and remove it at the end of the 
day. They were given a physical activity diary in which they were asked to 
record: the time the pedometer was attached, removed and total number of 
steps displayed on the pedometer at the end of each day. Weekly PA diaries 
were given to participants during the six-month intervention period.  
Baseline PA (defined as the average number of steps taken per day) was assessed 
during the first week using the pedometer. The participants were asked to wear 
the pedometer in week 1 while performing their normal PA, record the results in 
their PA diary, and bring the diary with them to the week 2 session. The mean 
daily step count of participants in week 1 was calculated by the physiotherapist, 
this figure represented the participant’s baseline PA. The participants were 
asked to add 1000 steps to their baseline value and this would be their step goal 
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for three days/week for the next two weeks, then 5 days/week for two weeks, 
see Table 3-2. 
Table 3-2 Weekly walking goal of intervention group 
 
Week of programme Steps count goal 
Week 2- week 3 Extra 1000 steps above baseline value on 3 days 
/week 
Week 4- week 5 Extra 1000 steps above baseline value on 5 days 
/week 
Week 6-week 7 Extra 2000 steps above baseline value on 3 
days/week 
Week 8-week 9 Extra 2000 steps above baseline value on 5 
days/week   
Week 10-week 11 Extra 3000 steps above baseline value on 3 
days/week  
Week 12-week 26 Extra 3000 steps above baseline values on 5 
days/week  
Modified from Fitzsimons et al. (2012) 
The aim of the WARA programme was for the participants to increase their 
average daily step count 3000 above their baseline value on at least 5 days of 
the week by 6 months and to maintain this for a further 6 months. The evidence 
suggests that the using pedometers, which provide feedback to users and assist 
in self-monitoring of PA behaviour, is one of the most effective approaches used 
to increase PA. It typically facilitates an increase in daily step count of 2000-
3000 steps/day over 12- 24 months (Harris et al., 2013, Tudor-Locke and Bassett, 
2004). An adult walking at a moderate pace takes approximately 100 
steps/minute (1000 steps in10 minutes).  
The walking programme was adapted from Baker et al. (2008a) where it was 
used successfully to increase walking and reduce sedentary behaviour in a 
community population in Scotland, aged 25–61 years (Baker et al., 2008b). 
Adding incremental targets to the average step count for people who are 
physically inactive may make it optimally challenging for them to increase their 
step count (Tudor-Locke et al., 2011a). However, in Baker et al. (2008a) the 
population was healthy and the goal of the walking programme was an increase 
of 1500 steps, maintained for 2 consecutive weeks. With the WARA intervention, 
the population had RA, therefore the goal of the walking programme was 
modified to an increase of 1000 steps maintained for 2 weeks.  
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Participants who achieved 3000 steps above their baseline after the initial 6 
weeks were asked to maintain that daily step count. Participants who did not 
reach this target were encouraged to continue to try to increase their step 
count, unless they had health problems that prevented them from so doing, such 
as joint pain, dyspnoea or tiredness.  
During the fourth education session, i.e. one month after beginning the 
programme, participants were asked to add strengthening exercises to their 
programme. This involved strengthening exercises for the major muscles of the 
lower limb, trunk and upper limb at home twice a week, with 8-12 repetitions of 
each exercise in accordance with the UK physical activity guidelines (2011). 
Participants were encouraged to keep a record of their strengthening exercises 
in the PA diary, recording time, duration and any barriers to performing the 
exercise and how these were overcome. 
2 Education Component 
Participants attended six weekly sessions in small groups of up to six people; the 
content of the sessions was based on social cognitive theory and the behaviour 
change techniques in order to allow participants to challenge their way of 
thinking, and change negative coping skills, cognition and emotions (John et al., 
2013). The sessions were interactive, took place at the participants’ local 
hospital and each session lasted approximately one hour. The sessions were 
facilitated by a physiotherapist who offered advice and assisted the participants 
to overcome their PA barriers, create action plans, self-monitor using a 
pedometer and programme PA diary and problem solve, see Table 3-3. 
Participants received education material in the form of a booklet that contained 
information describing the importance of both walking and a healthy diet for 
health benefits and the reduction of CVD risk and other co-morbidities of RA. 
The education material also discussed the importance of reducing sedentary 
behaviour and explained the strengthening exercise. In order to assess 
participant’s knowledge, it also included quizzes about RA, with some closed 
questions requiring e.g. Yes, or No answers (Is pain a symptom of Rheumatoid 
Arthritis?); or they could tick more than one choice, for example ‘From this list 
What other organs could be involved in Rheumatoid Arthritis? or open questions 
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such as ‘What are the benefits of physical activity in general and in relation to 
Rheumatoid Arthritis?’ The written material was presented in large text Times 
New Roman font, size 14 (Appendix 14). The facilitators’ manual was developed 
which helped maintain the consistency of delivery of the programme between 
groups. 
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Table 3-3 Content of WARA education sessions and behaviour change techniques 
 
Label Content BCT Process 
First 
education 
session 
CVD, RA, Risk of CVD in RA, the 
importance of PA, the 
importance of reducing 
sedentary behaviour, instruction 
and practice on how to use 
pedometer.  
Self- monitoring 
of behaviour 
Pedometers and PA diaries were given to each 
individual. They were instructed on how to use them. 
Second 
education 
session 
Exercise and PA and barriers to 
PA, discussion on the 
importance of social support. 
Goal setting  
 
 
 
 
Feedback on 
behaviour  
 
 
Problem solving 
 
 
Social support  
The participants set a step goal and planned how to 
achieve it. Each participant wrote their goal for the 
next week, using the SMART framework (specific, 
measurable and achievable, realistic and time 
limited). 
Review of activity diaries and immediate feedback 
from the pedometer raises the participants’ 
awareness regarding the current walking behavior. 
 
The participants discussed their problems and how to 
overcome them. That was done both individually and 
group.  
Providing the education programme in groups was a 
form of social support. The participants were 
encouraged to walk together at times if appropriate. 
Participants were asked to identify who might provide 
social support and how that would be provided. 
Third 
education 
session 
How to reduce the risk factors 
of heart disease in RA via 
healthy lifestyle. 
Goal setting 
Feedback on 
behaviour  
The participants were motivated to set a new goal. 
Review of PA diaries.  
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Action planning 
 
 
 
 
 
 
 
 
 
Relapse 
prevention 
 
Instructions were provided during the education 
session which encouraged participants to plan how 
they would reach their step goal (SMART goal). In 
addition, the physiotherapist encouraged the 
participants to plan their goal for the next few weeks 
and to write their own plans individually in the 
workbook– where, when, and who they would walk 
with. They also recorded any problems that they 
faced, how they overcome them and how they knew 
they had achieved their goal. 
Participants were taught about relapse and the skills 
needed to identify and cope with high-risk situations 
that might lead to relapse to sedentary or physical 
inactivity. The participants were encouraged to 
generate or suggest strategies to help overcome any 
problems to prevent or minimize the relapse. 
Fourth 
education 
session 
Relevance and importance of 
strength training and 
opportunity to practice 
exercises. 
Goal setting  
 
Feedback on 
behaviour  
Action planning 
 
The participants were motivated to set a new goal.  
 
Review of PA diaries. 
 
Participants planned their goal for the next week. A 
goal in relation to PA strength training was added.  
Fifth 
education 
session 
Healthy diet, how to reduce the 
risk of heart disease through 
dietary change.  
Goal setting 
 
Feedback on 
behaviour  
Action planning  
The participants were motivated to set a new goal.  
 
Review of PA diaries. 
 
Participants planned their PA goal for the next week.  
Sixth 
education 
Social support, maintaining 
change and review/revision of 
Goal setting 
Feedback on 
The participants were motivated to set a new goal.  
Review of PA diaries. 
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session the importance of reducing 
sedentary behaviour. Discussion 
around the implementation of 
the walking programme for the 
next 6 weeks.  
behaviour  
Relapse 
prevention 
 
 
 
 
 
Social support 
 
 
Action planning  
 
Participants were taught about relapse and the skills 
needed to identify and cope with high-risk situations 
that might lead to relapse to sedentary or physical 
inactivity. The participants were encouraged to 
generate or suggest strategies to help overcome any 
problems to prevent or minimize the relapse. 
 
Participants were asked to identify who might provide 
social support and how that would be provided. 
 
Participants planned their goals for the next 6 weeks 
and to write their own plans individually. 
First 
booster 
session 
Review the progress made over 
the previous six weeks. Discuss 
any barriers, and tips to avoid 
too much sitting, 
encouragement, motivation of 
the participants to continue in 
this programme. 
Feedback on 
behaviour  
Problem solving 
 
Relapse 
prevention 
Review of PA diaries. 
 
Discuss how participants overcome their PA barriers 
they have faced. 
Participants were asked to plan strategies to avoid 
relapse individually. 
Second 
booster 
session 
Review the progress made over 
the previous three months, 
barriers to PA and how to 
maintain their PA. 
Feedback on 
behaviour  
Problem solving 
 
Relapse 
prevention 
Review of PA diaries.  
 
Discuss how participants overcame any PA barriers 
they may have faced. 
 
Group discussion how to maintain their PA. 
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4 Literature Pertaining to the Methodology 
This chapter reviews the outcome measures used in this study and provides 
justification for the quantitative and qualitative methods used. It also presents 
evidence of the reliability and validity of the outcome measures chosen. 
4.1 Mixed methodology 
Quantitative and qualitative research methods have their strengths and 
weaknesses and they can be extremely effective when used in combination 
(Curry et al., 2009, Bryman, 2006, Harwell, 2011). Quantitative methods are 
commonly used to measure the impact of disease activity and clinical 
interventions, using a number of approaches such as instrumental tools and 
laboratory tests (Curry et al., 2009). The findings of phenomena studied by way 
of quantitative methods can be generalised and the time taken over data 
analysis can be reduced by using statistical software; however, general findings 
achieved in this manner may not be applicable to specific situations, individuals 
or contexts (Kruger, 2003). The quantitative method is based on numerical data 
and it has the benefit of allowing a comparison between variables, facilitating 
the comparison of results over time, allowing an understanding of relationships 
between variables and establishing cause and effect (Curry et al., 2009, Harwell, 
2011). 
Qualitative research is an in-depth approach that allows an understanding of the 
area under investigation (Bryman, 2006, Harwell, 2011). There are many 
methods by which to collect qualitative data such as interviews, focus groups 
and the observation of events or people in order to discern behaviour and their 
interaction within natural settings (Curry et al., 2009). The interview approach 
used in qualitative research can be directed by the researcher in the case of 
semi-structured interviews or focus group (Harwell, 2011). However, it is 
dependent on the researcher’s skills and can potentially be influenced by the 
researcher’s prejudices, interpretations and descriptions (Curry et al., 2009, 
Kruger, 2003). 
In this study, a mixed methodology was chosen in order to strengthen the study 
and to comprehensively answer the research questions. The outcome 
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measurements at baseline, three, and six months generated quantitative data. 
Qualitative data was obtained by way of semi-structured telephone interviews at 
six months (the end of the intervention) in order to explore participants’ views. 
4.2 Basic concepts of clinical measurements 
Clinical measurements are used to monitor changes in disease activity and 
responses to pharmacological and non-pharmacological interventions (Combe et 
al., 2017). The psychometric properties of outcome measures; reliability, 
validity and accuracy are important for both research and clinical practice 
(Wade D T, 2004, Roach, 2006, Streiner, 2015). Understanding the psychometric 
properties of the outcome measures is important in order to select the best 
measures for a particular purpose (McGoey et al., 2010, Roach, 2006). Outcome 
measures are important in terms of decision making in relation to healthcare 
provision for patients (Curry et al., 2009). In addition, outcome measures help to 
evaluate the patient’s response to a particular intervention (Boers et al., 2014). 
4.2.1 Reliability 
Reliability is an indicator of the accuracy of a measurement over time and under 
similar conditions (Streiner, 2015, Roach, 2006). There are several types of 
reliability. The first type is test–retest reliability where measurements are 
collected on more than one occasion, with the assumption that no real change 
will have occurred between sessions (Streiner, 2015, Roach, 2006). Another type 
of reliability, known as internal consistency, is a measure of the extent to which 
all items in an outcome measure address the same underlying concept (McGoey 
et al., 2010, Streiner, 2015). 
Participating raters should be adequately trained to administer and score 
measures; otherwise, measurement errors may occur, which will adversely 
affect reliability (Streiner, 2015, McGoey et al., 2010, Fitzpatrick et al., 
1998).There are two types of rater reliability: intra-rater reliability indicates 
how consistently a rater administers and scores an outcome measure, while 
inter-rater reliability indicates how well two or more raters agree on the way in 
which they administer and score an outcome measure (Streiner, 2015). An 
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outcome measure can be considered reliable only for a particular purpose with a 
particular type of subject (McGoey et al., 2010). 
4.2.2 Validity 
Validity is an indicator of whether an outcome measure is appropriate for the 
proposed purpose (Roach, 2006, McGoey et al., 2010, Fitzpatrick et al., 1998). It 
expresses the ability of a test to measure what it is supposed to measure 
(McGoey et al., 2010, Streiner, 2015). There are many types of validity, 
including concurrent validity, which can be determined by administering two 
tests simultaneously (the results of which should be consistent) and construct 
validity, which reflects the ability of a test to measure the underlying concept of 
interest to the clinician or researcher (Streiner, 2015). A number of strategies 
are employed to examine the construct validity of an outcome measure, 
including applying the test to groups of subjects who are known to differ on the 
construct of interest; the test scores of the groups will differ if the test actually 
measures what it is supposed to measure (McGoey et al., 2010, Roach, 2006). 
4.2.3 Floor and ceiling effects 
Related to the validity measurement is the influence of floor and ceiling effects. 
A floor effect is present where participants cannot achieve the minimum score 
of a measurement (Wang et al., 2009, Lim et al., 2015). Floor effects may occur 
when participants find the task too difficult so no improvements occur (McBee, 
2010, Windle et al., 2011). In order to overcome this problem, a pilot study can 
help to identify if there are any floor effects (Wang et al., 2009). A ceiling 
effect occurs when participants achieve the highest score on a measurement; 
this may happen if a test is relatively easy, allowing high-scoring participants to 
answer every item correctly and reach the highest possible score (Lim et al., 
2015, McBee, 2010). Ceiling effects can lead to unrealistic and biased results in 
data analysis and parameter estimation (Lim et al., 2015, Wang et al., 2009). 
Both described situations are considered problematic and will lead to an 
inaccurate representation of the outcome measure results. In this situation, so 
as to compensate for any floor and ceiling effects, the use of secondary outcome 
measures is recommended (Fries et al., 2014, Wang et al., 2009). In order to 
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avoid floor and ceiling effects in this study, a pilot of the intervention and 
outcome measures was undertaken and, in addition, primary and secondary 
outcome measures were employed. 
4.3 Study outcome measures 
The primary outcome measures in the current study were objective and 
subjective measures of PA, while secondary outcomes were related to RA and its 
consequences: disease activity, quality of life, functional capacity, 
cardiovascular risk factors, dietary assessment, PA self-efficacy and co-
morbidity. 
A large number of outcome variables have been used in recent decades to 
evaluate RA disease activity in clinical trials, and Core Outcome Measures in 
Effectiveness Trials (COMET) have been developed in order to improve the 
outcome measurements for many rheumatologic conditions such as RA, 
ankylosing arthritis and osteoarthritis (Boers et al., 2014). COMET classifies the 
core areas of health conditions into death, life impact, resource use, 
pathophysiology of the area of manifestation and contextual factors that are not 
the primary objects of the research, but may influence the results or 
interpretations (Boers et al., 2014, Prinsen et al., 2016). The outcome measures 
of the current study were included in the Core Outcome Set (COS), “A COS is 
defined as an agreed minimum set of outcomes that should be measured and 
reported in all clinical trials of a specific disease or trial population” (Prinsen et 
al., 2014). 
Efforts have been made to standardise the assessment of RA in order to allow 
study results to be interchangeable, for the purpose of both comparing study 
results and allowing meta-analyses to be carried out. The quantitative data of 
this study were generated by the way that both assessors rated the outcome 
measures, and self-administered questionnaires. 
4.3.1 Physical activity assessment 
Several methods can be used to assess PA including objective and subjective 
methods. PA can be objectively measured using such as activPAL™, or Actigraph 
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or using more simple devices such as pedometers (Broderick et al., 2014, 
Vanhees et al., 2005). Subjective methods include questionnaires such as 
international physical activity questionnaires (IPAQ) and PA diaries (Vanhees et 
al., 2005). Measures of PA gathered using objective methods are more accurate 
and less open to bias in comparison with subjective methods (Reilly et al., 
2008). Objective methods can provide data on the degree of PA and sedentary 
behaviour, and also allow an examination of the dose response of PA and health 
outcomes (Reilly et al., 2008, Vanhees et al., 2005). Therefore, it has been 
recommended that clinical trial studies assessing interventions related to 
changes in PA should use objective methods in order to confirm and quantify the 
magnitude of any changes (Reilly et al., 2008). 
Despite the advantages offered by objective methods of assessing PA and 
sedentary behaviour, they have several limitations: it is difficult to quantify non-
walking activities such as swimming and cycling; the participants have to 
remember to wear the device for several days; there is a lack of context of the 
activities; and they are more expensive than subjective methods (Bassett, 2003, 
Hoos et al., 2012). A number of studies recommend that both objective and 
subjective methods should be utilised in order to assess actual and contextual PA 
(Andre et al., 2006, Bassett Jr, 2000). In this study, activPAL™ inclinometers 
were selected to measure objective PA and the International Physical Activity 
Questionnaire short form (IPAQ) (Oyeyemi et al., 2011) was used to assess 
subjective PA. 
1 activPAL™ monitor 
The activPAL™ is a commonly used PA monitor (PAL Technologies Ltd, Glasgow, 
Scotland), it is a small, single unit device (Vanhees et al., 2005). The activPAL™ 
contains a uni‐axial accelerometer that responds to gravitational acceleration as 
well as acceleration resulting from segmental movement (Edwardson et al., 
2016). From the inclination of the thigh, posture can be classified as 
sitting/lying, standing or walking. In addition, lower limb movement can provide 
information relating to step number and cadence (Ryan et al., 2006). The device 
has a substantial processing capacity and memory, allowing activity and posture 
to be recorded continuously for periods of up to ten days (Vanhees et al., 2005). 
To assess habitual PA with intra-class correlation coefficient (ICC) of 0.80, 3–4 
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day of monitoring is required, and to estimate patterns of inactivity and to 
achieve reliability (ICC) of 0.90 for all the activity indices seven days of 
monitoring are required (Harrington et al., 2011, Trost et al., 2005). 
Although the reliability and validity of the activPAL™ have been ascertained in 
assessing objective PA in both healthy and chronic cases, only one study has 
assessed its validity in people with RA (Larkin et al., 2016c). This study included 
24 patients with a confirmed diagnosis of RA; the participants wore one 
activPAL™ on each thigh under video recording and direct observation for 
criterion measures. The testing procedure consisted of tasks of activities of daily 
living (ADLs) such as reading newspapers, gardening or cleaning and components 
included sitting, standing, lying and walking on a treadmill; the duration of each 
activity (two, three, four or five minutes) was randomly chosen. 
The activPAL™ was accurate in its measurement of sitting time, walking and 
standing/light activity of the 20 RA patients included in the final analysis. 
However, underestimations of step counts of 26% were noted (Larkin et al., 
2016c). The sample size was small, the duration of data collection during 
walking periods was short and the gait speed of the participants was not 
reported. The validation of daily physical activities in a laboratory environment 
was also a limitation of Larkin et al.’s study. In addition, the participants of the 
Larkin study affected the movement patterns. Just under half of the participants 
were either overweight or obese, and the majority of the participants had an 
inactive lifestyle, potentially leading to inaccurate measurements. 
Ryan et al. (2006) determined that the activPAL™ monitor is a reliable and valid 
method for measuring walking speeds between 0.90m.s ˉ¹ and 1.56m.s ˉ¹ among 
the general population. A study conducted by Dowd et al. (2012) using the 
activPAL™ and Actigraph accelerometer to compare posture with sedentary 
behaviour in adolescent females aged 15-18 years revealed that activPAL™ and 
Actigraph have a high concurrent validity of (r = 0.96, P<0.01). The study 
concluded that activPAL™ is a valid tool for the measurement of PA and 
sedentary behaviours in female populations. 
It has been reported that activPAL™ is more accurate in measuring sedentary 
behaviour more than Actigraph and a study concluded that activPAL™ should be 
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considered for studies that aimed to examined sedentary behaviour(Steeves et 
al., 2015). 
Dahlgren et al. (2010) assessed the test and retest reliability of the activPAL™ in 
healthy individuals over a one week period and reported the activPAL™ to be a 
reliable method for assessing PA. High levels of correlation were reported 
between treadmill walking at 4.5 km/h on the flat and with a very high incline 
(ICC, 0.94 and 0.95 respectively), high incline treadmill walking at 3.2 km/h 
(ICC, 0.88), jogging at 8.0 km/h and stair walking (ICC 0.81 and 0.70), whereas a 
moderate correlation was identified between self-paced ground walking and 
cycling at 75 rpm (ICC, 0.69 and 0.55 respectively). 
Convenience samples of healthy individuals were included in the study 
conducted by Busse et al. (2009) in which the step count data from StepWatch 
Activity Monitors (SAMs), activPAL™ data and self-reported PA levels were 
analysed and compared. The intra-class correlation coefficient was used to 
determine reliability. The study revealed that activPAL™ provides accurate and 
reliable data related to actual PA. 
In another study, no significant difference was evident between the results 
achieved using activPAL™ and Actigraph and in video recorded step rates of 62 
female participants who walked from 3.2 km h−1 (slow speed) and 7.0 km h−1 
(fast speed) on the treadmill. However, at the slowest speed both devices under 
estimated the number of steps taken (P < 0.05) (Harrington et al., 2011). Kanoun 
(2009) reported that the activPALTM is a valid tool in assessing walking steps at 
0.67, 0.90 and 1.33m.s-1 and recommended further study to investigate the 
validation of activPALTM in the elderly with a slower walking speed of 0.45m.s-1. 
Pedometers are reliable tools for the measurement of steps during walking and 
running (Broderick et al., 2014, Vanhees et al., 2005). They can record 
movement in the vertical direction and are very useful for measuring total daily 
steps; as such, they are a useful tool in providing real time feedback to people 
to promote PA. However, pedometers are unreliable in recording sedentary 
behaviour, intensity of activity and kilocalories (Broderick et al., 2014, Vanhees 
et al., 2005). Overall, based on the evidence, activPAL™ is reliable and valid tool 
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using to assess PA and sedentary behaviour therefore in this study, PA and 
sedentary time were assessed using an activPAL™ activity monitor. 
2 International Physical Activity Questionnaire (IPAQ) 
Several methods have been used to subjectively assess PA, such as PA diaries 
(Bratteby et al., 1997, Sylvia et al., 2014), Global Physical Activity Questionnaire 
(GPAQ) (Hoos et al., 2012) and the International Physical Activity Questionnaire 
(IPAQ) (either short or long form) (Oyeyemi et al., 2011). 
Diaries are inexpensive and can provide details regarding daily PA. However, this 
method of data recording can lead to an under- or over-estimation of PA 
(Bratteby et al., 1997, Sylvia et al., 2014). The Global Physical Activity 
Questionnaire (GPAQ) was developed by the World Health Organisation (WHO) in 
2002 for PA surveillance as part of the WHO stepwise approach to the risk of 
chronic disease (Hoos et al., 2012). The GPAQ includes 16 questions to assess PA 
in various domains of work, transport and leisure time (Singh and Purohit, 2012). 
It was used in a study assessing PA in nine countries. Although a moderate to 
strong relationship was demonstrated between the IPAQ (described below) and 
the GPAQ (in the range 0.45 to 0.65), validation of GPAQ was found to be poor 
(Bull et al., 2009). 
The International Physical Activity Questionnaire (IPAQ) is available in both a 
long form (which consists of 31 items) and a short form (9 items) (Oyeyemi et 
al., 2011). It is a self-report questionnaire containing items related to leisure 
time PA, domestic and gardening activities, work-related PA and transport-
related PA carried out over the previous seven days (Appendix 6). Results from 
the IPAQ categorise individuals into three levels of PA: inactive, minimally active 
and Health Enhancing PA (HEPA) (a more active category). Inactive is the lowest 
level of PA, those individuals who not meet criteria for categories of minimal 
and HEPA. Minimally active is categorised as three or more days of vigorous PA 
for at least 20 minutes per day, five or more days of moderate intensity activity 
or walking for at least 30 minutes per day, or five or more days of any 
combination of moderate intensity or vigorous intensity walking. Meanwhile, 
HEPA relates to vigorous intensity PA on at least three days, or seven days or 
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more of any combination of moderate intensity or vigorous intensity walking 
(Guidelines for data processing and analysis of IPAQ, 2004). 
The short form IPAQ is a reliable and valid self-administrated questionnaire. A 
greater number of validation studies have been undertaken in relation to the 
short form IPAQ than any other PA questionnaire (Bull et al., 2009, Craig et al., 
2003).The reliability and validity of the IPAQ short and long forms have been 
examined in 12 countries (including the UK) and the method has been found to 
moderately agree with objective methods (accelerometer) (Craig et al., 2003). 
A study undertaken by Tierney et al. (2015) examined the validity of the short 
form IPAQ (IPAQ SF) in comparison with the Sense Wear Armband (SWA) in terms 
of energy expenditure from PA in 22 patients with RA. There was a non-
significant correlation between SWA and IPAQ SF (r=0.407, P=0.60). In addition, 
the SWA estimated energy expenditure more accurately than the IPAQ short 
form by 41%. The authors concluded therefore that the IPAQ SF is of limited use 
as an absolute method of estimating energy expenditure during PA in those with 
RA. 
The IPAQ short form has high test-retest reliability for active and sitting hours 
per day. Intra-class correlations range from 0.30 for moderate PA hours to 0.80 
for sitting hours (Kurtze et al., 2008). The IPAQ short form also exhibits a 
moderate and significant correlation with VO2max (r = 0.41, P ≤ 0.01) (Kurtze et 
al., 2008). Craig et al. (2003) reported that the IPAQ instruments have 
acceptable and reasonable reliability and validity when assessing PA of adults 
from 18 to 65 years in both developed and developing countries. Furthermore, 
Craig et al. (2003) concluded that there is no difference between the reliability 
and validity of the short and long form IPAQ. 
Based on the evidence of the reliability and validity of self-administered 
questionnaires (IPAQ), and in an effort to avoid burdening participants, the short 
form was selected in this study. In this study, a subjective measure of PA (IPAQ) 
was used to assess any changes in the manner of PA that were not measured by 
objective measures (activPAL™). Using both subjective and objective measures 
of PA allowed an assessment of the actual activity and the context of this 
activity. 
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4.3.2 Rheumatoid arthritis assessment 
1 Disease activity 
RA disease activity is a reversible aspect of the disease and is affected by 
multiple factors. The unpredictable course of RA and the varied clinical 
presentations of the disease can confound the process of measuring disease 
activity. Therefore, monitoring of disease activity requires a composite 
evaluation of a variety of clinical parameters. Several methods have been 
identified to provide physicians and patients with simple and comprehensible 
instruments to measure disease activity, such as the Disease Activity Score 
(DAS), DAS 28, the Simplified Disease Activity Index (SDAI) and the Clinical 
Disease Activity Index (CDAI). 
The Disease Activity Score (DAS) is an important tool used to discriminate 
between active disease and disease that is in remission; it helps also in the 
evaluation of treatment outcomes and facilitates clinical decisions (Anderson et 
al., 2012). The DAS or DAS28 involves assessing the number of swollen and 
tender joints and the ESR measure. The DAS measures 44 joints and DAS28 
assesses 28 joints. The DAS is scored between 0 and 10 (Smolen et al., 2003) 
where disease activity is categorised into: high: >5.1, moderate: >3.2 to 5.1, 
low: 2.6 to ≤ 3.2, and remission <2.6 (Fransen and van Riel, 2009). The remission 
category of the DAS28 has been criticised as it does not take into account good 
radiographic outcomes (Wechalekar et al., 2012). Provider (physician) global 
assessments are not included in DAS28 and it requires a more complex 
calculation (Anderson et al., 2012). 
The SDAI score is the sum of the following: joint tenderness and swelling, a 
patient global score, which is a visual analogue scale (VAS) 0-10 cm, a provider 
global score, which is physician global assessment of disease activity (VAS) 
0-10 cm and C-reactive protein mg/dl (Appendix 7). An SDAI value of 3.4-11.0 is 
low disease activity, moderate is >11-26, high activity values range from 26.1 to 
86 and the remission value is 0.0-0.3 (Smolen et al., 2003). 
CDAI is a patient and provider composite tool that comprises provider 
assessments - 28 swollen joint counts, and 28 tender joint counts. However, it 
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does not provide detailed joint counts reliably and it does not include laboratory 
acute-phase reactants (Anderson et al., 2012). 
The DAS, DAS28, SDAI and CDAI are all valid and potentially useful tools for 
evaluating disease activity with intra-class correlation coefficients ranging from 
0.85 to 0.89 (Gaujoux-Viala et al., 2012). However, the DAS28 is less effective in 
defining remission than SDAI (Gaujoux-Viala et al., 2012, Gilek-Seibert et al., 
2013). Balsa et al. (2010) assessed 97 RA patients considered as being in 
remission using the DAS 28 and the SDAI. They found a moderate correlation 
between the DAS28 and SDAI (r = 0.45, P < 0.001) however the SDAI was superior 
to the DAS 28 in determining remission. 
The SDAI is a valid and reliable tool for the assessment of RA (Balsa et al., 2010, 
Fleischmann et al., 2015), the treatment response and also for evaluating RA 
disease activity in routine clinical practice (Anderson et al., 2012, Smolen et al., 
2003). It has been stated that the SDAI is the most sensitive and specific for 
prediction of clinical decisions to change DMARD and the remission score of SDAI 
is one of the recommended definitions of RA remission by the ACR and EULAR 
2011 to be used in RA clinical trials (Anderson et al., 2012). Therefore, the SDAI 
has been selected for use in this study. 
2 Rheumatoid Arthritis Quality of Life (RAQoL) 
Quality of life has become an important concept within health outcome 
appraisal, in general as well as with chronic disease. It is an indicator of burden 
of disease, in terms of both physical and mental health, and provides insight into 
the outcome of a treatment programme (Burckhardt and Anderson, 2003, Salaffi 
et al., 2009). A number of scales have been used to assess quality of life in RA, 
including the Health-Related Quality of Life (HRQoL), the Quality of Life Scale 
(QOLS) and the Rheumatoid Arthritis Quality of Life (RAQoL). 
The HRQoL measures overall quality of life in terms of the effects of health on 
different domains of life, such as physical, social, psychological/emotional and 
cognitive functioning (Centers for Disease Control and prevention, 2016b). The 
QOLS is a reliable and valid instrument that can be used in assessing quality of 
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life across different patient groups and cultures (Burckhardt and Anderson, 
2003). However, both tools are generic rather than disease specific. 
The RAQoL is a disease-specific, self-report questionnaire originally developed in 
the UK and the Netherlands. It consists of 30 items, with a yes/no (1/0) response 
format (Whalley et al., 1997) (Appendix 8). Whalley et al. (1997) interviewed 50 
RA patients (25 in the UK and 25 in the Netherlands) regarding their quality of 
life in relation to RA. The study concluded that RA affects people in many 
aspects of their life: social, mental, physical and emotional. A qualitative 
approach was used in order to develop a tool that was suitable for use in clinical 
trials as well as in the monitoring of patients in routine clinics. Based on the 
interviews, appropriate items for inclusion in the RAQoL were derived, and thus 
a tool specific for use with RA patients was designed. One negative aspect is that 
the disease-specific nature of the tool does not facilitate its results being 
compared to other diseases. The RAQoL has been found to be a reliable and 
valid instrument with which to measure quality of life among RA patients, with 
very good test and retest reliability (Spearman’s correlation > 0.90). It has also 
been demonstrated to correlate with the Disease Activity Score (DAS) (r 
0.41-0.82), and Health Assessment Questionnaire (HAQ) (r 0.73-0.86) (Maska et 
al., 2011a). As the RAQoL is a valid instrument for assessing quality of life in 
people with RA (Linde et al., 2008, Maska et al., 2011a, Tijhuis et al., 2001), it 
was chosen for measuring quality of life in the current study. 
4.3.3 Assessment of functional capacity 
Rheumatoid arthritis is a chronic disease that affects patients’ daily activity 
performance and may cause varying degrees of disability. There are no specific 
guidelines on assessing functional capacity in RA sufferers (Santana et al., 2014). 
However, various instruments have been used such as the Modified Stanford 
Health Assessment Questionnaires (MHAQ), Arthritis Impact Measurement scales 
(Aims), the six-minute walk test (6MWT), the hand grip test (dynamometer), and 
the sit and reach, sit back and stand up tests (Santana et al., 2014). In this 
study, the modified HAQ (Appendix 9), 6MWT and hand grip tests were selected 
to assess functional capacity, based on evidence of their reliability and validity 
in assessments of people with RA and also as they are simple clinical 
assessments, well tolerated by patients. 
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1 Modified Stanford Health Assessment Questionnaire (MHAQ) 
The HAQ is used to measure the capacity of participants to perform activities in 
their daily lives (Oliveira et al., 2015). This is a self-report questionnaire that 
quantifies the degree of disability in carrying out certain functional activity: 
dressing, grooming, rising, eating, walking, hygiene, degree of reach, strength of 
grip and other common daily activities. The HAQ has been identified as a 
reliable and valid instrument that can be used to assess functional capacity in 
various chronic conditions (Uhlig et al., 2006, Linde et al., 2008, Bruce and 
Fries, 2003). There are two versions of the HAQ: full and modified. The full HAQ 
was adopted by the Arthritis, Rheumatism, and Aging Medical Information 
System (ARAMIS) in 1980 for evaluating the clinical status and health outcomes in 
observational as well as in clinical trials. The modified HAQ is mainly used to 
assess disability and has been employed in the assessment of a variety of 
diseases such as osteoarthritis, juvenile rheumatoid arthritis, fibromyalgia, 
psoriatic arthritis and systemic sclerosis (Bruce and Fries, 2003). 
Although there are a number of instruments used in assessing the functional 
capacity of people with RA, the HAQ is considered the most familiar tool (Scott 
et al., 2000). In addition, the HAQ is a useful tool in evaluating functional 
capacity across all levels of RA severity (Marra et al., 2004). A study undertaken 
by Uhlig et al. (2006) examined both the HAQ and the modified HAQ (MHAQ) in 
182 RA patients and demonstrated strong significant correlations between 
adjusted/unadjusted HAQ and MHAQ scores of 0.85/0.88 (P<0.01). 
The HAQ has also been found to correlate with the RAQoL (r 0.73-0.86) and the 
test–retest reliability for the MHAQ is shown to be strong (0.65-0.91, P<0.01) 
(Maska et al., 2011a). As the HAQ and MHAQ remain the gold standard for 
measuring the functional capacity of people with RA (Maska et al., 2011a) the 
MHAQ was selected for use in this study. 
2 Six-minute walk test (6MWT) 
There are several walking tests, such as the two minute walk test, the 12-minute 
walk test and the self-paced walk, but the 6-minute walk test (6MWT) is the 
most commonly used test in research and clinical investigation, as it is a simple 
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test, and is well tolerated (Zielinska et al., 2013). The 6MWT was undertaken 
according to the American Thoracic Society (ATS) guidelines (2002) for assessing 
exercise tolerance in people with chronic respiratory disease and heart failure. 
The test has been used to assess functional capacity in a range of diseases such 
as stroke, fibromyalgia and heart failure (Pollentier et al., 2010) and also in 
healthy individuals (Zielinska et al., 2013). Enright (2003) reported that the 
6MWT distance was lower for old people, the obese and people with arthritis or 
any other musculoskeletal diseases than for healthy individuals. 
A study conducted by Pankoff et al. (2000) used the 6MWT as a tool to assess 
cardio-respiratory fitness in people with fibromyalgia, where the results 
demonstrated a significant correlation between the 6MWT and VO2max (P<0.001). 
In a later study, a positive correlation was found between the 6MWT and VO2max 
after knee arthroplasty (r = 0.71) (Bennell et al., 2011). However, the use of the 
6MWT has some contraindications in particular conditions, such as unstable heart 
disease, high blood pressure (>180 mmHg), diastolic BP (>100 mmHg) and 
tachycardia (Zielinska et al., 2013). However, a number of studies examined the 
validity and reliability of 6MWT in fibromyalgia (Pankoff et al., 2000), 
scleroderma and knee arthroplasty (Bennell et al., 2011) a lack of in RA. 
3 Hand grip strength 
Hand grip strength can be used as a measure of estimated general muscle 
strength (Wind et al., 2010). Hand dynamometers are widely used in measuring 
hand grip strength, and are considered gold standard tools (Roberts et al., 
2011). The reliability and validity of the hand grip test using a hydraulic hand 
dynamometer has been addressed in connection with several conditions, such as 
cervical radiculopathy (CR) (Savva et al., 2014) and RA (Shiratori et al., 2014), as 
well as in healthy individuals (Massy-Westropp et al., 2011). Hand grip tests 
administered on patients with cervical radiculopathy gave an interclass 
correlation coefficient of (0.97); this is evidence of high test-retest reliability 
and supports their applicability as indicators of muscle strength in those patients 
(Savva et al., 2014). 
In addition, Boon et al. (2010) stated that the hydraulic dynamometer and 
biometrics electronic dynamometer have excellent concurrent validity in both 
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the right hand (0.98) and left (0.98), and are valid tools in the measurement of 
grip strength in healthy individuals. A small change in hand grip strength 
magnitude may be significant and may reflect clinical changes in people with 
RA, and therefore it is recommended to evaluate hand grip strength using a tool 
that is sensitive to detecting the degree of change in people with RA (Kennedy 
et al., 2010, Shipham and Pitout, 2003). 
A literature review evaluating the hand grip strength test in people with RA 
reported that 47.5% of studies assessed hand grip strength using a hydraulic 
dynamometer and considered it to be a gold standard tool in terms of the 
provision of quantitative information regarding the physical capacity of people 
with RA. Therefore, a hand grip test using a hydraulic dynamometer was chosen 
in this study. 
4.4 Cardiovascular (CV) risk factors 
4.4.1 Blood samples and ASSIGN score 
Several studies have assessed the risk of CVD in healthy individuals as well as in 
RA patients, where biochemical variables such as C-reactive protein (CRP), 
erythrocyte sedimentation rate (ESR), plasma glucose, total cholesterol, low-
density lipoprotein (LDL), high density lipoprotein (HDL) and triglycerides have 
been assessed. The biochemical variables used in the assessment of risk of CVD 
in people with RA, such as the testing of lipids (e.g. total and HDL cholesterol 
and triglycerides), glucose, insulin, HbAlc, and inflammatory biomarkers (CRP) 
were based on the Scottish Intercollegiate Guidelines Network, 2008 (SIGN). 
Myasoedova et al. (2011) studied 651 people with RA and reported ESR to be an 
important biochemical variable in measuring inflammation related to the risk of 
CVD in people with RA (Hazard Ratio (HR) =1.2 per 10mm/h increase, CI 1.1-1.3 
95%). In addition, LDL level is associated with risk of CVD. Lipid levels have been 
found to be paradoxically associated with CVD risk among people with RA, where 
an increased risk of CVD has been noted with total cholesterol (TCH) < 4mmol/l 
(95% CI 1.5-7.2), whereas CVD risk has not been found to be increased with TCH 
≥4 mmol/l (Myasoedova et al. (2011). 
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To estimate the risk of developing CVD over a ten-year period, cardiovascular 
risk can be assessed with SIGN (Scottish Intercollegiate Guidelines Network) 
(ASSIGN score) Version 1.5.1 (http://assign-score.com). The ASSIGN score is a 
cardiovascular risk score developed by Dundee University, Scotland in 2006, 
which includes social deprivation and family history of CVD, features that are 
not included in certain other scores such as the Framingham risk score. The 
Framingham risk score calculates the risk of CVD based on a United States 
cohort. It includes age, sex, smoking, blood pressure, diabetes and lipids but 
does not include the social status items featured in the ASSIGN score (Tunstall-
Pedoe, 2011). There is a lack of literature regarding the use of ASSIGN scores in 
RA and further studies are required. 
4.4.2 Anthropometric variables 
Adipose tissue is a metabolically active tissue that has the ability to synthesise 
and secrete hormones; this in turn has an effect on metabolism, immune 
function and vascular homeostasis (Coelho et al., 2013). Adipose tissue is 
strongly associated with insulin resistance and CVD in the general population 
(Arbel et al., 2012) as well as in RA patients (Soeiro Ade et al., 2012). Body 
composition has been used as an important indicator of health outcomes, 
including CVD risk (Kremers et al., 2008). Anthropometric measures are 
employed to assess body mass index (BMI) and abdominal obesity [waist 
circumference (WC), waist to hip ratio (WHR) and waist to height ratio (WHtR)]. 
Studies have revealed a strong association between anthropometric measures 
(BMI, WHR, WHtR) and major metabolic CVD risks such as hypertension, 
hyperlipidemia and abnormal glucose tolerance (Ashwell et al., 2012, Paniagua 
et al., 2008). 
1 Body Mass Index (BMI) 
Body mass index (BMI) is a measure of total body fat and is an important tool in 
assessing the risk of CVD (Summers et al., 2008, Paniagua et al., 2008). The use 
of BMI alongside other anthropometric measures of abdominal obesity can be 
applied to enhance the identification of risk of CVD and other metabolic 
disorders, however BMI does not reflect fat distribution (visceral fat) (Zhu et al., 
2004).  BMI is calculated as weight (kg)/ height (m) 2. Based on information 
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taken from the World Health Organization (World Health Organization, 2011), 
BMI is categorised into <18.5 kg/m2 (underweight), 18.5 to 24.9 (normal weight) 
and 25 to 29.9 (overweight), with values above 30 being considered obese. 
2 Waist-to-Hip Ratio (WHR) 
WHR is an important tool for assessing CVD risk. It has been reported that WHR is 
a superior clinical measure of obesity for predicting all cases of CVD and CVD 
mortality (Welborn and Dhaliwal, 2007). In addition, WHR appeared to be a more 
appropriate measure of obesity than WC and BMI in high functioning older men 
and women. WHR was found to be positively associated with all causes of 
mortality (Srikanthan et al., 2009). 
3 Waist-to-Height Ratio (WHtR) 
Statistical evidence from studies conducted on over 300,000 adults from several 
ethnic groups shows the superiority of WHtR over WC and BMI for detecting 
cardiometabolic risk factors in both sexes because it measures central obesity, a 
better discriminator of CVD risk (Ashwell et al., 2012). WHtR helps differentiate 
between individuals with excess adipose tissue from high muscle mass, in 
addition, the distribution of body fat can be recognised (Ashwell et al., 2012, 
Lee et al., 2008). A meta-analysis conducted by Lee et al. (2008), which 
analysed data from 88,000 individuals, reported that WHtR was more accurate 
than BMI in discriminating those people with CVD risk factors such as 
hypertension, dyslipidaemia and diabetes from both sexes. There was a lack of 
studies examining WHR and WHtR in relation to RA. 
4.5 Dietary assessment–Dietary Instrument for Nutrition 
Education (DINE) 
There are a number of dietary assessments such as the Short Form Food 
Frequency Questionnaire (SFFQ), the long form Food Frequency Questionnaire 
(FFQ), the Five-A-day Community Evaluation Tool (FACET) and the Dietary 
Instrument for Nutrition Education (DINE). The SFFQ test is used to assess the 
quality of overall diet which includes examining the intake of a number of 
different foods such as fruit and vegetables (Shim et al., 2014). The reliability 
and validity of the SFFQ has not been examined extensively. The FFQ, which is a 
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long questionnaire consisting of 217 items, takes a long time to complete and is 
therefore inconvenient to the participants (Shim et al., 2014). 
The FACET, which was designed to examine the effectiveness of a pilot initiative 
to enhance the consumption of fruit and vegetables in deprived areas, focuses 
on the intake of fruits and vegetables (Ashfield-Watt et al., 2007). The DINE tool 
was chosen for this study (Appendix 11). It was developed in 1994 and is a simple 
self-administered inexpensive tool designed for dietary assessment within 
primary care health promotion programmes (Little et al., 1999, Roe et al., 1994) 
and it has also been implemented in a health survey conducted in England. The 
DINE consists of questions regarding food and drink consumed over the previous 
seven days, and scores are obtained for fatty foods, sugary foods, and fruit and 
vegetable intake. 
It is a valid method of dietary assessments that can be used effectively within 
the general population (Hardcastle et al., 2013, Roe et al., 1994). One of the 
advantages of the DINE questionnaire is that 70% of its questions concern fat and 
fibre, which are typical within the UK diet (Hardcastle et al., 2013). There are 
significant correlations between the DINE tool and estimated food diaries; total 
fat (r = 0.51), polyunsaturated: saturated fat ratio (r= 0.43) and fibre (r = 0.46) 
(Hardcastle et al., 2013, Roe et al., 1994). The DINE has been successfully 
implemented in a number of studies to investigate inflammatory polyarthritis 
and also in the field of the secondary prevention of coronary heart disease 
(Byrne et al., 2005, Pattison et al., 2004). However, no study has examined the 
reliability and validity of DINE among people with RA, but the same is true for 
the other methods of dietary assessment. 
4.6 Self-efficacy for physical activity 
Self-efficacy is related to people’s beliefs regarding their ability to perform 
exercise regularly (Neupert et al., 2009). Increasing levels of self-efficacy can 
play a role in the likelihood of an individual with RA achieving PA goals (Knittle 
et al., 2011). A number of methods have been used to assess an individual’s self-
efficacy in terms of regulating exercise, such as the general self-efficacy scale 
(GSE). The GSE is valid for the assessment of PA self-efficacy, and can be used 
with patients with chronic pain or in rehabilitation programmes. 
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The self-efficacy to regulate exercise is a straightforward, reliable and valid 
questionnaire that can be used within clinical settings (Bandura, 2006). Scores 
range from 0-100, with high scores (90-100) indicating a high certainty of 
undertaking exercise and low scores (0) indicating that the individual cannot 
participate in the exercise (Appendix 10). Its reliability is shown to be (0.92 
Cronbach’s alpha) and its validity of self-efficacy correlation with minutes of 
exercise per week is shown to be (r = 0.41, P < 0.0001) (Davis et al., 2007). A 
significant correlation has been demonstrated between self-efficacy for PA and 
the generalised self-efficacy scale (Spearman r = 0.316; P < 0.05) (Kroll et al., 
2007). The self-efficacy to regulate exercise has been used in this study as it is a 
reliable instrument with high internal consistency (alpha= 0.92 and r ranged 
from 0.38 to 0.76) (Resnick and Jenkins, 2000). 
4.7 Qualitative study 
A number of methods are used to collect qualitative data in research, such as 
focus groups and interviews, either face-to-face or via the telephone (Gill et al., 
2008). A focus group is a group discussion on a particular topic organised for 
research purposes (Gill et al., 2008). A focus group aims to identify the thoughts, 
perceptions and suggestions of a selected group of people regarding a specific 
topic under examination (Larkin et al., 2016b). This discussion is guided, 
monitored and recorded by a researcher (Gill et al., 2008). However, great care 
needs to be taken in order to obtain the best quality discussion. This depends on 
the researcher’s skills and the group interaction, which is considered the key to 
a successful focus group. In addition, the transcription of focus groups is more 
complex and time consuming than in one-to-one interviews (Gill et al., 2008). 
The interview is one of the most frequently used methods of collecting 
qualitative data. Although face-to-face interviews can collect good-quality data 
with visual aids and the detection of body language, they have a number of 
disadvantages such as being more time consuming, delivering a biased response, 
and safety concerns for the researcher and participants (Szolnoki and Hoffmann, 
2013). 
Semi-structured telephone interviews can be useful to collect quantitative and 
qualitative data (Burnard, 1994). Telephone interviewing may provide an 
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opportunity to obtain data from participant or groups who are otherwise difficult 
to access in person (Oltmann, 2016). Also, a telephone interview is preferred for 
the discussion of sensitive topics such as those that are emotionally painful. 
Telephone interviewing is a cost-effective method of data collection (Novick, 
2008). 
It was concluded that in general, telephone interviewing was an acceptable and 
valuable method of data collection and that it can also yield good-quality data 
with a good response rate (Sturges and Hanrahan, 2004). Therefore, semi-
structured telephone interviews were chosen to be used in this study. 
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5 Materials and Method 
This chapter will describe the study design, ethical approval, study setting, 
patient recruitment and selection and method of allocating participants to 
intervention or control groups. It also presents a description of the sample and 
sample size, data management, quantitative and qualitative data collection 
processes and methods of analysis of the outcome measures.  
5.1 Study design  
A single blind, randomised controlled trial was used to investigate the 
effectiveness of a six-month, community-based, pedometer-supported, walking 
programme, along with an education component, incorporating behavioural 
change techniques (BCTs), on step count and sedentary time, disease activity, 
functional capacity and cardiovascular risk of people within the first five years 
of being diagnosed with RA. 
The trial protocol was registered on Clinical Trials.gov (http://www. Clinical 
Trials.gov; Identifier NCT02467205). The assessments were taken by the chief 
investigator (AE) who was blind to the group allocation and the study 
intervention was delivered by a physiotherapist with expertise in this field. The 
primary outcome measures were objectively measured changes in daily step 
count and sedentary time from baseline to 6 months (end of the intervention) 
with data obtained using an activPALTM activity monitor. In addition, data was 
collected on subjectively measured PA and sitting time with a self-reported 
questionnaire (IPAQ). All measures were collected at baseline, 3 and 6 months 
(end of the intervention) and 12 months. The secondary outcome measures were 
related to disease activity, functional ability, cardiovascular risk factors, dietary 
assessment and physical activity for self-efficacy. In addition, interviews were 
conducted with 10 participants from the intervention group at six months in 
order to explore participant views regarding the WARA intervention. 
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5.2 Hypothesis 
The null hypothesis was that there was no significant difference between the 
control and intervention group in primary outcome measure (PA and sedentary 
time) over the study period (6 months). 
The alternative hypothesis was that there was a significant difference between 
the intervention and the control group in primary outcome measure over the 
study period (6 months). 
5.3 Ethical approval 
Ethical approval for the study was obtained from the West of Scotland Research 
Ethics committee (14/WS/0131) (Appendix 2) in July 2014 and all procedures 
were carried out in accordance with the Declaration of Helsinki. Participants 
were identified by a study number, and remained anonymous throughout the 
study. All participants provided written informed consent (Appendix 4) which 
included permission to access their medical records and were free to withdraw 
from the study at any time. Serious adverse events (SAE) are defined as any 
events or adverse reactions that result in death or are life threatening. They 
require hospitalisation or a prolongation of an existing inpatient’s hospital stay, 
or result in significant disability or incapacity (Good clinical practice, 2014). The 
safety of the participants was addressed at several stages in this intervention. 
Strength exercises and walking are considered a popular and ideal mode of 
physical activity; exercise is not only important for promoting and maintaining 
health in the general population, but it also poses little risk of injury for 
sufferers of RA (Baxter et al., 2016). However, a serious adverse event that 
happened in this study was reported to the West Scotland Research Ethics 
Committee (further discussed in section 6.1). 
5.4 Study setting  
The participants were recruited from rheumatology outpatient clinics at 
Gartnavel General Hospital, Glasgow Royal Infirmary Hospital and Stobhill 
Hospital, Glasgow, UK. Physiological assessment and completion of 
questionnaires took place in a room at the participant’s local hospital. 
112 
 
 
5.5 Patient recruitment and selection  
Participants were eligible to participate in the trial if they were aged 18 years or 
over, had a confirmed diagnosis of RA according to the American College of 
Rheumatology (ACR)/ European League Against Rheumatism criteria (EULAR) 
2010 (Aletaha et al., 2010), were within five years of diagnosis and willing and 
able to give written informed consent. Participants were excluded from the 
study if they suffered from severe hypertension, joint replacement in the 
previous 6 months, unstable cardiac conditions or other serious pathology such 
as uncontrolled diabetes which would affect their ability to take part in physical 
activity. Those who were pregnant, unable to understand written and spoken 
English or had cognitive impairment as determined by the clinical judgment of 
the researcher were excluded.  
Recruitment to this trial took place from November 2014 to August 2015. 
Patients were informed of the study at their routine clinical appointments and 
given study information sheets (Appendix 3). If the patient was willing to take 
part in the study, they contacted the chief investigator by phone and a suitable 
date/time for baseline assessment was arranged and confirmed by letter. 
Participants were recruited in blocks of 12 participants in order to randomise 
them into intervention and control group (six participants in each group). On the 
initial assessment day, the participant had the opportunity to ask further 
questions before signing a consent form for the study.  
5.6 Method of allocating participants to intervention and 
control groups 
All participants who agreed to take part in the study consented to being 
randomised to either the intervention group or control group. For the 
randomisation process the physiotherapist generated a list of random numbers 
using an Excel spreadsheet where odd numbers represented the intervention 
group and even numbers the control group. Then each number and the group 
which it represented were put into sealed envelopes, in the order they were 
listed on the spreadsheet and the physiotherapist gave the participants these 
envelopes consecutively. Randomisation was performed with 1:1 allocation for 
each of the two groups. The participants were not blind to the group allocation.  
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The flow of participants through the recruitment process and randomisation is 
presented in Figure 6-1. 
5.7 Sample and sample size 
Physical activity defined as the mean number of steps per day, was one of the 
primary outcome measures. The sample size for this study was calculated using 
data from the study by Mutrie et al. (2012) in which 41 healthy adults aged ≥65 
years were included in a 12 week crossover, two arm (intervention/control), 
randomised control trial; both groups were followed up at 12 and 24 weeks. The 
participants in the intervention group received two 30-minute PA consultations, 
as well as a pedometer and a walking programme. An activPALTM monitor was 
used to assess participants' step counts. The mean (SD) of the step count at 
baseline for the intervention group was 7469 (2312) and for the control group 
was 7351 (2360). At week 12, the mean (SD) step count of the intervention group 
was 9351(2017) and of the control group was 7138 (2169). At week 24, the mean 
(SD) step count of the intervention group was 9161 steps (2631) and of the 
control group was 9100 steps (3175).   
The interest of the current study is the difference in step count between the 
baseline and primary end points (six months – i.e. the end of the intervention). 
In order to achieve a 2000 step difference between the two groups, with a 
two-sided 5% significance level and a power of 90%, a sample size of 34 
participants per group was required. Sedentary time is defined as time spent 
sitting or lying (including sleeping time).  
5.8 Piloting the intervention 
Testing of the pedometers was carried out in the School of Nursing and Health 
Care at the University of Glasgow to ensure the validity and reliability of the 
pedometers. Each pedometer was individually tested at the first education 
sessions by the participants with help of the physiotherapist, by ensuring that a 
test of 100 walked steps provided an error of <5%, as suggested by the Japanese 
Industrial Standard of 3% by Hatano (1997, cited in Baker et al. (2008a). 
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The intervention included 6 weekly small group sessions and 2 booster sessions 
(at 3 and 6 months). The specific topics covered are outlined in Table 3-3.The 
intervention (education sessions and outcome measures) was piloted with the 
first group. Feedback from the participants and the physiotherapist who 
delivered the programme suggested a number of small changes were required; 
included promoting greater group interaction by the use of flip charts in the 
education sessions on RA and the benefit of reducing sedentary behaviour. Also, 
quizzes were employed on the subjects of ‘What is RA?’, ‘The risk of CVD in RA’ 
and ‘diet’, to help participants to self-assess their knowledge and in order to 
optimise the learning outcomes. Also, some participants reported the exercises 
were too easy, therefore some exercises using Theraband were added to 
education session 4.  
5.9 Data management  
All of the participants’ data (physiological and subjective data) were stored on a 
password protected computer server in the School of Nursing and Healthcare at 
the University of Glasgow. The names of the participants and their contact 
information were held separately in a securely locked room. They were checked 
by the chief investigator. 
5.10 The use of mixed methodology 
The use of mixed methodology can strengthen a study (Bryman, 2006, Harwell, 
2011). A mixed methodology approach was used to overcome the disadvantage 
of single methodology studies. For instance quantitative methodology may focus 
on numerical data and therefore lacks the ability to understand the context of 
participant’s behaviour however qualitative methodology may be seen as being 
subjective and lacking reliability and validity, (Creswell, 2014) (further discussed 
in section 4.1). Quantitative data were collected at baseline, 3, and 6 months 
(the end of the intervention) and 12 months (end of the study). The qualitative 
data were collected from telephone interviews of a sample of 10 participants in 
the intervention group at 6 months.  
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5.10.1 Quantitative data collection tools and processes  
The chief investigator recruited participants from each hospital in blocks of 12 
participants in order to randomise them into intervention and control group (six 
participants in each group). After participants gave their verbal consent to 
participate, a date and time was arranged for baseline assessment. If a 
participant had a ‘flare’ of their arthritis when the assessment was due the 
assessment was postponed until the flare reduced; up to 2 weeks after the 
original assessment date. 
During the baseline assessment, the chief investigator confirmed that the 
participants had read and understood the participant information sheet and also 
asked if they had any questions regarding the study before signing the consent 
form. Then, the participants were asked to complete the study questionnaires 
which included demographic, family history and medical history, current 
treatment, smoking, alcohol consumption and work status (data collection sheet 
in Appendix 5). Physical activity was assessed objectively with an activPALTM, 
(PAL Technologies, Glasgow, Scotland) which participants wore for seven days 
continuously to quantify daily PA step counts and time spent sitting/lying. The 
activPALTM provides valid and reliable data related to physical activity (Dahlgren 
et al., 2010, Ryan et al., 2006), (further discussed in section 4.3.1). 
The monitor was attached to the skin of participants at the midpoint of the 
anterior aspect of the right thigh, using Tegaderm (3MTM). Self-reported PA was 
assessed with the International Physical Activity Questionnaire (IPAQ) (Appendix 
6) (Bull et al., 2009, Craig et al., 2003), (further discussed in section 4.3.1). 
Continuous scores were calculated based on the IPAQ guidelines; the total 
minutes of walking, moderate and vigorous intensity PA per week was calculated 
by multiplying the minutes of PA activity per day by the number of days per 
week the activity was reported. The Metabolic Equivalent of Task (MET) scores 
of 3.3, 4.0 and 8.0 for walking, moderate and vigorous intensity activity were 
assigned as per the IPAQ scoring protocol. 
Walking MET-minutes/week = 3.3 walking minutes/ day for the days per week on 
which walking was reported. 
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Moderate MET-minutes/week = 4.0 moderate intensity minutes/day for the days 
per week on which moderate intensity activity was reported. 
Vigorous MET- minutes per week = 8.0 vigorous intensity minutes/ day for the 
days per week on which vigorous intensity activity was reported. 
Total physical activity MET-minutes/week = Walking + Moderate + Vigorous MET 
minutes/week scores. 
The self-efficacy for PA was assessed with the Self-Efficacy to Regulate Exercise 
(SERE) questionnaire (Appendix 10). The participants completed the SERE; scores 
can range from 0-100, with 90-100 indicating ‘high certainty can perform the 
exercise’ and zero indicating ‘cannot do’ (Davis et al., 2007, Kroll et al., 2007). 
Other assessments were the Rheumatoid Arthritis Quality of Life (RAQoL) for 
quality of life (Appendix 8). RAQoL scores range from 0 to 30 with higher scores 
reflecting a poorer quality of life (Linde et al., 2008, Maska et al., 2011a). The 
Modified Stanford Health Assessment Questionnaire (HAQ) assessed functional 
capacity (Appendix 9) and scores range from 0-3, with higher scores indicating 
more disability (Bruce and Fries, 2003, Linde et al., 2008, Uhlig et al., 2006). 
The Modified Dietary Instrument for Nutrition Education (DINE) (Appendix 11) 
scores were obtained for fatty foods, sugary foods, and fruit and vegetable 
intake (Little et al., 1999). If the participants had any questions regarding the 
questionnaires, the chief investigator clarified them at the time. Further details 
regarding the questionnaires used in this study were discussed in chapter 4. 
After the participants completed the questionnaires, their blood pressure was 
measured with the participants in a sitting position. Blood pressure were taken 
from the right arm and a mean of the three readings recorded. Height was 
measured to the nearest 0.5cm using a stadiometer (Seca 217 stadiometer, Ltd., 
Liverpool, UK), with the subject barefoot and standing erect. Weight in kg was 
measured using a portable electronic scale (Seca model 770, Ltd., Birmingham, 
UK) with the subject wearing light clothing and without shoes.  
The waist circumference was measured midway between the upper margin of 
the iliac crest and lower rib margin of the last palpable rib with the participant 
standing erect and with their clothing raised, and was measured with an 
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inelastic tape measure. Hip circumference was measured round the widest part 
of the buttocks (World Health Organization, 2011). 
To assess clinical disease activity the Simplified Disease Activity Index (SDAI) was 
used (Appendix 7) (www.rheumatology.org). The SDAI score consists of four 
components; joint tenderness and swelling based on a 28‐joint assessment, 
patient global score is a visual analogue scale (VAS) 0-10cm, provider global 
score is physician global assessment of disease activity (MDGA VAS 0-10cm (0-10) 
and C-reactive protein mg/dl. An SDAI value of 3.4-11.0 is low disease activity, 
moderate (>11-26), high activity values range from 26.1 to 86 and the remission 
value is 0.0-0.3 (Fleischmann et al., 2015).  
The chief investigator was trained by the rheumatologist at GGH on how to 
perform the SDAI. The chief investigator was trained on how to assess tender 
and swelling joint counts based on 28 joint assessments. This involved assessing 
10 proximal interphalangeal joints of the fingers, 10 metacarpophalangeal 
joints, the wrists, elbows, shoulders and knees. The swollen joint count reflects 
the amount of inflamed synovial tissue. Joint swelling is defined as soft tissue 
swelling of the joint which is detectable along the joint margins and 
characterised by fluctuation (Scott and Scott, 2014). The tender joint count is 
associated more with the level of pain. Joint tenderness is defined as pain at 
rest that is induced by pressure during the examination of the joints (Scott and 
Scott, 2014).  
A handgrip dynamometer (Hydraulic Hand Dynamometer, Model 5030J1, Ltd, 
Nottinghamshire, UK) was used for measuring handgrip strength. The hand grip 
test was done with the participant in a sitting position with shoulders adducted 
and neutrally rotated, elbow flexed at 90°, forearm in neutral and wrist 
between 0 and 30° of extension. The test was repeated 3 times with 
the dominant hand. The participant was instructed to apply as much grip 
pressure as possible on the dynamometer and the maximum reading was taken.  
The participant then completed the 6-minute walk test, where they were asked 
to walk for a period of six minutes, at their own pace, along a straight, 30 m 
hallway. Participants were asked to cover as much ground as possible in six 
minutes and allowed to stop if required; the reason and time of any stops were 
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recorded. The distance walked in metres at the end of the six minutes was 
recorded (Alameri et al., 2007).  
The Charlson Comorbidity index (Appendix12) was used as a prognostic measure 
of illness burden, the data were collected by the chief investigator from the 
participants’ medical records. The score was reached by adding the comorbidity 
score to the age score (Pedersen et al., 2006).  
For estimating the risk of developing cardiovascular disease over 10 years the 
ASSIGN score (Scottish Intercollegiate Guidelines Network, version 1.5.1) was 
used (ASSIGN score, 2008) (http://assign-score.com). The ASSIGN score includes 
age, sex, place of residence (Scottish postcode), family history of CHD/stroke, 
diabetes mellitus, tobacco smoking (cigarettes, pipe tobacco or cigars), systolic 
blood pressure reading, blood total cholesterol and HDL-cholesterol (SIGN 
guideline 97(2007) version 1.5.1). 
The ASSIGN score is between 1 and 99. The higher the score, the higher the risk 
of developing cardiovascular disease. Participants with a high score (20 or more) 
are considered to have a high chance of CVD or stroke compared to those who 
have a score below 20 (Hippisley-Cox et al., 2007, Woodward et al., 2007). The 
variables are filled out on a web form and a score of 20 or more is considered a 
high risk of CVD, where advice and treatment is required (http://www.assign-
score.com/estimate-the-risk/calculation-format/). 
To assess the level of PA, participants wore an activPALTM activity monitor (PAL 
Technologies, Glasgow, Scotland) for seven days continuously (24 hours a day) to 
quantify daily PA step counts and time spent sitting/lying. The monitor was 
attached by the chief investigator to the skin of participants on the midpoint of 
the anterior aspect of the right thigh, using Tegaderm (3MTM). Waterproof 
wrapping of the monitors allowed wearing during showering. The participants 
were asked to perform their normal daily activities and to remove the device 
only when they wanted to take a bath or swim. Participants were asked to 
return the monitor to the chief investigator at the end of the seven-day period 
in the stamped addressed envelope provided. Validity and reliability of the 
activPALTM in assessing PA has been discussed in (section 4.3.1). 
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Finally, the chief investigator took blood samples from participants. The blood 
samples were collected from the antecubital vein into EDTA 9 mls (purple top 
tubes in UK), Fluoride Oxalate 2 mls (grey top tube in UK) and Serum separator 7 
mls (orange top tubes in UK). Blood samples were processed according to the 
flow diagram in Figure 5-1. The following outlines the blood collection procedure 
based on standard operating procedure (SOP) of the WARA study, transportation 
of biological samples for processing and sample storage (Elliott and Peakman, 
2008, Somoza and Tora, 2009). 
A disposable tray for the blood sample was set out with the following: labelled 
blood sample bottles, alcohol wipe, gauze swab, plaster, vacutainer holder, 
butterfly needle and tourniquet. All equipment was collected together and 
expiry dates checked.  
The chief investigator explained the procedure to the participant, checked if the 
patient was taking any anticoagulant medications and ensured the participant 
was sitting/lying comfortably with their arm supported. Before starting the 
procedure hand hygiene was performed based on WHO guidelines (World Health 
Organization, 2010), and gloves were worn. The needle was attached to the 
vacutainer holder, and a tourniquet was applied to the patient’s upper arm. 
Venous blood flow was suppressed to ensure a pulse was palpable distal to the 
tourniquet. The limb was placed below the level of the heart, and participants 
were asked to open and close their fist. Palpation was used to find a suitable 
vein.  
The participant’s arm was cleaned with alcohol wipes and allowed to dry before 
a needle was inserted. After the entry site was cleaned, it remained untouched 
to preserve the sterile conditions. The non-dominant hand of the chief 
investigator was used to stabilise the vein by applying traction to the side or 
below the insertion site. A needle was inserted into a vein with the bevel up, to 
ensure the smooth puncture of the vein. The vacutainer bottles were attached 
to the holder and blood was collected in the tubes. All vacutainer tubes were 
labelled with details of the participants’ unique study identification and the 
date. The tourniquet was slackened once a good blood flow was achieved and at 
least10 seconds were allowed for a complete blood draw into each tube. It was 
ensured that blood had stopped flowing into the tube before it was removed. 
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Once a full sample had been collected, the tourniquet was removed and the 
puncture site covered with a gauze swab. The needle was removed from the arm 
and pressure was applied to the area. The participant was instructed to keep 
their arm straight and press firmly on the area for several minutes.  
All vacutainer bottles were inverted gently eight times, to ensure thorough 
mixing of the blood. Used needles and the vacutainer holder was placed in the 
sharps bin. The swab was disposed of in a clinical waste bag. The patient’s arm 
was checked to ensure that the puncture site had stopped bleeding before a 
small sterile self-adhesive plaster was applied, after first verifying that the 
participant was not allergic to plasters.  
All blood samples were stored and transferred to the sample processing area at 
4°C, in a cool bag with an ice pack. The aim was to get the samples processed 
(as per blood processing and storage standard operating procedure) and stored in 
the -80°C freezer within 24 hours of sample collection (ideally within 12 hours). 
Whole blood, plasma and serum aliquots were pre-labelled before specimens 
were added. The Specimen ID label was applied and the tube stored 
horizontally. The edges of the label were checked to ensure that the label was 
firmly affixed. 
For processing the 9 ml EDTA tube (purple top), a new transfer pipette was used 
to dispense 2 x 1 ml whole blood into pre-labelled storage tubes. The remaining 
blood in the EDTA tube was centrifuged at 4000 RPM at 4°C for 15 minutes. A 
new transfer pipette was used to dispense 5 x 0.5 ml EDTA plasma into pre-
labelled storage. Serum tube 7 ml (red top) was allowed to clot for at least 30 
minutes after sample collection. The serum tube was centrifuged at 4000 RPM at 
4°C for 15 minutes. A new transfer pipette was used to dispense 5 x 0.5 ml 
serum into pre-labelled storage. 
The fluoride oxalate tube 2 ml (grey top) was centrifuged at 4000 RPM at 4°C for 
15 minutes. The blood glucose was measured immediately using YSI 2300 STAT 
plus Glucose & Lactate Analyzer. A new transfer pipette was used to dispense 1-
2 x 0.5 ml fluoride oxalate plasma into pre-labelled storage tubes. 
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All 14 barcoded aliquots were stored at -70 or -80°C in bar-coded boxes in the 
West Medical Building of the University of Glasgow. The boxes were placed in an 
alarmed freezer, allowing samples to be promptly removed and placed into a 
spare freezer in the event of a freezer breakdown. 
 
Figure 5-1 Processing of study bloods for storage 
 
5.10.2 Walking programme for the intervention group   
The aim of the walking programme was for the participants to increase their 
average daily step count by 3000 steps above their baseline value on at least 5 
days of the week by 6 months and to maintain this up to 12 months. The UK 
physical activity guidelines (2011) recommended 150 minutes/week in 10-minute 
bouts, which can also be achieved with 30 minutes 5 days/week. 
Centrifuge remaining 
blood in EDTA tube 
at 4000 RPM @ 4°C 
for 15 minutes 
EDTA                              
PLASMA 
9 ml 
Aliquot 2 x 1 ml whole 
blood into pre-labelled 
cyrogenic tubes 
 
Wait at least 30 minutes after 
sample collection to centrifuge 
serum tube to ensure sample 
has fully clotted 
Aliquot 5 x 0.5 
ml plasma into 
pre-labelled 
cyrogenic 
tubes. 
Place all tubes into alarmed -80°C/-70°C freezer 
FLUORIDE 
OXALATE 
2 ml 
Centrifuge tube at 
4000 RPM @ 4°C 
for 15minutes 
Aliquot 5 x 0.5 
ml serum into 
pre-labelled 
cyrogenic 
tubes. 
SERUM 
7 ml 
Centrifuge tube at 
4000 RPM @ 4°C 
for 15 minutes 
Aliquot 1-2 x 0.5 
ml plasma into 
pre-labelled 
cyrogenic tubes 
 
122 
 
 
The walking programme of this study was adapted from (Baker et al., 2008a) 
where it was used successfully to increase walking and reduce sedentary 
behaviour in a Scottish community sample. The evidence showed that adding a 
fixed increment to the average step count for people who are physically inactive 
may make it challenging for them to increase their step count. It may also help 
participants to reinforce their increased levels of walking, or participants may 
try to create strategies in order to successfully accumulate the additional steps 
(Baker et al., 2008a). However, in Baker et al. (2008a) the population was 
healthy and the goal of the walking programme was 1500 steps increase, 
maintained for 2 consecutive weeks. With the WARA intervention, the population 
had RA, therefore the goal of the walking programme was modified to 1000 steps 
increase maintained for 2 weeks. 
5.10.3 Intervention and control group   
Participants in the intervention group attended six weekly sessions in small 
groups of up to six people; the sessions were interactive and each session lasted 
approximately one hour. Thereafter the physiotherapist contacted the 
participants at the end of weeks 7, 9 and 11 (i.e. when their step target 
increased by 1000 steps or changed from three to five days) to the end of the 
intervention (6 months) to discuss their step counts for the past month, their 
step goals for the following month, any barriers to PA they faced and how they 
planned to overcome them. Participants also received two booster sessions, 3 
and 6 months after starting the programme. The content of all education 
sessions and BCTs presented in Table 3-3. 
For the purposes of the current study participants randomly allocated to the 
control group received one education session regarding the importance of 
exercise and healthy diet, were given written education material and 
encouraged to read it (Appendix 15). The session took place at the participant’s 
local hospital and lasted approximately one hour. On completion of the study 
participants in the control group were given a pedometer and PA diaries and 
advised on how to use them. The study programme for intervention group shown 
in  Table 5-1 and the control group in  Table 5-2 . 
 
123 
 
 
Table 5-1 Study programme for intervention group  
Visit Label Programme Content Duration 
Visit (1) Baseline 
Assessment 
Study explanation and 
consent.  
Activity monitor attached to 
the participant’s thigh to 
wear for 7 consecutive days. 
Baseline assessment 
complete questionnaires face 
to face and measured blood 
pressure, anthropometric 
measurements,6-minute 
walk, and blood samples was 
collected.  
One hour 
Visit (2) 7-
10 days 
later 
First 
education 
session 
Interactive discussion on 
CVD, Rheumatoid arthritis, 
Risk of CVD in Rheumatoid 
Arthritis, the importance of 
physical activity, Goal 
setting, instruction and 
practice on how to use 
pedometer. Each participant 
will be given a pedometer to 
take away with them, as well 
as a physical activity diary, 
instructions on how to use it.  
One and 
half hour 
Visit (3) 
week 3 
Second 
education 
session 
Group discussion regarding 
exercise and physical activity 
and self-monitoring of 
behaviour, barriers to 
physical activity (Problem 
solving), advice, discussion 
on the importance of social 
support. 
One hour 
Visit (4) 
week 4 
Third 
education 
session 
Relapse prevention, Control 
over CVD via lifestyle 
behaviour. 
One hour 
Visit (5) 
week 5 
Fourth 
education 
session 
Relevance and importance of 
strength training and 
opportunity to practice 
exercises. 
One hour 
Visit (6) 
week 6 
Fifth 
education 
session 
Interactive discussion 
regarding healthy diet, 
strategies to enhance 
perceived control. 
One hour 
Visit (7) 
week 7 
Sixth 
education 
session 
Motivation, Social 
facilitation, Action planning 
for the next 6 weeks. 
One hour 
Visit (8) 
week 13 
First post 
intervention 
assessment 
Attach activity monitor to 
participant’s thigh; 
Complete questionnaires 
face to face. Measured blood 
One hour 
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pressure, anthropometric 
measurements,6-minute 
walk, and blood samples was 
collected.  
Visit (9) 
week 14 
First 
booster 
education 
session 
Discuss any barriers, 
encouragement and 
motivation of the 
participants to continue in 
this programme.  
One hour 
Visit (10) 
week 26 
Second post 
intervention 
assessment 
Attach activity monitor to 
participant’s thigh, complete 
questionnaires face to face 
and measured blood 
pressure, anthropometric 
measurements,6-minute 
walk, and blood samples was 
collected. 
One hour 
Visit (11) 
week 27 
Qualitative 
Interview 
Participant’s views on the 
programme. 
30 minutes 
Visit (12)   
week 28 
Second 
booster 
education 
session 
Discuss any barriers, 
encouragement and 
motivation of the 
participants to continue in 
this programme. 
One hour 
Visit (13)  
week52 
Last visit, 
final 
assessment 
(end of the 
study) 
 Attach activity monitor to 
participant’s thigh, complete 
questionnaires face to face 
and measured blood 
pressure, anthropometric 
measurements,6-minute 
walk, and blood samples was 
collected. 
One hour 
 
Table 5-2 Study programme for control group  
Visit Label Programme Duration 
Visit (1) Baseline 
Assessment 
Study explanation and consent. 
Activity monitor attached to the 
participant’s thigh to wear for 7 
consecutive days. Baseline 
assessment: (blood sample, 
anthropometric measurement). 
Complete questionnaires face to 
face.  
One hour 
Visit (2)7-
10 days 
later 
 
Education 
session 
Single education session will 
include topic regarding importance 
of physical activity and healthy 
diet. 
One hour 
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Visit (3) 
week 13 
First 
assessment 
post 
intervention 
Attach activity monitor to 
participant’s thigh, collect 
questionnaires posted one week 
before the appointment. If 
participants have not completed 
the questionnaire; will be done 
face to face. 6-minute walk, blood 
sample and anthropometric 
measurement. 
One hour 
Visit (4) 
week 26 
Second 
assessment 
post 
intervention 
Attach activity monitor to 
participant’s thigh, collect 
questionnaires posted one week 
before the appointment. If 
participants have not completed 
the questionnaire; will be done 
face to face, 6-minute walk, blood 
sample and anthropometric 
measurement. 
One hour 
 
 
Visit (5) 
week 52 
Third and 
final 
Assessment 
(end of the 
study) 
 
Attach activity monitor to 
participant’s thigh, collect 
questionnaires posted one week 
before the appointment. If 
participants have not completed 
the questionnaire; will be done 
face to face.6-minute walk, blood 
sample and anthropometric 
measurement. 
One hour 
 
5.10.4 Qualitative data collection  
To explore participant’s views regarding the effectiveness of the intervention a 
purposive sample of ten participants from the study was asked to take part in a 
semi-structured 30-minute telephone interview. This included both males and 
females, participants from the three recruiting hospitals, those who did and did 
not increase their PA, and those whose step counts declined. Telephone 
interviews were chosen as they are less time consuming, less expensive and less 
burdensome for participants. A topic guide was developed which contained main 
and prompt questions regarding the education sessions, questions regarding the 
programme (walking and strength exercise) and questions to determine the 
participant’s overall views of the intervention. The interview schedule can be 
found in (Appendix 13). 
The interview questions were piloted on PhD students at the Nursing and 
Healthcare School in order to determine the most logical order of the questions, 
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and to identify wording issues that need to be addressed for clarity. After 
participants gave their additional verbal consent to participate in interviews and 
a time was arranged for the physiotherapist to phone the participant. Telephone 
interviews were audio recorded, and transcribed. The telephone interview was 
done following the six months’ assessment and was carried out by the 
physiotherapist. 
5.11 Data Analysis of the outcome measures 
5.11.1 Quantitative data analysis 
Data were analysed using IBM SPSS Version-21 and Microsoft Excel. The normality 
assumption was assessed using the Shapiro-Wilk test. Descriptive statistics were 
calculated, and independent sample t-test and chi-square were used as 
appropriate to compare baseline values between groups. To assess the effect of 
the intervention on outcome measures, mixed Generalised Linear Models (GLM) 
were used incorporating restricted maximum likelihood (REML) to estimate 
missing values. The group x time interaction was used to assess the effect of the 
intervention on outcomes relative to the control, and the statistical significance 
was defined as P<0.05. 
Post-hoc analyses from the GLM-REML were used as appropriate, and the 
statistical significance was defined as P<0.05. Multiple comparisons between 
groups were carried out using the t-test. The Bonferroni correction was 
applied to control for type I error from multiple comparisons and the statistical 
significance was defined as P<0.025. 
The relationship between change in PA and sedentary behaviour and other 
outcomes was analysed using Pearson’s correlations where statistical 
significance was defined as P<0.05. 
The effect of the intervention was noted in terms of average changes of the 
outcomes in both groups. The difference between both groups (intervention and 
control) from the baseline to the end of the intervention (6 months) is 
considered the main comparison. The primary outcome measure was based on 
data from the activPALTM in terms of step count and time spent being sedentary 
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(including sleeping time). The average daily steps count and time spent 
sedentary (including sleeping time) were recorded over one week with 
activPALTM for each participant, and the total average daily steps and time 
sedentary (including sleeping time) of both the intervention and control group 
were calculated at each assessment time point (baseline, 3 and 6 months and 12 
months). 
5.11.2 Qualitative data analysis 
Qualitative data from the telephone interviews were analysed thematically. The 
process of thematic analysis includes identification, analysing and reporting the 
pattern (themes) within the data (Braun and Clarke, 2008). The interviews were 
audio-recorded, transcribed and coded independently by the chief investigator 
and the transcripts from the interviews were analysed thematically using the 
framework approach and NVivo 11 software for the coding and organization of 
data (Jane.Ritchie and Lewis, 2003).  
Inductive approaches were used where the researcher identified themes in the 
interview transcripts and attempted to verify, confirm and qualify them by 
searching through the data and repeating the process to identify further themes 
and subthemes. In the first stage the researcher read and re-read the transcripts 
and coded them. Then heading of thematic was chosen from grouped data in 
order to provide clarification of each theme. The coding, themes and sub-
themes were reviewed by supervisor (CG), and the interpretation and analysis 
were discussed and agreed (further discussed in section 7.2). 
  
128 
 
 
6 Quantitative Findings 
This chapter presents the study sample characterises and results of the analysis 
of quantitative data of primary and secondary measures outcome measures. It 
also includes a summary of the findings. 
6.1 Study sample 
Three hundred and twenty people with RA were asked to participate in the study 
between November 2014 and August 2015. Seventy-six individuals (63 women 
and 13 men), aged 56 (± 15) years, met the inclusion criteria and provided 
informed consent. After baseline assessment, the participants were randomised 
into intervention and control groups. The intervention group attended six, 
weekly sessions and two booster sessions in small groups of up to six 
participants. The control group had single education session in small groups of 
up to six participants. 
The primary end point of the study was 6 months. As shown in the CONSORT 
diagram, Figure 6-1, 37 (94.9%) people from the intervention group and 22 
(59.4%) people from the control group completed the trial. Due to the time 
limits of the study, only 22 participants were followed up at 12 months. While 
data were available for all 11 participants in the intervention group at 12 
months, 4 of the 11 participants in the control group were lost to follow-up. 
Three serious adverse events were reported in the intervention group, although 
they were not related to the study (Hodgkin lymphoma, nasopharyngeal 
carcinoma and oesophageal carcinoma). There were no SAEs in the control 
group.  
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Figure 6-1 CONSORT diagram for flow of participants through the trial  
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6.2 Demographic characteristics of study sample 
After the baseline assessments, the participants were randomised into 
intervention or control groups. The intervention group contained 39 participants, 
(29 females and 10 males) and the control group contained 37 participants (34 
females and 3 males). There was no significant difference between the 
intervention and control groups for any of the variables recorded at baseline. 
The characteristics of the participants in both groups are shown in Table 6-1 and 
Table 6-2. 
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Table 6-1 Descriptive characteristics of the study sample (n=76) 
 
Variable Intervention (n=39) Control(n=37) P-value 
Age(years)* mean(SD) 58.2 (13.5) 54.5 (15.8) 0.29 
Gender**, n (%) 10M (25.6) 
29F (74.4) 
 
3M (8.1) 
34F (91.1) 
 
0.06 
Level of education ** n (%) 
Elementary, and high 
school, Post-secondary 
education 
 
17 (43.6) 
22 (56.4) 
 
19 (51.4) 
18 (48.6) 
 
0.65 
Marital status**, n (%) 
Married 
Other (single, separated, 
divorced or widowed) 
 
20 (51.3) 
19 (48.7) 
 
19 (51.4) 
18 (48.6) 
 
0.59 
Height (m)*, mean(SD) 1.7 (0.1) 1.6 (0.1) 0.08 
Weight (kg)*, mean(SD) 78.1 (16.4) 71.2 (16.6) 0.07 
BMI(kg/m2)*, mean(SD) 28.1 (5.4) 26.7 (5.9) 0.27 
Waist circumference (cm)*, 
mean(SD) 
86.8 (12.2) 
 
81.3 (12.9) 
 
0.06 
WHR*, mean(SD) 0.86 (0.1) 0.83 (0.1) 0.08 
WHtR*, mean(SD) 0.52 (0.7) 0.49 (0.8) 0.19 
Hip circumference (cm)*, 
mean(SD) 
100.7 (11.4) 98.2 (11.6) 0.33 
Tobacco use**, n (%) 
Yes 
No and previous  
 
10 (25.6) 
29 (74.4) 
 
9 (24.3) 
28 (75.7) 
 
0.58 
Alcohol use**, n (%) 
Yes 
No 
 
26 (66.7) 
13 (33.3) 
 
20 (54.1) 
17 (45.9) 
 
0.26 
Disease duration (months)*, 
mean(SD) 
23.6 (18.9) 
 
19.7 (13.9) 0.30 
 
Medications, n (%) ** 
DMARDs  
Prednisolone  
Cholesterol lowering 
medication, 
 
39 (100.0) 
0 (0.0) 
3 (7.7) 
 
36 (97.3) 
1 (2.7) 
2 (5.4) 
 
0.89 
 
0.69 
PA activPALTM Step count 
(steps/day)*, mean(SD) 
 
7251 (2345.2) 
 
7219 (1938.8) 
 
0.95 
PA activPALTM Time being 
sedentary (hrs/day)*, 
mean(SD) 
18.0 (1.9) 18.5 (1.4) 0.20 
IPAQ Total MET-min/week*, 
mean(SD) 
 
2965.0 (2501.4) 
 
2799.9 (2877.4) 
 
0.79 
IPAQ Time spent sitting* 
Weekday (hrs), mean(SD) 
 
5.3 (1.9) 
 
4.7 (2.5) 
 
0.29 
IPAQ Time spent sitting 
weekend (hrs), mean(SD)* 
 
5.1 (2.1) 
 
4.6 (2.5) 
 
0.42 
The data were analysed using Independent sample t test*, chi square test or Fisher exact test**, 
Statistical significance was accepted at P < 0.05. SD= Standard Deviation, n= number, m= meter, 
kg= kilogram, cm= centimeter, min= minutes, hrs= hours, WHR=Waist to Hip Ratio, WHtR= Waist 
to Height Ratio, DMARDs= Disease-Modifying AntiRheumatic Drugs, IPAQ= International Physical 
Activity Questionnaire, MET= Metabolic Equivalent of Task. 
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Table 6-2 Descriptive characteristics of rheumatoid arthritis features at baseline (n=76) 
 
RA features variable Intervention (n=39) Control (n=37) P-value 
Functional capacity  
HAQ, mean(SD) 
Hand grip (kg), mean(SD) 
 
1.1 (0.8) 
23.2 (11.2) 
 
1.2 (0.8) 
19.9 (11.3) 
 
0.72 
0.13 
RA outcome 
RAQoL, mean(SD) 
SDAI, mean(SD) 
 
10.3 (7.9) 
13.5 (19.7) 
 
13.3 (9.7) 
13.2 (12.5) 
 
0.13 
0.94 
Self-efficacy for PA, 
mean(SD) 
42.9 (23.6) 
 
37.7 (26.6) 
 
0.37 
 
Blood pressure, mmHg 
mean(SD) 
Systolic 
Diastolic 
 
 
124.0 (14.5) 
77.0 (6.9) 
 
 
125.0 (17.5) 
75.0 (8.8) 
 
 
0.82 
0.38 
Blood analysis, mean (SD) 
Blood glucose (mmol/L), 
GGT (U/L) 
Insulin (µIU/mL) 
CRP (mg/L) 
ALT (U/L) 
AST (U/L) 
HDL (mmol/L) 
Trig (mmo/L) 
Cholesterol (mmo/L) 
HbA1c (%) 
 
6.2 (2.4) 
26.9 (17.8) 
15.2 (13.0) 
8.5 (19.4) 
24.1 (12.1) 
21.5 (6.2) 
1.5 (0.5) 
1.4 (0.5) 
5.3 (1.1) 
5.4 (1.1) 
 
5.7 (1.4) 
32.1 (29.9) 
16.4 (14.7) 
5.6 (7.6) 
27.6 (15.3) 
23.4 (7.8) 
1.4 (0.4) 
1.6 (0.8) 
5.4 (1.2) 
5.2 (0.9) 
 
0.23 
0.36 
0.69 
0.40 
0.27 
0.24 
0.19 
0.14 
0.63 
0.50 
ASSIGN score, mean(SD) 19.4 (16.3) 19.6 (15.0) 0.95 
DINE, mean(SD) 
Fatty food 
Sugary 
Fruits and vegetables 
 
17.6 (6.7) 
5.3 (2.0) 
3.2 (2.0) 
 
17.6 (5.4) 
5.8 (2.4) 
2.6 (2.0) 
 
0.99 
0.27 
0.18 
The data were analysed using Independent sample t test*. Statistical significance was accepted at 
P < 0.05. SD= Standard Deviation, n= number, mmol/L = millimole per litre, mmHG= millimeter of 
mercury, mg = milligram , U/L = Units/Litre , µIU/mL=micro litre unite per millimole, HAQ= Health 
Assessment Questionnaire, RAQOL= Rheumatoid Arthritis Quality of Life, SDAI= Simple Disease 
Activity Index, ASSIGN score =Assessing cardiovascular risk using SIGN (Scottish Intercollegiate 
Guidelines Network), DINE= Dietary Instrument for Nutrition Education. CRP= C-Reactive Protein, 
GGT= Gamma-Glutamyl Transpeptidase , ALT= Alanine aminoTransferase ,AST= Aspartate 
aminoTransferase , HDL= High Density Lipoprotein, Trig= Triglyceride, Chol= Cholesterol, 
HBA1c=Glycated Haemoglobin. 
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There was no significant difference in the demographic characteristics of the 
people in the intervention group who were lost to follow up at 6 months (n=2) 
and those who completed the 6-month assessment (n=37), however, although 
presented the number lost to follow up was very small for meaningful analysis. 
Also, there was no significant difference between control group who were lost to 
follow up (n=15) and those who completed the 6-month assessment (n = 22). 
However, there was a significant difference in the overall group who 
assessments at 6 months (n=59) and those who were lost to follow up (n=17) in 
terms of age (P=0.017) and gender (P=0.033). Overall, the people who were lost 
to follow up were younger and more likely to be female, Table 6-3. 
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Table 6-3 Descriptive characteristics at baseline of the sample who did and did not attend 6 month follow up in the both groups 
 
Variable Intervention 
(completed 
study) 
n=37 
Intervention 
(lost to  
follow up) 
n=2 
P-
value 
Control 
(completed 
study) 
n=22 
Control 
(lost to 
 follow up) 
n=15 
P-
value 
Overall 
(completed 
study) 
n=59 
Overall 
(lost to 
follow up) 
n=17 
P- 
value 
Age (years)* 
mean(SD) 
57.9 (13.2) 64.0 (24.0) 0.540 56.0 (15.5) 50.4 (17.7) 0.330 58.2 (13.3) 48.4 (18.2) 0.017* 
Gender, ** 
Female,  
n (%) 
27 (73.0) 2 (100.0) 1.000 19 (86.4) 15 (100.0) 0.261 46 (78.0) 17 (100.0) 0.033* 
Disease 
duration*, 
mean (SD)  
22.6 (18.9) 42.0 (8.5) 0.162 19.9 (14.1) 19.3(14.1) 0.904 21.6 (17.2) 22.0 (15.3) 0.933 
Marital 
status**, 
 n (%) 
Married  
Other (single, 
separated 
,divorced or 
widowed) 
 
 
 
19 (51.4) 
18 (48.6) 
 
 
 
 
1 (50.0) 
1 (50.0) 
 
 
 
0.657 
 
 
 
11 (50.0) 
11 (50.0) 
 
 
 
8 (53.3) 
7 (46.7) 
 
 
 
0.842 
 
 
 
30 (50.8) 
29 (49.2) 
 
 
 
9 (52.9) 
8 (47.1) 
 
 
 
0.879 
Level of 
education**,  
n (%)  
Elementary 
and high 
school, 
 
 
 
17 (45.9) 
20 (54.1) 
 
 
 
1 (50.0) 
1 (50.0) 
 
 
 
 
0.254 
 
 
 
14 (63.6) 
8 (36.4) 
 
 
 
5 (33.3) 
10 (66.7) 
 
 
 
0.070 
 
 
 
 
31 (52.5) 
28 (47.5) 
 
 
 
5 (29.4) 
12 (70.6) 
 
 
 
0.092 
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Post-secondary 
education 
Tobacco use 
**, n (%) 
Yes 
No and 
previous 
 
 
9 (24.3) 
28 (75.7) 
 
 
1 (50.0) 
1 (50.0) 
 
 
0.452 
 
 
6 (27.3) 
16 (72.7) 
 
 
3 (20.0) 
12 (80.0) 
 
 
0.711 
 
 
15 (25.4) 
44 (74.6) 
 
 
4 (23.5) 
13 (76.5) 
 
 
1.000 
Alcohol use **,  
n (%) 
Yes 
No 
 
 
25 (67.6) 
12 (34.4) 
 
 
1 (50.0) 
1 (50.0) 
 
 
1.000 
 
 
14 (63.6) 
8 (36.4) 
 
 
6 (40.0) 
9 (60.0) 
 
 
0.157 
 
 
39 (66.1) 
20 (33.9) 
 
 
7 (41.2) 
10 (58.8) 
 
 
0.064 
DMARD**, n (%) 37 (100.0) 2 (100.0) 0.751 21 (95.5) 15 (100.0) 0.842 58 (98.3) 17 (100.0) 0.645 
BMI (kg/m2) *, 
mean (SD) 
28.2 (5.4) 27.8 (5.3) 0.926 26.5 (5.3) 26.9 (6.8) 0.842 27.8 (5.3) 27.0 (6.5) 0.647 
PA activPAL TM 
Step count 
(steps/day), 
mean (SD) 
 
7195 (2392.5) 
 
8295 (784.2) 
 
0.530 
 
7754 (1777.0) 
 
6436 (1956.0) 
 
 
0.06 
 
7369 (2182.3) 
 
6772 (1990.9) 
 
0.315 
PA activPALTM  
Time being 
sedentary 
(hrs/day)  
mean (SD) 
 
18.0 (1.9) 
 
17.7 (0.6) 
 
0.801 
 
18.4 (1.3) 
 
18.7 (1.6 ) 
 
0.53 
 
18.1(1.7) 
 
18.8 (1.4) 
 
0.092 
The data were analysed using Independent sample t test* or chi square or Fisher exact test**, Statistical significance was accepted at P < 0.05, n=number, SD=Stander 
Deviation, hrs=hours, PA= Physical Activity, BMI= Body Mass Index, DMARDs= Disease-Modifying AntiRheumatic Drugs.
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6.3 Attendance at education sessions 
The physiotherapist who carried out the education sessions provided attendance 
records for both groups. Twenty-six (66.7%) participants in the intervention 
group attended all 8 education sessions (6 sessions and 2 booster sessions) and 
28 (71.8%) attended 6 sessions. The control group had a single education session 
in small groups of up to six people; 21 (56.8%) of the participants in the control 
group attended this session. There was no significant association between 
attendance of education sessions and step count in the intervention group at 3 
and 6 months respectively (r= 0.27, P=0.11 and r=0.14, P= 0.41) or sedentary 
time (r= - 0.07, P=0.72 and r=0.09, P= 0.63). Although attendance was high 
overall, the highest attendance was recorded at the first two education sessions, 
then it declined but stayed above 70% throughout, see Figure 6-2.  
 
Figure 6-2 Attendance of intervention group in each session (n=39) 
 
6.4 Physical activity and sedentary behaviour results at 
baseline, 3 and 6 months 
The step count and time spent being sedentary (including sleeping time) was 
measured using objective monitoring (activPALTM) at 3, 6 and 12 months. At 
baseline 44 (57.9%) participants had a data for 7 consecutive days, 12 (15.8%) 
participants for 6 days, 9 (11.8%) participants for 5 days, 4 (5.3%) participants 
for 4 days and 7 (9.2%) participants had 3 days of data for analysis. At 3 months 
28 (45.2%) participants had data from 7 consecutive days, 19 (30.6%) participants 
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for 6 days, 5 (8.1%) participants for 5 days, 3 (4.8%) participants for 4 days and 7 
(11.3%) participants had 3 days of data for analysis. At 6 months 28 (47.4%) 
participants had data for 7 consecutive days, 15 (25.4%) participants for 6 days, 
9 (15.3%) participants for 5 days, 4 (6.8%) participants for 4 days and 3 (5.1%) 
participants had 3 days of collected data. At 12 months 13 (72.2%) participants 
had data from 7 consecutive days, and 5 (27.8%) participants had data for 5 
days. Participants who had activPAl TM data for 3 days or more were analysed.  
Table 6-4 displays the objective measure of PA (average step count/day, 
sedentary time/hrs) and subjective data of IPAQ total MET min/week and time 
spent sitting at weekday and weekend/hrs) for both groups at baseline, 3 
months and 6 months. The step count increased over time in the intervention 
group, but decreased in the control group. A significant interaction was 
identified between the groups (intervention and control) in step count, (P < 
0.001). Post hoc analysis demonstrated a significant increase in the average step 
count from baseline to 3 months, and from baseline to 6 months (P < 0.001). The 
participants’ step count continued to be high between 3 and 6 months 
(P=1.000). However, in the control group the step count reduced between 
baseline and 3 months (P=0.024) and baseline 6 months (P=0.039), see Table 6-4. 
Also, there was significant differences between groups (intervention and 
control), step count at 3 months (mean difference 3413 steps/day, 95% CI: 1835-
4990) (P<0.001) and at 6 months (mean difference 3599 steps/day, 95% CI: 2135-
5062) (P<0.001).  
There was a significant interaction effect in the IPAQ total MET (P=0.006). The 
IPAQ total MET-min/week increased in the intervention group at 3 months then 
declined at 6 months, but was still higher than the baseline. Total MET-
min/week increased in the intervention group between the baseline and 3 
months (P= 0.005), and it then reduced between 3 months and 6 months (P= 
0.037). In the control group however, non-significant change were noted, 
between baseline and 3 months (P= 0.622), and between 3 months and 6 
months, (P=1.000), see Table 6-4 and Table 6-5. 
There was a non-significant interaction effect between the groups (intervention 
and control) in objective sedentary time (including sleeping time) (P=0.190). 
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However, a significant interaction effect between the groups (intervention and 
control) was noted in the self-reported weekday (P= 0.014) and weekend sitting 
time (P= 0.046). There was a significant difference within the groups 
(intervention and control) in the weekday and weekend self-reported sitting 
time. The weekday and weekend sitting time reduced in the intervention group, 
between baseline and 3 months, (P=0.036) and between baseline and 6 months, 
(P=0.016). The weekend sitting time reduced between baseline and 3 months, 
(P= 0.057) and between baseline and 6 months, (P= 0.003). However, in the 
control group it increased, between baseline and 3 months, (P= 0.391), and 
between baseline and 6 months, (P=0.493), Table 6-4. 
There was a significant difference between groups in the self-reported weekday 
sitting time at 6 months – it reduced in the intervention group and increased in 
the control group (P = 0.009), Table 6-5. No significant changes between both 
groups in weekend sitting time were noted at 3 months (P = 0.047) or at 6 
months (P = 0.034). 
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Table 6-4 Findings from primary outcome measures at baseline, 3 and 6 months within groups changes 
 
Variables Intervention (n=39) Control (n=37) Significance Post hoc Analysis 
P value (Within group changes) 
 B 3 m 6 m B 3 m 6 m Interaction 
effect P 
value 
B 
v 3 m 
(InG) 
B 
v 3 m 
(CG) 
B 
v 6 m  
(InG) 
B 
v 6m 
(CG) 
3 m 
v 6m  
(InG) 
3 m 
v 6m 
(CG) 
PA activPALTM  
Step count 
(step/day) 
 
7251 
(345) 
 
9820 
(504) 
 
9802 
(447) 
 
7219 
(355) 
 
6182 
(574) 
 
5933 
(550) 
 
< 0.001* 
 
< 0.001* 
 
0.024* 
 
< 0.001* 
 
0.039* 
 
1.000 
 
1.000 
PA activPALTM  
Sedentary 
time(hrs/day) 
 
18.0 
(0.27) 
 
17.6 
(0.3) 
 
17.2 
(0.3) 
 
18.5 
(0.2) 
 
18.3 
(0.37) 
 
18.7 
(0.41) 
 
0.190 
      
IPAQ 
Total, MET 
min/week  
2965 
(431) 
4239 
(468) 
3080 
(416) 
2799 
(448) 
2147 
(526) 
2080 
(513) 
0.006* 0.005* 0.622 1.000 0.698 0.037* 1.000 
IPAQ Time 
spent sitting 
(hrs)Weekday  
 
5.3 
(0.36) 
 
5.4 
(0.3) 
 
4.2 
(0.3) 
 
4.7 
(0.3) 
 
5.0 
(0.38) 
 
5.6 
(0.46) 
 
0.014* 
 
0.036* 
 
0.555 
 
0.016* 
 
1.000 
 
1.000 
 
1.000 
IPAQ Time 
spent sitting 
(hrs)Weekend  
5.1 
(0.37) 
4.1 
(0.3) 
3.9 
(0.4) 
4.6 
(0.3) 
4.8 
(0.38) 
5.1 
(0.50) 
0.046* 0.057 0.391 0.003* 0.493 1.000 1.000 
The data were analysed using GLM REML = Generalized Linear Model, Post hoc analysis within GLM REML output, statistical significance was accepted at P < 0.05. The 
data are mean ±SE, SE =Standard Error, IPAQ=International Physical Activity Questionnaire, hrs=hours, n= number, B= Baseline, m= months, MET= Metabolic Equivalent 
of Task, min= minutes. 
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Table 6-5 Findings from primary outcome measures at baseline, 3 and 6 months between groups (intervention and control) 
 
Variables Intervention Control P Value 
IG v CG 
B 
P Value 
I G v CG 
3 months 
P value 
I G v CG 
6 months 
Between- group differences 
(Intervention- Control) 
B 
(n=39) 
3 
months 
(n=36) 
6 
months 
(n=37) 
B 
(n=37) 
3 
months 
(n=26) 
6 
months 
(n=22) 
3 months 
 
 
6 months 
 
PA 
activPALTM  
Step count 
(step/day) 
7251 
( 345) 
9855 
(788) 
9820 
(499) 
7219 
(355) 
6442 
(739) 
6221 
(466) 
0.4745 < 0.001* < 0.001* 3413 
(1835-4990 
3599 
(2135-5062)  
IPAQ- 
Total 
MET(min/
week) 
2965 
(400) 
4269 
(506) 
3055 
(408) 
2799 
(479) 
2311 
(471) 
2500 
(408) 
0.431 0.002* 0.021 1957 
(520-3394) 
555 
(-824-1934) 
 
IPAQ Time 
spent 
sitting 
(hrs) 
Weekday 
5.3 
(0.31) 
4.4 
(0.32) 
4.2 
(0.33) 
4.7 
(0.41) 
5.1 
(0.41) 
5.7 
(0.53) 
0.143 0.094 0.009* -0.69 
(-1.73-0.34) 
-1.56 
(-2.75 to-0.36) 
IPAQ Time 
spent 
sitting 
(hrs) 
Weekend 
5.3 
(0.36) 
4.1 
(0.31) 
3.9 
(0.33) 
4.6 
(0.38) 
4.9 
(0.42) 
5.1 
(0.63) 
0.211 0.047 0.034 -0.87 
(-1.91-1.55) 
-1.22 
(-2.52-0.09) 
The data were analysed using Independent sample t test, statistical significance was accepted at adjusted P < 0.025. The data are mean ± SE, SE= Stander Error, B= 
Baseline, IG= Intervention Group, CG= Control Group, min =minutes, hrs= hours, PA= Physical Activity, MET= Metabolic Equivalent of Task, IPAQ= International Physical 
Activity Questionnaire
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Multiple comparison t test illustrated a significant difference in step count 
between both groups at 3 and 6 months. The step count of the intervention 
group significantly increased; however the step count in the control group 
significantly decreased at 3 and 6 months, see Figure 6-3.  
 
Figure 6-3 Changes in objective physical activity (step count/days) between the intervention 
group and control group at 3 and 6 months, error bars represent (mean ±SEM) at 3 & 6 
months. 
Statistical significance was accepted at adjusted P < 0.025 
The intervention group showed a reduction in objective sedentary time 
(including sleeping time) whereas the control group showed a slight increase in 
time spent sedentary. However, this was not significant, therefore post-hoc 
analysis was not undertaken, Figure 6-4. However, sedentary times were not 
powered to detect a difference so this finding is not unexpected. 
 
Figure 6-4 Change in objective time being sedentary (hrs) for intervention group (n=39) and 
control group (n=37) at 3 and 6 months, error bars represent (mean ±SEM) at 3 & 6 months. 
(However, the changes is not significant therefore post hoc analysis did not apply) 
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There was a non-significant decline in self-reported weekday sitting time in the 
intervention group, whilst it increased in the control group at 3 months. There 
was a significant decline in self-reported weekday sitting time in the 
intervention group at 6 months, however in the control group it had further 
increased at 6 months, see Figure 6-5.   
 
Figure 6-5 Changes in self-reported weekday time spent sitting (hrs) between the 
intervention and control group at 3 and 6 months, error bars represent (mean ±SEM) at 3 & 6 
months. 
Statistical significance was accepted at adjusted P< 0.025  
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There were no significant changes in weekend sitting time between the groups 
at 3 and 6 months. Although there was a decline in weekend sitting time at 3 
and 6 months in the intervention group and a slight increase in the control 
group, these were non-significant, see Figure 6-6. 
 
Figure 6-6 Changes in self-reported weekend time spent sitting (hrs) between the 
intervention and control group at 3 and 6 months, error bars represent (mean ±SEM) at 3 & 6 
months. 
Statistical significance was accepted at adjusted P < 0.025 
There was a significant difference in terms of marital status between the people 
whose step count increased over 6 months and the people whose step count 
reduced or continued the same as the baseline over the 6-month period, (P = 
0.031), see Table 6-6.
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Table 6-6 Demographic characteristics of people who their step count increased over study 
time period and those who their step count continues same or reduce in the intervention 
group 
 
Variables Step count 
increased over 
study period 
(n=25) 
Step count 
reduced or same 
over study 
period(n=11) 
P 
value 
Age (yrs)*,mean(SD) 60.4 (10.4) 52.9 (18.8) 0.139 
Gender**, n (%) 
 
8M (32.0) 
17F (68.0) 
2M (18,2) 
9F (81.8) 
0.688 
Disease duration 
(months)*,mean(SD) 
26 (20.7) 12.7 (7.3) 0.058 
Level of 
education**, n (%), 
Elementary and 
high school, 
Post-secondary 
education 
 
 
13 (52.0) 
 
12 (48.0) 
 
 
4 (36.4) 
 
7 (63.6) 
 
 
0.481 
Marital status**,  
n (%) 
Married  
Other (single, 
separated, divorced 
or widowed) 
 
 
10 (40.0) 
15 (60.0) 
 
 
9 (81.8) 
2 (18.2) 
 
 
0.031* 
Tobacco use **,  
n (%) 
Yes 
No & previous 
 
 
6 (24.0) 
19 (76.0) 
 
 
3 (27.3) 
8 (72.7) 
 
 
1.000 
Alcohol use **, n (%)  
Yes 
No 
 
17 (68.0) 
8 (32.0) 
 
7 (63.6) 
4 (36.4) 
 
1.000 
BMI (kg/m2) *, 
mean (SD) 
27.9 (4.5) 29.2 (6.6) 0.508 
SDAI, mean(SD) 14.1 (23.9) 13.2 (11.7) 0.901 
The data were analysed using Independent sample t test*, chi square test or Fisher exact test**, 
Statistical significance was accepted at P < 0.05. SD= Standard Deviation, n= number, m= meter, 
kg= kilogram, yrs= years.
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6.5 Rheumatoid arthritis outcome results at baseline, 3 
and 6 months 
Table 6-7 displays a mixed- model analysis of SDAI, RAQoL and Charlson co-
morbidity index at study time points. There were no significant changes in either 
group over time in the SDAI and RAQoL. There was no significant interaction 
effect noted in SDAI, RAQoL or Charlson co-morbidity index. 
Table 6-7 Rheumatoid arthritis outcome results at baseline, 3 and 6 months 
 
Variables Intervention (n=39) Control (n=37) Significance 
 B 3 m 6 m B 3 m 6 m Interaction 
effect  
SDAI 13.4 
(2.7) 
10.9 
(2.6) 
7.3 
(1.4) 
13.2 
(2.7) 
13.0 
(3.0) 
13.4 
(1.8) 
0.179 
RAQoL 10.3 
(1.4) 
7.9 
(1.4) 
7.5 
(1.4) 
13.3 
(1.4) 
11.2 
(1.6) 
12.3 
(1.6) 
0.085 
Charlson 
co- 
morbidity 
index 
3.6 
(0.3) 
3.6 
(0.3) 
3.6 
(0.3) 
3.3 
(0.3) 
3.4 
(0.3) 
3.4 
(0.3) 
0.274 
The data were analysed using GLM REML = Generalized Linear Model, statistical significance was 
accepted at P < 0.05. The data are mean ±SE, SE =Standard Error, SDAI=Simple Disease Activity 
Index, RAQoL=Rheumatoid Arthritis Quality of Life, n= number, B= Baseline, m= months. 
6.6 Disease activity - Simple Disease Activity Index score 
(SDAI) at baseline, 3 and 6 months 
The percentage of participants who had remission scores increased between the 
baseline and 6 months in the intervention group and decreased in the control 
group, however these changes were not statistically significant as shown in Table 
6-8.  
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Table 6-8 The percentage of participants in each SDAI category at baseline, 3 and 6 months 
 
SDAI Score 
Interpretation 
Intervention 
n (%) 
Control 
n (%) 
P 
B 
P 
3m 
P 
6m 
B 
(n=39) 
3 m 
(n=36) 
6 m 
(n=37) 
B 
(n=37) 
3m 
(n=26) 
6m 
(n=22) 
0.521 0.322 0.102 
Remission 
(0-3.3) 
5  
(12.8) 
9  
(25.0) 
12 
 (32.4) 
4  
(10.8) 
2 
 (7.7) 
2 
 (9.1) 
Low activity  
(3.4-11) 
20  
(51.3) 
17 
(47.2) 
18 
(48.7) 
18  
(48.7) 
14 
(53.8) 
11 
(50.0) 
Moderate activity  
(33.1-26) 
13 
(33.3) 
8  
(22.2) 
6 
 (16.2) 
11 
(29.7) 
8 
(30.8) 
6 
(27.3) 
High activity  
(26.1-86) 
1  
(2.6) 
2  
(5.6) 
1  
(2.7) 
4  
(10.8) 
2  
(7.7) 
3  
(13.6) 
The data were analysed using Likelihood ratio, statistical significance was accepted at P < 0.05, SDAI= Simple Disease Activity Index, 
                            n=number, B= Baseline, m=months. 
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6.7 Physical activity self- efficacy at baseline, 3 and 6 
months 
There was a significant difference between the groups (intervention and control) 
in overall PA self-efficacy. There was a significant interaction effect in PA self-
efficacy. A significant difference within the groups (intervention and control) 
was noted. PA self-efficacy increased in the intervention group but decreased in 
the control group. In the intervention group PA self-efficacy increased from 
baseline to 3 months, (P= 0.002) and between baseline and 6 months, (P= 
0.002). However, it reduced in the control group over the study time points (6 
months), see Table 6-9. A multiple comparison t test illustrated a significant 
difference between the intervention and control groups in PA self-efficacy at 3 
and 6 months, see Table 6-10. 
6.8 Dietary Instrument for Nutrition Education (DINE) at 
baseline, 3 and 6 months 
In terms of the DINE there were non-significant interaction effects between the 
intervention and control groups in the consumption of fatty foods, sugary foods 
or fruits and vegetables, as shown in Table 6-9. Although there was a slight 
increase in the consumption of fruits and vegetable and a decline in sugary and 
fatty foods in the intervention group, these were not significance. Diet was not 
powered to detect a difference so this finding is not unexpected.
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Table 6-9 Physical activity self-efficacy and DINE outcome results at baseline, 3 and 6 within groups changes 
  
Variables Intervention (n=39) Control (n=37) Significance Post hoc Analysis 
P Value (Within group changes) 
 B 3 m 6 m B 3 m 6 m Interaction 
effect 
B 
v 3 m 
(InG) 
B 
v 3 m 
(CG) 
B 
v 6 m 
(InG) 
 B 
v 6 m  
(CG ) 
3 m 
v 6m 
(InG) 
3 m 
v 6m  
( CG)  
PA Self-
efficacy  
43.0 
(4.0) 
58.0 
(4.3) 
57.0 
(3.9) 
38.0 
(4.1) 
35.0 
(4.9) 
33.5 
(4.7) 
0.008* 0.002* 1.000 0.002* 1.000 1.000 1.000 
DINE 
 Fatty food 
17.6 
(0.9) 
17.3 
(0.9) 
17.1 
(0.8) 
17.6 
(1.0) 
19.2 
(1.0) 
17.0 
(1.0) 
0.239       
DINE Sugary 
food  
5.3 
(0.4) 
4.9 
(0.4) 
4.6 
(0.3) 
5.8 
(0.4) 
5.3 
(0.4) 
5.2 
(0.3) 
0.838       
DINE 
Fruits and 
vegetables 
3.2 
(0.3) 
3.7 
(0.3) 
3.9 
(0.3) 
2.6 
(0.3) 
2.9 
(0.3) 
2.7 
(0.3) 
0.583       
The data were analysed using GLM REML = Generalized Linear Model, Post hoc analysis within GLM REML output, statistical significance was accepted at P < 0.05. The 
data are mean ±SE, SE =Standard Error, DINE= Dietary Instrument for Nutrition Education, n= number, B=Baseline, m= months, InG= Intervention Group, CG= Control 
Group. 
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Table 6-10 Physical activity self-efficacy outcome results at baseline, 3 and 6 months between groups (intervention and control) 
 
Variables Intervention Control P Value 
IG v CG 
B 
P Value 
I G v CG 
3 
months 
P value 
I G v CG 
6 
months 
Between- group differences 
(Intervention- Control) 
B  
(n=39) 
3 
months  
(n=36) 
6 
months 
(n=37)  
B 
(n=37) 
3 
months 
 (n=26) 
6 
months 
(n=22) 
3 months 6 months 
PA self-
efficacy  
43.0 
(4.0) 
58.9 
(3.8) 
57.3 
(3.9) 
38.0 
(4.1) 
36.2 
(5.9) 
36.1 
(5.6) 
0.183 < 0.001* 0.001* 22.7(9.3-36.1) 21.2(7.8-34.5) 
The data were analysed using Independent Sample t test, statistical significance was accepted at adjusted P < 0.025. The data are mean ± SE, SE= Stander Error, B= 
Baseline, IG= Intervention Group, CG= Control Group, n= number, PA=Physical Activity. Between groups difference (intervention and control) with 95% confidence 
interval.
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Multiple comparison t test illustrated a significant difference in PA self-efficacy 
between the groups over 6 months. There was a significant increase in PA self-
efficacy in the intervention group at 3 months and this remained high at 6 
months. In the control group there was decline at 3 months and 6 months, see 
Figure 6-7. 
 
Figure 6-7 Changes in self-efficacy for physical activity score between the intervention and 
control group at 3 and 6 months, error bars represent (mean ±SEM) at 3 & 6 months. 
Statistical significance was accepted at adjusted P< 0.025 
6.9 Functional capacity (6MWT, HAQ and hand grip 
strength) at baseline, 3 and 6 months 
The distance walked in six minutes (6MWT) improved in the intervention group 
but reduced in the control group between baseline and 6 months. There was a 
significant interaction effect between groups in 6MWT (P < 0.001) – an increase 
was observed in 6 MWT in the intervention group between baseline and 3 
months, (P=0.021); between baseline and 6 months (P < 0.001); and between 3 
months and 6 months, (P=0.001). 
A significant decline in the 6MWT in the control group was observed between 
baseline and 3 months (P=0.039) and between baseline and 6 months (P=0.003). 
There was no difference however between 3 months and 6 months, (P=0.189), 
see Table 6-11. Multiple comparison t test illustrated a significant difference in 
the 6MWT between the groups at 3 and 6 months, see Table 6-12. 
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There were no significant changes in the Health Assessment Questionnaire (HAQ) 
in either group. Hand grip strength reduced in the control group and slightly 
improved at 6 months in the intervention group, although this was not 
significant. There was no interaction effect in either group, see Table 6-11. 
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Table 6-11 Functional capacity outcome results at baseline, 3 and 6 months within groups changes 
 
Variables Intervention (n=39) Control (n=37) Significance Post hoc Analysis 
P Value (Within group changes) 
 B 3 m 6 m B 3 m 6 m Interaction 
effect 
B 
v 3 m 
(InG) 
B 
v 3 m 
(CG) 
B 
v 6 m 
(InG) 
 B 
v 6 m 
(CG ) 
3  
v 6 m 
(InG) 
3 
v 6 m  
(CG)  
6MWT 
(m) 
361 
(19.7) 
389 
(19.4) 
417 
(18.9) 
341 
(20.2) 
311 
(20.6) 
295 
(20.7) 
< 0.001* 0.021* 0.039* <0.001* 0.003* 0.001* 0.189 
HAQ 1.1 
(0.1) 
0.7 
(0.1) 
0.7 
(0.2) 
1.1 
(0.1) 
1.0 
(0.1) 
1.2 
(0.2) 
0.074       
Hand grip 
strength 
(kg) 
23.2 
(1.8) 
22.1 
(1.7) 
24.2 
(1.7) 
19.8 
(1.8) 
19.3 
(1.9) 
19.6 
(1.9) 
0.182       
The data were analysed using GLM REML = Generalized Linear Model, Post hoc analysis within GLM REML output, statistical significance was accepted at P < 0.05. 
The data are mean ±SE, SE =Standard Error, InG= Intervention Group, CG= Control Group, B= Baseline, m=months, kg= kilogram,6MWT= Six Minutes’ Walk Test, 
HAQ= Health Assessment Questionnaire. 
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Table 6-12 Six minutes’ walk outcome results at baseline, 3 and 6 months between groups (intervention and control) 
 
Variable Intervention Control P Value 
IG v CG 
B 
P Value 
I G v CG 
3 months 
P value 
I G v CG 
6 months 
Between- group 
differences 
(Intervention- 
Control) 
B  
(n=39) 
3 
months  
(n=36) 
6 
months 
(n=37)  
B 
(n=37) 
3 
months 
 (n=26) 
6 
months 
(n=22) 
3 months 6 months 
6MWT 
(m) 
361 
(19.7) 
397 
(17.2) 
421 
(18.6) 
341 
(20.2) 
323 
(27.3) 
311 
(24.7) 
0.240 0.009* < 0.001* 74.1 
(12.6-
135.6) 
109.2 
(47.6 -
170.8) 
The data were analysed using Independent Sample t test, statistical significance was accepted at adjusted p < 0.025. The data are mean ± SE, SE= Stander Error, B= 
Baseline, IG= Intervention Group, CG= Control Group, n= number, 6MWT= Six Minutes’ Walk Test. Between groups difference (intervention and control) with 95% 
confidence interval.
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In the 6MWT there was a significant difference between the intervention and 
control groups over 6 months. There was a significant increase in the 6MWT in 
the intervention group at 3 months with 95% CI; 74.1 (12.6-135.6) and at 6 
months 109.2 (47.6 -170.8). However, in the control group there was a 
significant decline at 3 months, and it continued to decline at 6 months, see 
Figure 6-8. 
 
Figure 6-8 Changes in 6MWT (m) between the intervention group and control group at 3 and 
6 months, error bars represent (mean ±SEM) at 3 & 6 months. 
Statistical significance was accepted at adjusted P < 0.025 
6.10 Cardiovascular risk at baseline, 3 and 6 months 
Systolic blood pressure fell in the intervention group but increased in the control 
group over 6 months; with a significant interaction effect between groups 
(P=0.002). There was a significant difference within group changes. A significant 
reduction was seen in systolic blood pressure in the intervention group between 
baseline and 6 months, (P= 0.013), however in the control group there was a 
non-significant increase between baseline and 6 months, (P=0.120),Table 6-13. 
There were no significant differences in diastolic blood pressure in either group, 
Table 6-13. Multiple comparison t test illustrated a significant difference 
between the intervention and control groups in SBP at 6 months, 95% CI; - 13.9(- 
21.9 to -5.8), see Table 6-14. 
The 10 Year CVD score (ASSIGN score) reduced in the intervention group however 
increased in the control group, in the intervention group ASSIGN score declined 
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from the baseline score 19.4 to 17.1 at 6 months (P <0.001). The ASSIGN score 
increased in the control group from score 19.6 at baseline to 21.5 at 6 months, 
(P=0.016), Table 6-13. Also, Multiple comparison t test illustrated a significant 
difference between the intervention and control groups in the ASSIGN score at 6 
months (P<0.001) and 95% CI; -7.8 (-8.4 – to -6.5), see Table 6-14.
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Table 6-13 Cardiovascular risk outcome results at baseline, 3 and 6 months within groups changes 
 
Variables Intervention (n=39) Control (n=37) Significance Post hoc Analysis 
P Value (Within group changes) 
 
 B 3 m 6 m B 3 m 6 m Interaction 
effect 
B 
v 3 m 
(InG) 
B 
v 3 m  
(CG) 
B 
v 6 m  
(InG) 
B 
v 6 m  
(CG) 
3 m 
v 6m 
(InG) 
3 m 
v 6m  
(CG) 
Systolic 
blood 
pressure 
(mmHg) 
124.0 
(2.6) 
120.7 
(3.2) 
116.8 
(2.4) 
125.0 
(2.6) 
124.0 
(3.5) 
129.0 
(2.9) 
0.002* 0.572 1.000 0.013* 0.120 0.437 0.089 
 
Diastolic 
blood 
pressure 
(mmHg) 
77.0 
(1.3) 
78.4 
(1.8) 
75.4 
(1.4) 
75.3 
(1.3) 
76.3 
(2.0) 
78.6 
(1.7) 
0.063       
ASSIGN 
score 
19.4 
(2.5) 
18.6 
(2.5) 
17.1 
(2.5) 
19.6 
(2.6) 
20.5 
(2.7) 
21.5 
(2.7) 
<0.001* 0.527 0.736 <0.001* 0.016* 0.027* 0.179 
The data were analysed using GLM REML = Generalized Linear Model, Post hoc analysis within GLM REML output, statistical significance was accepted at P < 0.05. The 
data are mean ±SE, SE =Standard Error, InG= Intervention Group, CG= Control Group, B= Baseline, m= months, mmHG = millimeter of mercury, ASSIGN score 
=Assessing cardiovascular risk using SIGN (Scottish Intercollegiate Guidelines Network). 
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Table 6-14 Findings from secondary outcome measures at baseline, 3 and 6 months between groups (Intervention and Control) 
 
Variables Intervention Control P Value 
IG v CG 
B 
P Value 
I G v CG 
3 
months 
P value 
I G v CG 
6 
months 
Between- group 
differences 
(Intervention- Control) 
B  
(n=39) 
3 
months  
(n=36) 
6 
months 
(n=37)  
B 
(n=37) 
3 
months 
 (n=26) 
6 
months 
(n=22) 
3 months 6 months 
SBP 
(mmHG) 
124.0 
(2.6) 
121.6 
(3.4) 
116.9 
(2.4) 
125.0 
(2.6) 
123.5 
(3.5) 
130.7 
(3.2) 
0.410 0.359 < 0.001* - 1.8  
(-11.9-8.2) 
-13.9  
(- 21.9 -5.8) 
ASSIGN 
score 
19.4 
(2.5) 
18.2 
(2.4) 
16.1 
(2.3) 
19.6 
(2.6) 
21.8 
(3.4) 
24.0 
(3.9) 
0.473 0.382 <0.001* - 3. 6 
(-11.7- 4. 6) 
-7. 8 
(-8.4 -6.5) 
The data were analysed using Independent Sample t test, statistical significance was accepted at adjusted P < 0.025. The data are mean ± SE, SE= Stander Error, B= 
Baseline, IG= Intervention Group, CG= Control Group, n= number. SBP= Systolic Blood Pressure, ASSIGN score =Assessing cardiovascular risk using SIGN (Scottish 
Intercollegiate Guidelines Network). Between groups difference (intervention and control) with 95% confidence interval.  
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In both groups SBP declined at 3 months however this was not significant. A 
significant difference between the intervention and control group was noted at 6 
months, SBP declined in the intervention group and increased in the control 
group, Figure 6-9. 
 
Figure 6-9 Changes in systolic blood pressure (mmHG) between the intervention group and 
control group at 3 and 6 months, error bars represent (mean ±SEM) at 3 & 6 months. 
Statistical significance was accepted at adjusted P < 0.025 
There was a significant difference in the ASSIGN scores between the groups at 6 
months. A significant decline in the ASSIGN score was observed in the 
intervention group at 6 months, however in the control group it increased over 
time, Table 6-10. 
 
Figure 6-10 Changes in ASSIGN score between the intervention and control group at 3 and 6 
months, error bars represent (mean ±SEM) at 3 & 6 months. 
Statistical significance was accepted at adjusted P < 0.025 
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6.11 Blood analysis results at baseline, 3 and 6 months 
There were non-significant changes in blood results in both groups. Some 
variables increased from baseline to 6 months, such as insulin in the intervention 
group and triglyceride in the control group. Other variables were found to 
decrease in the intervention group, such as CRP, GGT and cholesterol and HDL in 
the control group, however there were no statistically significant changes. There 
was no significant interaction effect noted in terms of the results for insulin, 
CRP, glucose, GGT, ALT, AST, triglyceride, cholesterol, HDL or HBA1c, see Table 
6-15. 
Table 6-15 Blood results full analysis at baseline, 3 and 6 months 
 
Intervention Control Significance 
P Value 
Variables  B  3 m 
 
6 m 
 
B 
 
3 m 6 m Interaction  
effect 
Insulin 
(µIU/mL) 
15.2  
(2.2) 
26.6 
 (7.0) 
27.9 
(7.5) 
16.4 
(2.2) 
19.0 
(8.2) 
20.7 
(8.9) 
0.704 
CRP (mg/L) 8.5 
 (2.4) 
5.6 
(1.2) 
5.8 
(1.1) 
5.6 
(2.4) 
4.0 
(1.4) 
4.1 
(1.4) 
0.936 
Glucose 
(mmol/L) 
6.2 
(0.3) 
5.5 
(0.4) 
5.6 
(0.3) 
5.7 
(0.3) 
6.2 
(0.5) 
6.0 
(0.4) 
0.131 
GGT (U/L) 26.9 
(3.9) 
23.4 
(3.3) 
24.5 
(10.9) 
32.1 
(4.0) 
31.7 
(3.7) 
48.0 
(13.6) 
0.532 
ALT (U/L) 24.1 
(2.2) 
24.6 
(2.2) 
24.4 
(2.3) 
27.6 
(2.3) 
25.0 
(2.5) 
23.5 
(2.7) 
0.332 
AST (U/L) 21.5 
(1.1) 
20.3 
(0.8) 
20.8 
(1.0) 
23.4 
(1.1) 
21.4 
(0.9) 
21.1 
(1.2) 
0.602 
HDL 
(mmol/L) 
1.5 
(0.1) 
1.4 
(0.1) 
1.4 
(0.1) 
1.4 
(0.1) 
1.3 
(0.1) 
1.2 
(0.1) 
0.485 
Trig 
(mmol/L) 
1.4 
(0.1) 
1.3 
(0.1) 
1.3 
(0.1) 
1.6 
(0.1) 
1.8 
(0.2) 
1.8 
(0.2) 
0.375 
Chol 
(mmol/L) 
5.3 
(0.2) 
4.7 
(0.2) 
4.6 
(0.1) 
5.3 
(0.2) 
5.2 
(0.2) 
5.1 
(0.2) 
0.139 
HbA1c (%) 5.4 
(0.2) 
5.2 
(0.1) 
5.2 
(0.2) 
5.3 
(0.2) 
5.2 
(0.1) 
5.3 
(0.2) 
0.761 
The data were analysed using GLM REML= Generalized linear model, statistical significance was 
accepted at P < 0.05. The data are mean ±SE, SE =Standard Error. B= Baseline, m= months, 
CRP= C - Reactive Protein, GGT=Gamma-Glutamyl Transpeptidas, ALT= Alanine 
aminoTransferase  Alanine, AST= Aspartate aminoTransferase, HDL= High Density Lipoprotein, 
Trig= Triglyceride, Chol= Cholesterol, HBA1c=Glycated Haemoglobin. 
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6.12 Anthropometric measures at baseline, 3 and 6 
months 
There was a decline in BMI in the control group but not in the intervention 
group. There was an interaction effect between groups in terms of BMI, 
(P=0.044), Table 6-16. Although post hoc tests showed no significant difference 
over the 6 months, a significant difference between the intervention and control 
groups in BMI at 3 months was noted with multiple comparison t test, Table 
6-17. There were no interaction effects in terms of weight, waist or hip 
circumference, WHR, and WHtR in either group, Table 6-16. 
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Table 6-16 Anthropometric full analysis at baseline,3 and 6 months within groups changes 
 
Variables Intervention (n=39) Control (n=37) Significance Post hoc Analysis 
P Value (Within group changes) 
 B 3 m 6 m B 3 m 6 m Interaction 
effect 
B 
v 3 m 
(IG) 
B 
v 3 m  
(CG) 
B 
v 6 m 
(IG)  
B 
v 6 m 
(CG)  
3 m 
v 6m  
(IG) 
3 m 
v 6m 
(CG) 
Weight (kg) 78.1 
(2.6) 
78.9 
(2.6) 
78.5 
(2.5) 
71.2 
(2.7) 
70.6 
(2.6) 
70.4 
(2.6) 
0.080       
WC (cm) 86.8 
(2.0) 
86.9 
(2.0) 
87.6 
(2.0) 
81.3 
(2.1) 
80.5 
(2.1) 
80.2 
(2.1) 
0.122       
HC (cm) 100.7 
(1.8) 
100.5 
(1.8) 
100.6 
(1.8) 
98.2 
(1.9) 
97.1 
(1.9) 
96.3 
(1.9) 
0.307       
 WHR 0.86 
(0.01) 
0.86 
(0.01) 
0.87 
(0.01) 
0.82 
(0.01) 
0.83 
(0.01) 
0.83 
(0.01) 
0.897       
 WHtR 0.52 
(1.2) 
0.52 
(1.2) 
0.52 
(1.2) 
0.50 
(1.2) 
0.49 
(1.2) 
0.49 
(1.3) 
0.085       
BMI (kg/m2) 28.1 
(0.9) 
28.5 
(0.9) 
28.3 
(0.9) 
26.7 
(0.9) 
26.4 
(0.9) 
26.3 
(0.9) 
0.044* 0.082 0.596 1.000 0.342 0.316 1.000 
The data were analysed using GLM REML = Generalized Linear Model, Post hoc analysis within GLM REML output, statistical significance was accepted at P < 0.05. B= 
Baseline, m= months. The data are mean ±SE, SE =Standard Error, WC= Waist circumference, HC=Hip circumference, WHR= Waist-to-Hip Ratio, WHtR= Waist-to-Height 
Ratio, BMI= Body Mass Index, kg= kilogram, cm= centimeter. IG= Intervention Group, CG= Control Group. 
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Table 6-17 Results of BMI at baseline, 3 and 6 months between groups (intervention and control) 
 
Variable Intervention Control P Value 
IG v CG 
B 
P Value 
I G v CG 
3 
months 
P value 
I G v CG 
6 
months 
Between- group 
differences 
(Intervention- 
Control) 
B  
(n=39) 
3 
months  
(n=36) 
6 
months 
(n=37)  
B 
(n=37) 
3 
months 
 (n=26) 
6 
months 
(n=22) 
3 months 6 months 
BMI(kg/m2) 28.1 
(0.9) 
28.7 
(0.9) 
28.3 
(0.9) 
26.7 
(0.9) 
26.0 
(0.9) 
26.1 
(1.0) 
0.134 0.022* 0.054 2.7 
(0.07-5.3) 
2.2 
(- 0.5-5.0) 
The data were analysed using Independent Sample t test, statistical significance was accepted at adjusted P < 0.025. The data are mean ± SE, SE= Stander Error, B= 
Baseline, IG= Intervention Group, CG= Control Group, n= number, BMI=Body Mass Index. Between groups difference changes with 95% confidence interval. 
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There were significant differences in BMI between the groups at 3 months. BMI 
was reduced in the control group, whereas it increased in the intervention 
group. However, there was no significant difference between the intervention 
and control groups at 6 months, see Figure 6-11. 
 
Figure 6-11 Changes in BMI score between the intervention and control group at 3 and 6 
months, error bars represent (mean ±SEM) at 3 & 6 months. 
Statistical significance was accepted at adjusted P < 0.025 
6.13 Relationships between step count and secondary 
outcome measures in both groups  
In the intervention group, a higher step count was inversely associated with 
functional capacity (HAQ) at baseline in the intervention group, (P= 0.04), but 
not at 3 or 6 months. A higher step count was associated with higher 6MWT in 
the intervention group at baseline (P= 0.03) and 3 months (P=0.01), Table 6-18. 
A higher step count was inversely correlated with triglyceride at 3 months 
(P=0.04); in the intervention group, Table 6-18. In addition, a non-significant 
correlation was identified between step count and blood glucose, cholesterol, 
HDL, insulin and ALT at baseline, 3 and 6 months in either group. 
A higher step count was associated with better PA self-efficacy at baseline 
(P=0.01), and 3 months, (P=0.04) in the intervention group. SDAI was associated 
with higher step count (P= 0.03) in the intervention group, Table 6-18. No 
significant relationships were found between step count and other variables in 
either group.  
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Table 6-18 Relationships between step count and secondary outcome measures in both 
groups at baseline, 3 and 6 months   
  
Variables Intervention Control 
B 
(n=39) 
3 m 
(n=36) 
6 m 
(n=37) 
B 
(n=37) 
3 m 
(n=26) 
6 m 
(n=22) 
HAQ r 
p value 
- 0.33 
0.04* 
- 0.23 
0.19 
- 0.12 
0.47 
0.31 
0.06 
- 0.14 
0.48 
0.17 
0.43 
6MWT r 
p value 
0.18 
0.23 
0.49 
0.03* 
0.43 
0.01* 
0.37 
0.02* 
0.22 
0.28 
0.22 
0.33 
PA Self-
efficacy r 
p value  
 
0.41 
0.01* 
 
0.35 
0.04* 
 
0.15 
0.39 
 
0.15 
0.36 
 
0.01 
0.99 
 
- 0.11 
0.64 
SDAI r 
P value 
0.04 
0.83 
- 0.36 
0.03* 
- 0.04 
0.82 
- 0.19 
0.26 
0.06 
0.75 
0.54 
0.12 
Triglyceride r 
p value 
0.29 
0.06 
- 0.35 
0.04* 
- 0.08 
0.65 
0.07 
0.69 
- 0.02 
0.92 
0.33 
0.12 
Hand grip 
strength r 
p value 
 
0.042 
0.799 
 
0.072 
0.675 
 
0.059 
0.732 
 
0.292 
0.080 
 
0.132 
0.521 
 
0.080 
0.722 
WC r  
p value 
-0.268 
0.098 
-0.081 
0.645 
-0.215 
0.208 
-0.083 
0.625 
-0.139 
0.499 
0.036 
0.875 
HC r 
p value 
-0.083 
0.615 
-0.146 
0.404 
0.108 
0.530 
-0.035 
0.839 
-0.030 
0.884 
-0.029 
0.898 
BMI r 
p value 
0.243 
0.135 
-0.189 
0.278 
-0.116 
0.502 
-0.125 
0.460 
-0.330 
0.099 
0.071 
0.755 
WHtR r 
p value 
-0.241 
0.140 
-0.190 
0.267 
-0.159 
0.355 
-0.155 
0.361 
-0.182 
0.375 
-0.012 
0.959 
SBP r 
p value 
-0.220 
0.179 
-0.059 
0.734 
-0.238 
0.103 
-0.147 
0.385 
-0.068 
0.743 
0.028 
0.900 
GGT r 
p value 
-0.210 
0.200 
-0.141 
0.420 
-0.123 
0.481 
-0.138 
0.415 
0.031 
0.882 
-0.101 
0.655 
The data were analysed using Pearson’s correlations, Statistical significance was accepted at p 
<0.05. n=number, B= Baseline, m= months, HAQ= Health Assessment Questionnaire, 6MWT= 6 
Minutes’ Walk Test, SDAI=Simple Disease Activity Index, SBP= Systolic Blood Pressure, GGT= 
Gamma-Glutamyl Transpeptidase , WC= Waist Circumference, HC=Hip Circumference, WHtR = 
Waist-to-Height Ratio. 
6.14 Relationships between time sedentary and 
secondary outcome measures in both groups 
A greater time spent being sedentary was associated with an increase in systolic 
blood pressure, WC, HC, BMI, WHtR, triglyceride and GGT in the intervention 
group at 3 months, (P < 0.05), Table 6-19. A higher time spent being sedentary 
was also associated with lower functional capacity (HAQ) at 6 months in the 
control group (P=0.04). In addition, greater sedentary time was correlated with 
an increase in triglyceride level at 3 months in the control group, (P=0.03) and 
SDAI at 3 months in intervention group (P=0.02). Lower objective measured 
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sedentary time (including sleeping time) was significantly associated with 
improved hand grip strength (P= 0.03) and PA self-efficacy, (P=0.02), among the 
control group at 6 months, Table 6-19.  
Table 6-19 Relationships between time being sedentary and secondary outcome measures 
in both groups at baseline, 3 and 6 months   
  
Variable Intervention Control 
B 
(n=39) 
3 m 
(n=36) 
6 m 
(n=37) 
B 
(n=37) 
3 m 
(n=26) 
6 m 
(n=22) 
HAQ r 
p value 
0.22 
0.18 
0.07 
0.71 
0.04 
0.82 
0.02 
0.93 
0.17 
0.41 
0.43 
0.04* 
6MWT r 
p value 
-0.28 
0.07 
-0.16 
0.35 
-0.14 
0.41 
0.066 
0.699 
-0.100 
0.627 
-0.271 
0.222 
Hand grip 
strength r 
p value 
 
- 0.34 
0.03* 
 
0.05 
0.79 
 
- 0.15 
0.39 
 
0.11 
0.51 
 
0.18 
0.38 
 
- 0.45 
0.03* 
PA self-efficacy 
r 
p value 
 
- 0.21 
0.21 
 
- 0.13 
0.46 
 
0.08 
0.62 
 
- 0.28 
0.09 
 
0.08 
0.69 
 
- 0.49 
0.02* 
SDAI r 
P value 
0.033 
0.844 
0.391 
0.021* 
-0.109 
0.539 
-0.175 
0.300 
-0.260 
0.200 
-0.139 
0.549 
SBP r 
p value 
0.17 
0.32 
0.36 
0.03* 
0.02 
0.89 
0.03 
0.87 
0.04 
0.85 
- 0.13 
0.57 
WC r 
p value 
0.10 
0.55 
0.41 
0.02* 
- 0.10 
0.55 
- 0.14 
0.41 
0.31 
0.12 
0.30 
0.09 
HC r 
p value 
0.16 
0.34 
0.37 
0.03* 
0.09 
0.59 
0.06 
0.71 
0.05 
0.79 
- 0.25 
0.26 
BMI r 
p value 
0.16 
0.32 
0.39 
0.02* 
0.02 
0.91 
- 0.04 
0.80 
0.26 
0.20 
- 0.39 
0.07 
WHtR r 
p value 
0.02 
0.90 
0.35 
0.04* 
- 0.08 
0.62 
- 0.18 
0.29 
0.28 
0.16 
- 0.38 
0.08 
GGT r 
p value 
0.14 
0.41 
0.38 
0.03* 
- 0.17 
0.33 
- 0.25 
0.14 
- 0.26 
0.22 
- 0.08 
0.74 
Triglyceride r 
p value 
0.20 
0.92 
0.43 
0.01* 
0.15 
0.38 
- 0.29 
0.07 
0.42 
0.03* 
0.31 
0.15 
The data were analysed using Pearson’s correlations, Statistical significance was accepted at p 
<0.05. n=number, B=Baseline, m= months, WC= Waist Circumference, HC= Hip Circumference, 
BMI= Body Mass Index, SBP= Systolic Blood Pressure, WHtR= Weight Height Ratio, GGT= 
Gamma-Glutamyl Transpeptidase. 
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6.15 Physical activity outcome results at 12 months (end 
of study) 
Twelve-month data was available for only 18 participants due to the limited 
time of the study; intervention (n=11) and control (n=7). The step count of the 
intervention group continued at a high level at 12 months follow up, however it 
had reduced in the control. As displayed in Table 6-20, there was a significant 
interaction effect in step count in the 12 month data (P < 0.001). However, the 
step count of the control group reduced at 3 and 6 months and then returned 
back to the baseline level at 12 months, see Table 6-20.  
Also, a multiple comparison t test illustrated a significant difference between 
the intervention and control groups in the step count at both at 3 and 6 months. 
The step count increased in the intervention group over 6 months, and it was 
maintained at high levels at 12 months, very small numbers at 12 months 
although at a non-significant level. However, the step count regressed in the 
control group over 6 months, Table 6-21. 
There was no significant interaction effect between the intervention and control 
groups in terms of sedentary time, total MET-min/week, weekday and weekend 
sitting time of the IPAQ at 12 months, Table 6-20.
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Table 6-20 Physical activity outcome results at baseline, 3, 6 and 12 months within groups changes 
 
The data were analysed using GLM REML = Generalized Linear Model, Post hoc analysis within GLM REML output, statistical significance was accepted at P < 0.05. The 
data are mean ±SE, SE =Standard Error, IPAQ=International Physical Activity Questionnaire, hrs=hours, n= number, B= Baseline, m= months, Sig =Significant. 
  
Variables Intervention (n=11) Control (n=11) Sig Post hoc Analysis 
P Value( Within group changes) 
 B 3 m 6 m 12 m B 3 m 6 m 12m Interaction 
effect 
B 
v 
6m 
(InG) 
B 
v 
6m 
(CG) 
B 
v  
12m 
(InG) 
B 
v  
12m 
(CG) 
6m 
v  
12m 
(InG) 
6m 
v 
12m 
(InG) 
PA activPALTM  
Step count 
(step/day) 
 
8402   
(806) 
 
12133  
(957) 
 
11314  
(845) 
 
10268 
(1138) 
 
7780  
(806) 
 
6867 
(990) 
 
6868 
(1014) 
 
7797 
(1442) 
 
0.007* 
 
0.075 
 
1.000 
 
0.829 
 
1.000 
 
1.000 
 
1.000 
PA activPALTM  
Sedentary 
time (hrs/day) 
17.2 
( 0.49) 
16.4 
(0.68) 
17.2 
(0.59) 
16.8 
(0.52) 
18.0 
(0.49) 
17.6 
(0.71) 
17.8 
(0.64) 
18.4 
(0.66) 
0.590  
 
     
IPAQ 
Total MET-
min/week  
4057 
(1198) 
7746 
(1889) 
6139 
(1391) 
4041 
(685) 
4963 
(1256) 
5103 
(1981) 
4920 
(1601) 
2180 
(841) 
0.175       
IPAQ 
 time spent 
sitting (hrs) 
Weekday  
 
4.7 
(0.54) 
 
 
4.2 
(0.48) 
 
 
4.1 
(0.63) 
 
 
4.3 
(0.68) 
 
4.8 
(0.54) 
 
 
5.0 
(0.50) 
 
 
5.8 
(0.74) 
 
 
5.0 
(0.83) 
 
0.516 
 
 
 
     
IPAQ 
 time spent 
sitting (hrs) 
Weekend  
4.7 
(0.63) 
3.5 
(0.52) 
3.7 
(0.65) 
3.5 
(0.60) 
4.8 
(0.63) 
5.0 
(0.53) 
5.7 
(0.76) 
5.1 
(0.72) 
0.220       
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Table 6-21 Physical activity outcome measures at baseline, 3, 6 and 12 months between groups (intervention and control) 
 
The data were analysed using Independent Sample t test, statistical significance was accepted at adjusted P < 0.025. The data are mean ± SE, SE= Stander Error, B= 
Baseline, IG= Intervention Group, CG= Control Group, PA= Physical Activity, n= number, m= months.
Variable Intervention Control P V 
IG v 
CG 
B 
P V 
I G v 
CG 
3 m 
P V 
I G v 
CG 
6 m 
P V 
I G v 
CG 
12 m 
Between- 
group 
differences 
(Intervention- 
Control) 
B  
(n=11) 
3 m  
(n=11) 
6 m 
(n=11)  
12 m 
(11) 
B  
(n=11) 
3 m 
 (n=10) 
6 m 
(n=7) 
12 m 
(n=7) 
    6 m 12 m 
PA 
activPALTM  
Step count 
(step/day) 
8402 
(925) 
12133 
(1043) 
11314 
(787) 
10269 
(949) 
7779 
(667) 
6084 
(910) 
6943 
(1168) 
7871 
(4877) 
0.295 <0.001* 0.002* 0.117 4370 
(1499-
7241) 
2396 
(-1728-
6522) 
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6.16 Summary of the results 
The quantitative study found that participation in the WARA intervention 
positively influenced the primary outcome measure (step count/day), with the 
average step count increasing over the 6 months by around 35% in the 
intervention group, whereas it reduced in the control group. However, the co-
primary outcome measure (sedentary behaviour) was not achieved.  
Participants’ self-efficacy for PA was also improved. The participants in the 
intervention group had improved functional capacity in terms of the 6MWT, 
cardiovascular profile and 10-year risk of CVD.  
Higher PA and a lower time being inactive were associated with a higher self-
efficacy for PA, functional capacity, and hand grip strength, and a lower body 
mass index, waist circumference, hip circumference and blood triglyceride. 
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7 Facilitators and Barriers of the WARA 
Intervention – Participants’ Experiences: A 
qualitative Study 
This chapter will present the views and experiences of the participants in the 
WARA intervention. Qualitative methods were chosen to obtain a participant-
centred perspective in relation to: positive and negative aspects of the 
intervention; experiences of PA facilitators and barriers that were faced during 
the intervention; and perceptions of the role of intervention components in 
supporting and encouraging PA. A semi-structured topic guide (Appendix 13) was 
developed. Telephone interviews were undertaken after the intervention (at 6 
months), and these were then analysed using a general inductive method. 
7.1 Rationale for using qualitative methods 
Using a mixed methodology is important as it facilitates a deeper explanation of 
findings revealed by quantitative research. Utilising qualitative data, the views 
and opinions of the participants can be obtained in a way that quantitative 
methods are unable to achieve (Michie et al., 2008). Qualitative data that is 
based on human experience is powerful and sometimes more compelling than 
quantitative data (Anderson, 2010), a view that is further discussed in (section 
4.1,4.7). 
The evidence suggests that PA facilitators and barriers should be considered in 
intervention studies to help health providers plan interventions that will safely 
and successfully improve or maintain PA levels (Flynn et al., 2009, Larkin et al., 
2016a). In addition, evidence-based behavioural change techniques for the 
identification of barriers and problem solving were specifically used to help 
participants overcome their personal PA barriers. 
A number of methods are used in qualitative study. The most common methods 
of qualitative data collection used in research are focus group and interviews, 
with the latter being either face-to-face or over the telephone. The results 
obtained through these two qualitative methods depend mainly on the subject 
being investigated. In-depth interviews are an effective qualitative method for 
getting people to talk about their views of the research topic and also to express 
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their personal feelings, opinions, and experiences (van Achterberg et al., 2011). 
However, sometimes sensitive topics are easier to discuss on the telephone than 
in face-to-face interviews, and they may lead to more honest answers. In 
addition, telephone interviews save resources (time and money) (Bauman et al., 
2012). 
Participants in the WARA intervention had a number of commitments, such as 
attending eight education sessions plus being assessed at the baseline and at 
follow-up, in addition to their routine check-up with the GP and rheumatologist; 
therefore, telephone semi-structured interviews were chosen to reduce the 
burden on the participants. This also enabled the researcher to discuss the 
participants’ views regarding the WARA intervention openly; it might have been 
difficult in a face-to-face interview to discuss negative aspects of the WARA 
intervention or the reasons behind not changing or even reducing their PA. 
The WARA intervention and its outcomes were the main focus of the interviews – 
they allowed the researcher to understand why some participants in the WARA 
intervention increased their PA and for others their PA reduced or stayed much 
the same over the study time period. Of 37 participants who completed the 
intervention, a sample of 10 participants was invited to take part in a semi- 
structured telephone interview at 6 months (after the end of the intervention). 
The sample included 7 females and 3 males with a mean age 59.6 (± 13.0) years. 
Two participants from each group were invited to take part in the interviews, 
however in groups 5 & 6 only one participant did so; the reason for this was that 
it was difficult to secure an appointment with the participants as they had 
commitments or were on holiday. Participants whose step count either increased 
or decreased by 10% or more compared with their baseline over the 6 months 
and participants whose step count did not change (within 10%) of their baseline 
value were invited to take part. Table 7-1 illustrates the characteristics of the 
participants who were interviewed. The mean time of the interviews was around 
22 minutes (15-30 minutes). All of the participants consented at baseline to take 
part in an interview at the end of the intervention, and additional audio- 
recorded verbal consent was taken from selected participants at the beginning 
of the telephone interview. 
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Table 7-1 Participants characteristics who taken part in a telephone interview at end of the intervention 
 
Participants 
number 
Gender Age 
(years) 
Step count 
mean 
(steps/day) 
Baseline 
Step count 
mean 
(steps/day) 
6 months 
Difference of 
step count 
from Baseline 
to 6 months (%) 
Physical 
activity 
category 
PN 5 (IG1) M 74 14,444 14,362  - 0.6 Not changed 
PN 11(IG1) F 64 6661 10,019  + 50.4 Increased 
PN 16(IG2) F 32 7636 8439  + 10.5 Increased 
PN 21(IG2) F 51 5855 14,802  + 152.8 Increased 
PN 23(IG3) F 67 7030 7178  + 2.1 Not changed 
PN 24(IG3) F 74 5979 5571 - 6.8 Not changed 
PN 40(IG4) F 50 9050 8908  - 1.6 Not changed 
PN 47(IG4) F 65 5904 14,093 + 138.7 Increased 
PN 50(IG5) M 66 7250 9677  + 33.5 Increased 
PN 71(IG6) M 53 7340 5023 - 31.6 Reduced 
                          PN= Participant Number, IG= Intervention Group. 
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As the chief investigator was blinded to group allocation, the physiotherapist 
who facilitated the WARA carried out all of the telephone interviews, which 
were conducted from a private office at the School of Nursing and Health Care, 
University of Glasgow. The interview time was arranged by the physiotherapist 
based on a suitable time for the participants. At the beginning of the interviews, 
the participants were informed that their participation was voluntary and that 
the interview could be stopped at any time. All interviews were audio-recorded 
and transcribed by chief investigator with participant consent. 
7.2 Analysis of interviews 
There are a number of approaches to qualitative data analysis such as the 
inductive and deductive approaches. The former uses data to generate ideas 
(hypothesis generating), while the latter starts with the idea and then uses the 
data to confirm this idea (hypothesis testing) (Gale et al., 2013, Thorne, 2000). 
In this study, the data were analysed using a general inductive approach similar 
to that described by Thomas (2006) as described below. 
The chief investigator listened to the recordings of the telephone interviews, 
and read the transcripts several times with the transcribed notes in order to 
improve the reliability of coding and the identified themes. The data was coded 
independently by the chief investigator and supervisor (CG) to identify the initial 
topic areas. Then the chief investigator and supervisor (CG) met to discuss the 
coding. If new codes emerged, the coding frame was changed and the transcripts 
were reread according to the new structure. Themes were discussed, refined 
and agreed with the supervisor (CG), leading to the presented themes and sub-
themes. 
7.3 Overview of thematic analysis 
Analysis revealed three broad themes that were subsequently coded to sub-
themes, see Figure 7-1. Illustrative quotes are used to report the findings, and 
individual participant numbers, age and gender are provided in parenthesis. 
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Figure 7-1 Themes and sub-themes on physical activity in WARA intervention 
 
Three broad themes were identified, which were: acceptability of the WARA 
intervention, participant’s experience of increasing PA and the theoretical 
mechanism of action. Although there was variation in the PA outcomes amongst 
the participants who were interviewed, the thematic analysis revealed that 
many participants shared the same views regarding the WARA intervention. This 
is potentially important to determine the key factors of the WARA intervention 
that might help future research in designing an intervention for people with RA. 
Physical activity was explored throughout the entire interview as the 
participants talked about what was important to them and how the WARA 
intervention had influenced their PA. However, the clearest information about 
what influenced them and the reasons why some participants reduced or did not 
change their PA was brought out in the answers to the following two questions: 
“What are the positive aspects of the WARA intervention that make you 
physically active?” and “What are the reasons for it not influencing you to 
change your physical activity?”. 
The three themes emerged from a number of different sub-themes. Overall the 
acceptability of the WARA intervention emerged as a bridge that allowed some 
participants to adhere to the programme regardless of whether their PA changed 
or not. 
Acceptability
Participants 
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programme sessions 
• Handout
•Walking programme
•Physical activity 
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7.3.1 Acceptability 
The interviewees found the WARA intervention to be acceptable in terms of 
convenience of the sessions, the handout and walking programme. The following 
sections present each sub-theme of acceptability with illustrative quotes. 
1 Convenience of the sessions 
a Group size 
The WARA intervention recruited participants aged 18 years and above who had 
been diagnosed with RA within the last 5 years. The group size was about 6 
people per group, which helped them to enjoy the programme. Almost all of the 
participants found the group size acceptable. For example, one-woman 
participant highlighted the benefits of being in a small group, as she said that a 
small group can facilitate engagement in the sessions in terms of practising the 
exercises, entering into discussions and asking questions. She mentioned that a 
small group was likely to be more beneficial than a large group. 
 “Small group was fine because you were able to show us the exercises 
and explain things clearly and we were able to ask questions and you 
were able to answer specific questions. Small group people became 
friendly. I think in a big group it would have been less effective” 
(PN40, 50yrs, F, IG4). 
The participants liked the group sessions and found them helpful. This was the 
case regardless of whether the participants increased, reduced or did not change 
their PA. For example, one old man whose PA level did not change over 6 
months said: 
“Group sessions are more encouraging, better than being on your own. 
It [group] was motivating” (PN5, 74yrs, M, IG1). 
b Sessions content 
The WARA intervention consisted of eight education sessions. The content of the 
sessions was related to PA, RA and heart disease. The majority of the 
participants spoke favourably about the education sessions; they acknowledged 
that many of them had learned new things. They highlighting topics that the 
participants were not aware of, and this encouraged the participants to be 
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physically active. One-woman participant whose PA increased over 6 months 
attended all of the education sessions and found that the sessions were good, 
with all the relevant topics of a healthy lifestyle being covered with the right 
level of content. She said: 
“I think the sessions covered everything – what you are eating, 
drinking, walking, it was quite comprehensive just made us all think 
about everything that we’re doing on a daily basis so I think that was 
good” (PN47, 65yrs, F, IG4). 
c Sessions venue 
The education sessions were held at the hospital. With regard to the venue, 
almost all participants acknowledged that they had no problem accessing the 
venue where the education sessions took place. The majority of the participants 
considered that the hospital was a good place to have the group sessions as they 
were used to going there. For example, one man said: 
“…used to go to hospital, it suited me perfectly, I live nearly to the 
hospital it was easy to access …” (PN50, 66yrs, M, IG5). 
However, one woman said that she would prefer the sessions to be held outside 
the hospital setting in a leisure centre (gym). Going to the gym emerged as an 
important external barrier to people with RA. 
 “I think maybe taking a session in the gym might be useful to show 
the kinds of exercise and to get the people going to the gym and they 
understand what they should be trying to do within the gym” (PN40, 
50yrs, F, IG4). 
Although the participants would have liked the sessions to be held at a leisure 
centre, this participant still performed the strengthening exercise regularly. 
However, if the WARA intervention took place at a gym it would be more 
exciting and encouraging, and also help people to go to the gym in the long 
term. 
It seems that people with RA had a limitation with regards to going to the gym as 
they had no idea what they could do there – therefore offering the sessions at 
the gym would have been a good opportunity, as it would have helped people to 
realise what they could do safely in the gym. This might have helped them to go 
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to gym regularly even after the intervention and adhere to the exercise goals. 
This highlighted a barrier that could be considered in future interventions, and 
also regarding the services provided at the gym, it would be helpful if there 
were a specialised trainer to teach those with RA to allow them to feel safe and 
understood. 
d Sessions time 
The education sessions were normally attended, mostly between 4 and 5pm, as 
some participants were employed; others had to take care of children and others 
had to pick up their grandchildren from school. These factors were considered 
when arranging the time of the education sessions. 
The participants were satisfied and generally found the time to be suitable. 
However, one participant said that she would have preferred a different time, 
such as the morning. The time of the sessions was difficult for her as she had a 
commitment with her grandson to take care of him after school as his parents 
were working. She attended four education sessions out of eight. 
“I would have preferred probably to be morning sessions, I have to 
pick up my grandson from school and he stays with me until his 
parents finish their work” (PN24, 74yrs, F, IG3). 
This participant was 74 years old and retired - this might another reason why she 
preferred the sessions to be in the morning. This discussion provided an insight 
into the external barriers that may have prevented this participant from 
attending all the education sessions. 
e Booster sessions 
The WARA intervention involves two group booster sessions, after 3 and 6 
months. Their aim was to encourage participants' maintenance of and motivation 
for PA by providing support, evaluating their own barriers to PA and how to 
overcome them. They also encouraged them to continue to use their pedometers 
and to record their steps in their PA diary. The participants talked about the 
booster sessions and how they helped them to progress towards their PA goal 
since the start of the WARA intervention. 
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There was positive feedback regarding the booster sessions. Quantitative data 
showed 71.8 % attended the first booster session and 76.9% attended the second 
booster session. It seems that the booster sessions influenced the participants to 
keep physically active. For example, a woman whose PA increased over the 6-
month period commented on the benefits of the booster sessions that made her 
keep on the programme. She said: 
 “The booster sessions made you think about the content again, it 
made you motivated towards the goal you were trying to achieve and 
helped to come back again” (PN16, 32yrs, F, IG2). 
This was also the view of the participants whose PA did not change – they also 
found that the booster sessions helped them to keep motivated. This highlighted 
an important factor that the RA participants did not think only about the PA, but 
that meeting people with a similar condition acted as a motivator for them. The 
participant stated for example: 
 ‘’I think it probably did help to keep you motivated because you 
knew that you were going to meet again” (PN40, 50 yrs, F, IG4). 
2 Handout 
A WARA booklet given to the participants contained information describing the 
importance of both walking and a healthy diet for health benefits and the 
reduction of CVD risk and other co-morbidities of RA. The handout also described 
the importance of the strengthening exercise, and reducing sedentary time. 
There was a general agreement amongst all participants in the intervention 
group that the booklet was helpful for them as a reference point for the 
instructions on exercise. The following two participants spoke about the handout 
given in the WARA intervention; they found it useful although the two 
participants were in different age groups and also their PA levels differed over 6-
month period. For example, one woman liked the handout and she commented 
on how she used the handout. She spoke about the handout facilitating the 
performance of the strengthening exercise, by looked at the instructions. This 
participant’s hand strength increased over 6 months. 
 “It [handout] was useful to have to refer to, especially with exercise. 
If I forget I can go back and look to the strength exercise. The 
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exercises I found were kind of the best things in WARA intervention 
because I still have it [handout]” (PN24, 74yrs, F, IG3). 
However, this participant’s PA level did not change over 6 months. She only 
attended 4 education sessions, but she enjoyed the strengthening exercise and 
really performed it. This was confirmed by the quantitative data as this 
participant increased her grip strength over 6 months. 
A young woman whose PA level increased by 10.5% over 6 months used the 
handout. She found that the handout was informative and it also reaffirmed her 
knowledge. She stated: 
 “I looked through them [handout] a couple of times. They were 
helpful, they confirmed things that you knew. It was very useful. It 
was good” (PN16, 32yrs, F, IG2). 
It emerged that providing the participants with a handout may play a role in 
facilitating the intervention; the handout seems to help participants to perform 
the strengthening exercise and also think about the content of the sessions. 
3 Walking programme 
There was a general agreement that the WARA intervention was well- 
constructed, even among participants whose PA did not change at 6 months. For 
example, one woman found that the WARA intervention walking programme was 
good, but because of various issues she encountered (for example, she has to 
pick up her grandson from school and he stays with her until his parents finish 
their work, see section 7.3.1, 1d) this affected her regular attendance of the 
education sessions. She attended only four education sessions, and she was 
unable to increase her PA. 
 “The walking programme is excellent and I think it’s up to the 
individual” (PN24, 74yrs, F, IG3). 
There were some participants who directly expressed that the walking 
programme had such a positive effect on them and that they had improved their 
health, which kept them walking. One man who was able to increase his step 
count over the study period, talked about being out walking improving his 
health. However, he spoke about his experience in the past before joining the 
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programme and at that time, pain, stiffness and his feeling of inability to walk 
were enough to stop him going outside. The WARA programme seemed to be 
able to change his attitude and experience. 
“The walking programme is excellent, I did increase my walking and I 
continue to walk, I have been quite enjoying it. Walking has helped 
me, I feel much better and I try to do a walk every day. Before I 
joined the programme I would be going out but I was getting 
frustrated because of pain and stiffness so difficult, I am afraid” 
(PN50, 66yrs, m, IG5). 
Although many reflected on the WARA intervention as an excellent intervention 
and one that motivated them to keep walking and increase their physical 
activity, two participants regretted the lack of group walking in the WARA 
intervention, which they thought would be a good motivator to walk more. For 
example, one woman said: 
“… group walking is a good idea; a group walk is an incentive to go out 
but it never happened in the WARA programme. I would have liked it 
more if in the WARA programme there was group walking at least 
once” (PN11, 64yrs, F, IG1)." 
Another woman highlighted the benefits of walking with a group; it seems 
that people liked to engage with each other. She said: 
 “Walking with other people encourages you when you have got other 
company or if somebody is taking you on the kind of route so you can 
try and you do not have to be in the flat all the time” (PN47, 65yrs, F, 
IG4). 
Although these participants talked about the lack of a walking group in the 
WARA intervention, both were able to increase their PA above their baseline 
over 6 months. Thus, the lack of group walking did not affect their physical 
activity progress. 
However, including group walking for people with RA in the intervention would 
need to take into account people’s physical abilities and safety. Also, it would 
have been difficult to include in the WARA intervention because the participants 
started the programme at different times of year with different weather. Some 
groups started their intervention programme in winter, others in spring, summer 
or autumn. 
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7.3.2 Participants’ experience of increasing physical activity 
1 Physical activity facilitators 
This discussion provided an insight into the facilitators of the WARA intervention 
that helped to make the WARA intervention successful by increasing 
participants’ PA. Almost all of the participants whose PA level increased over 6 
months found that social support was a key factor in helping them to adhere to 
the programme and increase their PA. 
They were a key part of the WARA intervention as they allowed the participants 
to share their experiences and to receive practical advice from each other on 
overcoming barriers, progressing towards their PA goals or handling setbacks. 
The findings suggest that the group-based nature of the programme supported 
the participants’ adherence to the programme. For example, one woman whose 
PA increased 152.8% over 6 months commented on the benefits of sharing 
experiences with other people with a similar condition. She said: 
“It was quite interesting to know how other people were getting on, I 
liked the group sessions because you got to hear other people’s 
perspectives and any problems.” (PN21, 50yrs, F, IG2). 
Another old woman whose PA level increased over 6 months found that meeting 
with other people with a similar condition helped her to engage in PA. She 
stated: 
“...group meetings were very good, helping me to get started with the 
physical activities, just discussing things with other people it was 
quite good, you were getting feedback from other people with 
rheumatoid arthritis” (PN11, 64yrs, F, IG1). 
Another factor that emerged as a facilitator of the WARA intervention and 
helping participants to increase their PA was the participants’ increased 
ability to perform PA (self-efficacy for PA). There is a further discussion of 
self-efficacy for PA in section Error! Reference source not found. and also 
a discussion of social support in (section 7.3.3). 
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2 Physical activity barriers 
This sub-theme captured the participants’ barriers regarding the PA barriers 
they faced when taking part in the WARA intervention. Although the majority of 
the participants believed that they had received many benefits from walking, 
they faced some difficulties during the intervention such as the weather, 
working, health problems and a lack of motivation. 
a Weather 
The weather especially was experienced as a barrier, preventing a few 
participants from engaging in daily activities. For example, a 66-year-old male 
participant commented on the weather as the main barrier for him to walking. 
However, his PA increased by 33.5% over 6 months so it seems that even with 
bad weather he could manage and overcome his barrier – maybe his 
improvement would have been higher if the weather had been better. He said: 
 “Because of the bad weather I am doing a wee bit less walking. 
Gradually I will build up my physical activities with the weather 
improving. I am waiting for the good weather to come back” (PN50, 
66yrs, M, IG5). 
Another woman identified the weather as a barrier to doing PA outside, however 
the shopping centre was a facilitator for her to continue her walking and she 
overcame her PA barrier and her PA increased over 6 months. She said: 
 “If it’s bucketing with rain it’s easier to go to the shopping centre. 
Scottish weather is pretty harsh but still I walk at the shopping centre, 
I walk up and down” (PN47, 65yrs, F, IG4). 
b Work commitments 
A few participants described that when the goal increased and they had to walk 
5 days a week, it was difficult due to work commitments. For example, a woman 
participant was working full time, and her work was at a reception, so it 
entailed a lot of time sitting down. She said that because of work commitments 
she tried to be physically active at the weekend. Although she spoke about her 
barriers to PA, this participant’s PA increased by 152%, so it appeared that she 
overcame her barrier and she did a lot of walking at weekends. She said: 
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 “In the last stage when I had to do it every day because there are 
couple of days I am working, it was not quite easy. I tend to do the 
walking more at the weekend. Because of my work commitments I 
cannot do much walking on normal days I tried to walk more at 
weekends” (PN21, 51yrs, F, IG2). 
c Health problems 
Two participants in the WARA intervention said that symptoms such as back pain 
and fatigue limited their daily PA levels. However, these are the commonly 
experienced symptoms of people with RA. For example, one old male participant 
had back pain, and he felt low because of his back problem, and it made it 
difficult for him to walk and also he only attended 3 education sessions out of 8. 
His PA level reduced by 31.6% over the 6-month period. This barrier emerged as 
an important PA barrier as the participant could not overcome it and it had a 
negative effect on his PA. This discussion revealed an important barrier that 
should be considered in future research; some exercises could be added that 
would help to overcome this barrier. 
 “It was a bit disappointing later on when I had problem in my back 
and I could not do it [walking]” (PN71, 53yrs, M, IG6). 
d Lack of motivation 
Self-motivation is what influences the individual to initiate or undertake the task 
that needs to be done. A lack of self-motivation also emerged as a barrier to 
carrying out daily physical activity. A few participants commented on the lack of 
self-motivation; one woman said that her barrier to PA was mainly a lack of 
motivation. However, this participant attended only 4 education sessions and 
her PA did not change over the 6-month period. 
 “I am probably not pushing myself enough to go out…” (PN24, 74yrs, 
F, IG3). 
7.3.3 Theoretical mechanisms of action 
The theoretical mechanisms of action were identified as the participants talked 
about what was important to them and how the WARA intervention helped them 
to modify their PA lifestyle, and the benefits to their health that they gained 
from being physically active, see Figure 7-2. 
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1 Observational learning- physical activity group 
The majority of participants reported that observing other participants’ progress 
towards achieving the PA goal and sharing their experiences regarding PA 
motivated them and increased their likelihood of adhering to the WARA 
intervention. For example, one younger woman who was able to increase her PA 
over 6 months spoke about her experience with the WARA intervention. She felt 
low when she started the WARA intervention as she was unable to progress 
towards her goal because of her symptoms. She found the programme intense 
and described how observing other participants who were older than her 
progressing towards their PA goal motivated her to walk, she said: 
 “At the beginning I struggled at first to try to do all the steps, I 
struggled to do exercise some days. It was negative for me and I was 
getting frustrated because of pain and stiffness. I felt like I have done 
enough and I cannot do more. I was looking at the other people who 
were older than me and were managing to do it; I was thinking how 
can they do it and I cannot? I think we’re good sharing the experience. 
It was an encouragement” (PN16, 32yrs, F, IG2). 
2 Self-monitoring 
a Pedometer 
The majority of participants also talked about the use of the pedometer and the 
PA dairy as key parts of their success in reaching their goal. The pedometer (DIGI 
WALKER SW-200, Japan) used in this programme was a research-quality device 
that had been validated at the Nursing and Health Care School before being 
given to participants. Two PhD students had worn the pedometer while walking 
for a couple of days and compared their counting of steps manually with steps 
recorded on the pedometer by ensuring that a test of 100 walked steps provided 
an error of <5%, as suggested by the Japanese Industrial Standard of 3% by 
Hatano (1997, cited in Baker et al., 2008b). 
The majority of participants found that the pedometer encouraged and 
motivated them to walk more. It helped them to know what distance they had 
covered, and which days they were inactive. For instance, one old woman was 
able to increase her PA over 6 months. She used the pedometer at the beginning 
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of the WARA intervention, and she talked about her positive experience with the 
use of the pedometer – it motivated her to buy a Fit Bit. She said: 
 “It [pedometer] was wonderful at the beginning. I bought a Fit Bit 
after the sessions finished. I would never have done it by myself, only 
because of being in the programme. I check every day and I check my 
progress. I am actually addicted to my steps” (PN47, 65yrs, F, IG4). 
However, not all of the participants agreed about the positive effects from the 
use of the pedometer, as a few participants had a negative experience. For 
example, one woman found that the pedometer was stressful, and it make her 
nervous and she kept checking it all the time. She said: 
 “When I stopped it, I did feel a bit of freedom. I lost it at the airport 
and I remember the effort at the airport to check all sort of things 
and I said after about an hour I am free. I did develop a nervous habit 
of checking it all the time, to see if it has not fallen off, it was a 
stressful experience, I was worrying about losing the pedometer” 
(PN11, 64yrs, F, IG1). 
Although the participant talked about her negative experience with the 
pedometer, her PA increased by 50% over 6 months. 
Two participants found other technology such as a Fit Bit and an iPhone more 
accurate than the pedometer. They claimed that the pedometer was inaccurate 
in counting the steps and also that it did not record steps done at a slow speed. 
 “I did not think the pedometer was accurate, I needed to take my 
iPhone out with me and the iPhone was always more than the 
pedometer and actually that’s why I bought a Fit Bit. I thought a Fit 
Bit watch would more accurately count the steps” (PN71, 53yrs, M, 
IG6). 
The other participant claimed that the pedometer did not record slow speed or 
incidentally movement such as cooking and she found the iPhone better than the 
pedometer in terms of accuracy. She stated: 
“I think the pedometer does not always record small movements. The 
iPhone seems to give more steps than the pedometer – when you are 
cooking or walking gently I am not convinced that the pedometer 
actually records” (PN 23, 67yrs, F, IG3). 
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b Physical activity diary 
The other important self-monitoring tool was the PA diary. PA diaries were given 
to the participants each session, including booster sessions, to ensure that the 
diaries covered the whole trial period. The participants were asked to record 
their step count. The majority of the participants were positive about the PA 
diaries and described how they encouraged them to keep up their walking, for 
example a woman participant said: 
 “I did keep my diary. Made you think about your steps because you 
had to write it down daily, it made you work harder, I was very aware 
of my steps. It is absolutely wonderful when I look back at those days 
and now” (PN21, 50yrs, F, IG2). 
This participant’s PA level increased 152.8% over 6 months; it appeared that the 
use of the PA diaries was one of the key factors that increased participants’ PA. 
However, one participant disagreed with the positive comments on the use of 
the PA diaries in the WARA intervention. He found that the PA diaries were 
boring as he had to record his steps every day. He stated: 
 “It [diary] was a chore; it’s too much you have to remember it and to 
write every day I did use it at the beginning” (PN5, 74yrs, M, IG1). 
However, this participant had not really used it, just at the beginning of the 
programme. He commented on the use of pedometer, and he talked about the 
benefit of the pedometer as it made him think about the distance he was 
walking. However, this participant was unable to increase his PA. He said: 
 “I use it [pedometer], I am aware of the distance; you get to the 
stage when you know roughly how many steps you have taken in 
certain directions. If I’m walking to town I know that would be five or 
six thousands steps. It is very good, it makes me walk” (PN5, 74yrs, M, 
IG1). 
It seems that he used the pedometer at the start of the WARA intervention then 
replaced it with the distance walked, which was roughly measured. This might 
explain the reason why his PA did not improve, as he focused on the distance 
without recording the steps. 
187 
 
The qualitative thematic analysis of the interviews showed that some 
participants whose PA level did not change or reduce did not follow the 
recommendations of the WARA intervention, such as using the pedometer, PA 
diaries, or both. For example, in the previously mentioned example of the old 
man who did not change his PA levels, it was noted that he only used the 
pedometer at the beginning of the WARA intervention. He then replaced this by 
walking and estimating the distance. Also, he did not use the PA diaries 
therefore his PA did not change. 
Additionally, there was a participant whose PA level did not change over 6 
months, and she only attended 4 education sessions because of her social 
commitments. It was also noted that she lacked the motivation to walk and also 
she claimed that the pedometer was not accurate and therefore it seems she did 
not use it. Another participant whose PA reduced over 6 months attended only 3 
education sessions and also he claimed that the pedometer did not count the 
steps accurately. However, it seems he did not follow the recommendations of 
the WARA intervention, and in addition this participant noted that he had back 
pain as a PA barrier. 
3 Social support 
The education sessions in the WARA intervention contained some interactive 
discussion activities. There was a general agreement about the benefits of 
conducting the sessions in groups. The participants found the groups to be a 
good opportunity to meet other people with a similar condition. They were able 
to interact with others with similar experiences of RA, to build friendships and 
share information. At times this motivated them to keep attending the sessions. 
The participants liked the group discussion; people with RA may feel isolated 
because of their condition. Feelings of isolation were evident throughout the 
interviews. There was also insight into the physical difficulties experienced when 
they could not join social activities or join friends because of the condition, and 
it also affected their daily lives. Their condition also restricted them from going 
to some places such as going to the gym, as discussed in (section;7.3.1, 1c). 
They felt isolated from the community, and this feeling might have led to 
loneliness and they felt they lacked a useful role in society, which may 
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contribute to psychological problems such as depression. For example, one 
young woman participant commented on the benefits of having group 
discussions, she said: 
 ‘’It was very helpful, you get to hear what other people are doing and 
how they sort of managing to keep mobile. You get told you have 
arthritis and this is the tablets go take them and that is all. Attending 
the sessions gave us awareness about what you are doing every day” 
(PN16, 32yrs, F, IG2). 
The same participant talked about her experience with arthritis and how it 
affected her life - she said: 
‘’…Group sessions are a chance to meet others with arthritis, sharing 
experience, not everyone understands my condition, I have difficulties 
to have normal life some days I have pain I cannot work, go out, I 
cannot enjoy life’’ (PN16, 32yrs, F, IG2). 
Another woman attended all the education sessions however she works, as 
discussed in the PA barriers section. Despite her barriers to PA and her 
commitments she was able to increase her PA over 6 months and adhere to the 
programme. She commented throughout the interview that the WARA 
intervention was a good opportunity to meet people with RA, she said: 
This is a good chance to share experience with other rheumatoid 
arthritis people, not everyone in the community has arthritis” (PN21, 
50yrs, F, IG2). 
The group sessions helped reduce the feelings of social isolation they normally 
experienced. An-old man said that RA is not well understood in the general 
population and once you are diagnosed with this disease your daily life will 
change and other people will not understand. He talked about a negative 
experience with his friends. 
“The group sessions were good because rheumatoid arthritis people 
are very isolated, if you get an illness like this because other people 
don’t understand it, they know about arthritis but the other type like 
osteoarthritis, your perception, daily life is changed completely 
because you have got this. I lost a friend or two because of this. So 
it’s good to meet other people who know the disease” (PN5, 74yrs, M, 
IG1). 
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4 Understanding of condition and awareness of benefits of healthy 
lifestyle in terms of physical activity in relation to rheumatoid 
arthritis 
Additionally, attending the education sessions of the WARA intervention helped 
the participants to understand their condition, and to raise their knowledge and 
awareness regarding a healthy lifestyle. For example, one participant whose PA 
did not change over the study period, and who attended all the education 
sessions, commented that the education sessions content had positively 
encouraged him and raised his knowledge and awareness of his condition. He 
stated: 
 “It [session’s content] was good to learn things I was not aware of; I 
did find it useful. It covered everything to make me more active. I 
think it was very well covered, refreshed my memory, made me 
knowledgeable, aware of the condition and encouraging” (PN5, 74yrs, 
M, IG1). 
The majority of the participants found that the topics covered the basics as they 
provided them with information about RA, PA, heart disease and PA in RA and 
also a healthy diet. They stated for example: 
“The sessions were varied. The information about heart risk was new 
to me. It also gives us information about what we have to eat as you 
know the Scottish diet is terrible. I did stop a few things and I stopped 
sugar and bread. I became even more careful about my diet and I 
made it much healthier” (PN50, 66yrs, M, IG5). 
Some participants appreciated that the sessions were giving them information 
about a healthy diet that could help them to control their co-morbidities with 
RA, such as diabetes. They therefore considered that the sessions offered new 
knowledge for them. The participants talked about a lack of information 
regarding their condition and also health issues in general. They were within five 
years of being diagnosed with RA, had been prescribed medication and no 
further explanations had been given in terms of, for example, the associated co- 
morbidity. 
 “The sessions gave me the information that I was not aware of, it 
made me think more of what’s happening and what I could do to help 
myself. It was helpful and I should be more careful about my diet, it 
helps my diabetic diet” (PN40, 50yrs, F, IG4). 
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The sessions also helped the participants to become more aware of the 
importance of being physically active. 
It emerged from the interviews that the participants held false beliefs about 
walking in RA, as they believed once you were diagnosed with RA it was better 
to sit. 
“I thought walking worsened my arthritis. Now, I am very much aware 
of spending too much time sitting down and more aware of going for a 
walk” (PN 47, 65yrs, F, IG4). 
Some of the participants were also unsure about the safety of strengthening 
exercises in RA. It seems that this uncertainty made them physically inactive. 
The education sessions and the handout highlighted an important issue related 
to the safety of strengthening exercise in RA. One stated for example: 
 “Strengthening exercise, that is really good idea, I was not sure about 
strengthening exercise, whether it is safe or not in RA, was good to do 
or not, and now I know it is good to do strengthening exercise” (PN21, 
50yrs, F, IG2). 
5 The benefits of being more physically active 
The participants who successfully increased their step count and maintained a 
high step count over 6 months stated that with the walking programme they felt 
much healthier, had less joint pain and their mood improved. In addition, no 
adverse effects from walking were reported. This was true even for those who 
previously believed that walking was not good for their condition. 
“Walking helped me and I try to walk every day, it helps to lift your 
mood. It might be nice if group walks were included in the 
programme. I don’t have any problems with walking. My joints are 
better, but it could be that they have just got the balance right with 
my medication, I just feel better” (PN50, 66yrs, M, IG5). 
Participants described their enjoyment and the benefits of being more physically 
active during the WARA intervention. For instance, one woman was able to reach 
her weekly walking goal, and talked about the benefits of being physically 
active. She spoke about the importance of being able to walk even short 
distances outside and how that helped her to overcome the pain she had. 
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“I reached my weekly walking goal. I feel quite good; I did feel 
better. I am in a good mood. I think if you go even for short walk 
outside I think it seems you able to forget your pain and you feel 
better” (PN47, 65yrs, F, IG4). 
The same participant found that in addition to the exercise, the healthy diet 
helped her in terms of losing weight and improving joint pain, which made her 
feel healthier. She stated that: 
 “I lost two stone with healthy food and the exercise and I found 
losing weight helped my joints. Now if I do not walk enough my legs 
start crawling. It was very positive, I feel much healthier than I have 
for years, my pain is much less. I feel better; I feel a difference” 
(PN47, 65yrs, F, IG4). 
These participants were their PA increased over 6 months therefore they 
enjoyed the benefits of being more physically active. 
In addition, some participants reported positive benefits from the strengthening 
exercises within the programme. For example, a young woman stated: 
 “I look at my strength exercise and use my Theraband. I was watching 
TV it is easy to do it, I did find a bit of improvement” (PN16, 32yrs, F, 
IG2). 
Although many participants found that the strengthening exercises helped them, 
an equal number found that it made their pain worse. 
“I did strength exercise at the beginning, I have not done any of the 
strength exercise now, I think because I feel sore after the exercise” 
(PN47, 65yrs, F, IG4). 
This finding may explain the lack of improvement in hand grip strength in both 
groups in the study. 
6 Self-efficacy 
Self-efficacy has been demonstrated to influence health behaviours. Self-
efficacy is an important mediator of PA's effects on health outcomes (McAuley et 
al., 2011). The participants stated that their ability to perform PA improved 
after the programme. Observing others perform the task and sharing the 
192 
 
experience may explain the increased self-efficacy for PA in the participants. 
They stated for example: 
“I have much more energy. I am doing much more than the 
programme; I reach my target every single day. I need steps, I need to 
walk. It has been wonderful to join the programme, my life is 
changing, I feel confident. It’s very easy to sit down when you are 
sore whereas you do walking the more you do the more you can do 
and you start to feel more confident about going out and doing things 
and it just make such a difference” (PN47, 65yrs, F, IG4). 
193 
 
 
Figure 7-2 The theoretical mechanisms of action in WARA intervention 
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7.4 Summary of qualitative findings 
The participants found that the WARA programme was enjoyable and helpful in 
terms of raising their knowledge regarding their condition and their awareness of 
the importance of being physically active. They also learned that walking did not 
worsen their condition. The participants found that group-based education 
sessions, observed learning and self-monitoring (pedometer, PA diaries) 
improved their confidence and were the keys to reaching their goals. In 
addition, many stated that walking helped them in terms of feeling healthier, 
reducing joint pain and improving mood. However, not all of the participants 
agreed on that. 
In fact, not all of the participants adhered to the WARA intervention – for 
example, some participants did not perform the strengthening exercises and a 
few of the participants, who suffered from fatigue and tiredness, did not have 
the motivation to walk; they felt much more comfortable with sitting. Also, a 
few of the participants did not use the PA diaries so they may not have realised 
how much they had walked; others claimed that the pedometer was inaccurate 
when recording the step count. These factors may explain why not all of the 
participants increased their step count, improved their strength or enjoyed the 
health benefits of being physically active. 
7.5 Integration of both qualitative and quantitative 
findings 
The quantitative study found that participation in the WARA intervention 
positively influenced the primary outcome (average step count/day), with the 
average step count increasing over 6 months by around 35% in the intervention 
group. Similarly, participants’ interviews showed that those participants whose 
PA increased over 6 months talked about being out walking and their PA 
improved after engaging in the WARA intervention. They stated that group-based 
education sessions were one of the key factors that motivated them to increase 
their PA and adhere to the programme. In addition, attending the education 
sessions helped them to understand their condition, as it highlighted the 
importance of being physically active in people with RA and also corrected their 
incorrect beliefs regarding walking and strengthening exercise and how these 
195 
195 
 
would affect their condition. They also commented on the pedometer, PA diaries 
and walking programme as motivators that helped them to progress towards 
their PA goal. Despite some of them facing some PA barriers during the 
programme, they were able to overcome them and increased their PA. 
However, the participants whose PA reduced or did not change over 6 months 
did not follow the recommendations of the WARA intervention as they either did 
not use the pedometer or PA diaries and also did not attend the education 
sessions regularly. 
Thus, adherence to the WARA intervention and following the recommendations 
had a strong influence on PA and increased the participants’ confidence in 
performing PA. Subsequently they enjoyed the benefits of being physically 
active, as was evident in the interviews. For example, one participant whose PA 
increased by 138.7% over 6 months felt less joint pain, and much healthier. This 
participant attended all the education sessions and she really used the 
pedometer, and bought a Fitbit. Another participant who adhered to the 
programme and the recommendations was able to increase his PA by 33.5% over 
6 months and he found that his mood improved and he had less joint pain. 
Thus, based on the findings of both studies (quantitative and qualitative), it 
seems that there was an interactive theoretical mechanisms of action. 
Increasing the participants’ awareness and the knowledge of their condition, and 
increasing their PA self-efficacy by using motivation methods such as group 
education sessions, self-monitoring and feedback tools (pedometer and PA 
diary), may lead to increased adherence to the programme, increased PA and 
improved health outcomes.
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8 Discussion 
This chapter discusses the results from the quantitative data (primary and 
secondary outcome measures) and the findings of the qualitative study. It then 
considers these results in relation to previous literature. It discusses the findings 
in order to provide a comprehensive understanding of the motivators and key 
factors of the success of the participants’ engagement in PA and also the 
barriers that the participants faced during the intervention. The strengths and 
limitations of the study are also presented. 
A six-month, community-based, pedometer-supported walking programme, with 
an education programme incorporating behavioural change techniques (Walk for 
RA – WARA) resulted in an increased step count over 6 months (primary outcome 
measure). There were also changes in some secondary outcome measures such 
as 6MWT, self-efficacy for PA, systolic blood pressure and 10-year CVD risk. 
8.1 General findings 
The six-month WARA intervention had a statistically significant effect on the 
primary outcome measure of physical activity. For the secondary outcome 
measures, the results indicated a statistically significant improvement in the 
functional capacity of the intervention group in terms of the 6MWT; however, 
there were no significant differences in HAQ or the hand grip test. Although 
there were no significant differences between the groups in SDAI, a greater 
proportion of those in the intervention group went into remission (as defined by 
a score 0-3.3). Also, a significant improvement was noted in self-efficacy for PA, 
systolic blood pressure and the ASSIGN score (10-year CVD risk) due to the 
intervention. There was no evidence that the WARA intervention had any 
statistically significant effect on RAQoL, DINE score or co-morbidity over 6 
months. 
Thus, the null hypothesis for the outcome measures was rejected and the 
alternative hypothesis was accepted – i.e. there was a significant difference 
between the intervention group and the control group in primary outcome 
measures over the time period of the study (6 months) (further discussed in 
section 5.2). Generally, the intervention group improved in most of the outcome 
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measures, however of note the control group deteriorated compared to the 
baseline for measures of functional capacity (6MWT), systolic blood pressure and 
the 10-year risk of CVD. The following sections will discuss the results for each 
outcome measure. 
8.2 Discussion of primary outcome measures 
8.2.1 Physical activity levels (over 6 months) 
The key finding from this study is the improved PA levels in the intervention 
group in terms of step count/day as measured objectively by the activPALTM 
while the control group displayed a decrease in steps per day at all study time 
points compared to the baseline. 
In the present study, the mean step count of the intervention group increased by 
2569 steps per day, 35% above the baseline, over the 6-month period. This result 
is in line with the previous RCTs of Beghianimoghaddam et al. (2016), Baker et 
al. (2008a) and Stovitz et al. (2005), which also used pedometers to provide 
feedback but to healthy people in terms of their daily step count. These studies 
reported increased step counts in the intervention group over the study period 
(over 6 months) by around 40% (Baghianimoghaddam et al., 2016, Baker et al., 
2008a, Stovitz et al., 2005). The increase in PA in the study by 
Baghianimoghaddam et al., carried out on Tabriz University employees, reported 
a significant improvement in step count in the intervention group from baseline 
(4715 ± 1751) to the end of the study (16 weeks) (8279 ± 2759 steps/day) by 
around 75.6% (Baghianimoghaddam et al., 2016). 
Additionally, a cross-over study by Baker et al. (2008a) found that a 12-week 
pedometer-supported walking programme with PA consultations promoted 
walking in healthy individuals. They reported a significant increase in step count 
(activPALTM) from baseline (6802 ± 3212 steps/day) to week 12 (9977 ± 4669 
steps/day) (P < 0.001) (46.7%) for the participants on the programme; however, 
no change was observed in the control group. The step counts of the 
intervention group were maintained in the follow-up period, between 12 and 24 
weeks of the programme. 
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The pedometer and consultation evaluation (PACE-UP) study also found a 
significant increase in PA in the intervention group (Harris et al., 2017). There 
was significant difference in the change in step counts from baseline to 3 months 
between the intervention group and the control group. It also identified an 
increase in exercise self-efficacy in both the intervention groups (pedometer 
intervention or nurse-supported pedometer intervention). However, the increase 
was greater for those in the nurse-supported pedometer group (face-to-face). 
The study concluded that the pedometer-based walking intervention was 
effective in increasing PA among physically inactive people aged 45 to 75 years 
old. A pedometer intervention, with minimal support, provided in primary care 
may address the challenge of public health physical inactivity (Harris et al., 
2017). 
Hurkmans et al. (2010) reported that a pedometer is an important tool for 
health initiatives (Hurkmans et al., 2010). However, this is not consistent with a 
systematic review of PA interventions that used accelerometers or pedometers 
in people with chronic musculoskeletal pain, which found no significant 
difference between the intervention and control groups in objectively measured 
PA (Oliveira et al., 2016). This was true in the short-term (≤3 months), 
intermediate (>3 months and <12 months), and long-term (≥12 months) trials. 
There was notable heterogeneity in the studies reviewed with regard to data-
processing techniques as well as reported outcomes. There was also a risk of 
bias, as most of the trials failed to blind the assessors and a high dropout rate 
was noted in the studies (Oliveira et al., 2016). 
The current study supports the evidence from a systematic review by Bravata et 
al. (2007), who demonstrated that the use of a pedometer can increase PA levels 
by 27% and daily step count by 2000-3000 steps/day. The feedback from the 
pedometer in terms of step count encourages and motivates changes in 
behaviour as it raises awareness of the current level of walking, which may help 
to promote increasing levels of physical activity (Baker et al., 2008a, Mansi et 
al., 2013, Pal et al., 2009). 
However, few pedometer-based PA intervention studies in RA could be found 
within the literature. One, a pedometer-based PA intervention in people with 
RA, by Katz  et al. (2015) (further details discussed in section 2.6 ) showed a 
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positive change in step count from the baseline to 21 weeks (2132 ± 2698 
steps/day, 92% ± 125%) in the intervention group, who used a pedometer and PA 
diary. When a step target was included in addition to the pedometer and diary, 
the step counts increased (by 1299 ± 2389 steps/day, 188% ± 506 %) (P=0.02). In 
the control group, the step count also increased but by a much smaller amount 
(-327 ± 2429 steps/day, 3% ± 56%) (P=0.53) (Katz  et al., 2015). 
The result suggests that prescribing pedometers, with or without a specific step 
target, to people with RA can be effective in promoting PA (Katz  et al., 2015). 
This finding is in agreement with that of the current study where those who used 
a pedometer and PA diary, attended the education sessions and followed the 
recommendation of the WARA intervention increased their step count by up to 
152%. Thus, the result may be related to the adherence of the participants to 
the programme. 
In the present study, the step count increased in the intervention group, 
comparable to that observed in pedometer-based PA interventions in other 
populations, indicating that this type of intervention is effective for people with 
RA. In addition, the participants’ views, explored during the telephone 
interviews, helped explain the improvement in step count. The participants who 
successfully increased their step count identified the pedometer, PA diary, a 
challenging goal, the group sessions, booster sessions and handout as keys to 
their success. The majority of the participants specifically identified the 
pedometer as being key to their success, as it encouraged them to work towards 
their walking goal and because the feedback it provided allowed self-monitoring 
of their PA. Thus, pedometers may be an important tool in influencing PA in 
people with RA. 
The present study supports previous literature in the fact that the use of a PA 
diary may play a role in increasing participants' adherence to a PA programme, 
in self-monitoring behaviour (Conn et al., 2011, Dalle Grave et al., 2011) and 
progressing more effectively towards their PA goal (Bravata et al., 2007). 
Similarly, participants in the current study said that the pedometer and PA 
diaries were good tools for feedback, encouraging them to achieve their PA goal. 
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The findings of the interviews in this study suggest that group-based education 
enhanced the participants’ adherence to the programme. This finding is 
supported by Withall et al. (2016), who conducted focus groups with people 
with RA: 15 females and 4 males with a mean age of 59.9 ± 10.3 years and a 
mean disease duration of 44 ± 34 months. They identified that group-based 
education as part of a PA programme supported by health care workers 
positively influenced the recruitment and adherence to the programme as it 
facilitated social support from other members of the group and provided a 
source of motivation. Furthermore, a focus group conducted by Crowley and 
Kennedy (2009) involving 12 people with RA found that the factors that 
enhanced adherence to exercise include disease activity (remission), 
environmental (social support) and personal factors (individual motivation). 
Specifically having less pain and having good social support played a role in 
motivating the individual. This agreed with the findings of this study where the 
participants commented that the group-based programme and a good motivation 
within the WARA intervention helped the participants’ adherence to the 
sessions. 
In the present study, one of the main targets of the intervention was to increase 
self-efficacy for PA and to encourage social support through group education 
sessions. However, there was a significant difference between the marital status 
of the participants in the intervention group and the change in step count. 
Single, separated, divorced or widow participants increased their step count 
more than those who were married. Although there is a lack of literature in this 
area, it may be that those who were single, separated, divorced or widowed had 
more free time to perform PA than those who were married and further study is 
recommended. The interviews also highlighted the important issue of people 
with RA feeling isolated due to their condition. There was also insight into the 
physical difficulties experienced when they could not join social activities or 
meet up with friends because of their condition. Their RA therefore affected 
their daily lives; they felt isolated and away from the community as there was a 
lack of people who understood their condition. Social support can be provided by 
friends, relatives, colleagues or a group that shares the same interests (Kim et 
al., 2008). 
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In the interviews, the participants expressed the view that they enjoyed the 
group-based programme, as they found it a good opportunity to meet other 
people with a similar condition. They were able to interact with others with 
similar experiences of RA, to build friendships and share information. They 
mentioned that the group-based nature of the programme was one of the key 
factors of their success in increasing PA levels and also it motivated them in 
issues related to the condition such as joint pain. People who receive more 
social support tend to have higher levels of self-efficacy (Kim et al., 2008). 
Providing an education programme in groups is a form of social support and may 
play a role in improving individual PA self-efficacy (Somers et al., 2012), as well 
as helping individuals to cope with stress and enhancing their self-confidence 
(Miller and Dimatteo, 2013, Wang et al., 2015). Furthermore, interventions 
delivered by face-to-face methods (mentored meetings, led walks, or 
educational sessions) significantly increase the levels of self-reported walking 
(Ogilvie et al., 2007). Thus, face-to-face groups with the associated social 
support were motivating factors that helped participants to succeed with the 
WARA intervention. 
A systematic review and meta-analysis carried out by Warsi et al. (2003) 
identified that education programmes increase the awareness of patients and 
are highly effective for managing arthritis. Also, Withall et al. (2016) reported 
that people with early RA requested group education with information regarding 
RA, along with discussions and sharing thoughts with other people with RA. 
Consistent with the findings of this study, the participants found that the 
education sessions with WARA helped them to understand their condition, and to 
raise their knowledge and awareness regarding a healthy lifestyle. 
In the current study, the participants were also given a handout during the 
education sessions. They found the handout a useful reference, particularly for 
the strengthening exercises. The findings of the present study are consistent 
with the evidence of Glanz and Bishop (2010), Artinian et al. (2010), who stated 
that education sessions and associated material allow participants to access 
information on PA and to interact with other study participants through 
interactive discussions. Similarly the focus groups by Crowley and Kennedy 
(2009) found that people with RA liked to receive exercise instructions. 
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The interviews in this study suggest that the booster sessions reinforced the 
progress that had been made since the start of the WARA programme, and 
motivated the participants to keep walking. This finding is consistent with the 
evidence that booster sessions help people to maintain recently adapted 
behaviour acquired during interventions (Goyder et al., 2014). Furthermore, 
there was a significant improvement in the physical function of the participants 
who received exercise therapy with booster sessions, compared to the 
participants who received exercise therapy alone (Abbott et al., 2015), (further 
details discussed in section 3.6). 
In order to increase the adherence of participants to the programme, the venue 
and time of the sessions should be considered (Alvarado et al., 2015). In the 
current study, the participants found the hospital a suitable place to hold the 
education sessions. The focus group by Crowley and Kennedy also revealed that 
people with RA preferred the sessions to take place on ‘common ground’ 
(defined as a comfortable place that is available to people with good 
transportation and facilities) (Crowley and Kennedy, 2009). People with RA are 
used to going to the hospital and may find it a comfortable and familiar setting 
as they know the place and the staff, and have experience of the services 
offered. 
The aforementioned influential factors such as self-monitoring, group sessions, 
social support, use of handouts and a familiar location may explain the success 
of the WARA intervention in promoting PA among participants in the intervention 
group. 
In the interviews of the present study, the participants stated that the duration 
of the intervention was suitable for them, that the number of the sessions was 
adequate and that they covered the content well. A study by Withall et al. 
(2016) involved a PA programme in people with RA, which consisted of 5 
education sessions over 12 weeks (4 group sessions and 1individual session with 
guided exercise). The findings of the focus group of Withall et al. (2016) 
suggested that the participants would have preferred a less intense programme 
with less contact and more flexibility. However, an RCT carried out by Mayoux-
Benhamou et al. (2008) identified that a 12-month study consisting of home-
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based exercise with guidelines for leisure PA was suitable for people with RA 
(further details discussed in section 2.5.3). 
Although programmes that last more than six weeks are more successful, they 
carry an inherent risk of attrition in people with RA (Riemsma et al., 2004). In 
the present study however, with 6 weekly education sessions with two booster 
sessions at 3 and 6 months, the loss to follow-up was higher in the control group 
(40%) compared to the intervention group (5%). 
In the current study, as well as an increase in objectively measured PA, the total 
metabolic equivalent task (MET)/minutes, measured by the IPAQ, increased in 
the intervention group between baseline and 3 months, but declined between 3 
and 6 months. In the control group it declined between baseline, and 3 and 6 
months. Also, there was a significant difference between the groups at 3 
months. This finding is contrary to the results of a pedometer-based workplace 
intervention of 154 women employees (Baghianimoghaddam et al. 2016) which 
found a significant increase in self-reported PA at the end of the study (16 
weeks) in the intervention group but not in the control group. However, in the 
current study, the finding of the IPAQ does not reflect the finding of activPALTM, 
where the step count increased over the study period. The IPAQ is a self-
reported measure of PA, and participants may have underestimated (Ahn et al., 
2015) or overestimated (Quick et al., 2016) their levels of PA. Self-report 
questionnaires do not provide accurate estimates of the absolute amount of PA 
due to, for example, the accuracy of recall of PA and social desirability bias 
(under or over-reporting good behaviour) (Boon et al., 2010, Sallis and Saelens, 
2000). Participants in the current study commented that their PA had reduced at 
the 6-month assessment period; however, their objective step count showed an 
increase. This may explain the lower IPAQ scores at 6 months. 
Alternatively, the discrepancy between the objective and subjective measures of 
PA could be explained by the fact that the activPALTM measured all PA and the 
IPAQ only measured activity in bouts of 10 minutes and longer (Baker et al., 
2008a, Wolin et al., 2008). However, Larkin et al. (2016c) reported that 
activPALTM underestimated step counts by 26% in people with RA, but there were 
some limitations in Larkin et al.’s study such as the fact that the validation of 
daily physical activities was carried out in a laboratory setting. In addition, the 
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participants of Larkin et al.’s study affected movement patterns, (further 
discussed in section 4.3.1). 
The reason why some participants increased their step count and others did not 
in the present study may be explained by several factors. For example, group- 
based education and social support helped the participants to increase their 
steps; however, a lack of individual motivation was one of the barriers that led 
to a reduced step count. As this study was based on social cognitive theory, it 
seems that self-efficacy plays an important role in increasing participants’ PA. It 
assumes that self-efficacy is an important factor of behaviour, and associates 
self-efficacy with many other components such as goals, outcome expectations 
and individuals’ motivation and behaviour (John et al., 2011a, Glanz et al., 
2002). 
The finding of the current study was consistent with that of a study conducted 
by Anderson-Bill et al. (2011) which involved 703 adults aged between 40 and 92 
years old. The participants received a pedometer, and a PA diary. Participants 
also used a step counter to verify the recordings in the PA diary. The change in 
mean daily step count between the baseline and 16 months, the end of the 
study, was calculated using a pedometer. Also, PA-related social cognitive 
theory components (social support, self-efficacy, outcome expectations and self-
regulation) were assessed. It was reported that increasing self-efficacy is an 
effective way of increasing PA. Indeed, the results of the present study showed 
that a higher step count was associated with higher self-efficacy in the 
intervention group, which fits with social cognitive theory. 
The findings of the interviews in this study suggest that work commitments, 
individual motivation, weather, fatigue and back pain were the main barriers to 
PA. A previous review of barriers to PA in people with RA also identified that 
pain and fatigue were barriers to PA and additionally the fear that PA would 
aggravate their condition (van Zanten et al., 2015). Focus groups, carried out by 
Withall et al. (2016), also found that people with RA have a fear that exercise 
may worsen their condition. Although the participants of the current study did 
not mention a lack of knowledge regarding exercise and safety as barriers, they 
stated that the study increased their knowledge and awareness regarding PA, 
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and that it corrected misconceptions and also the fear they had regarding 
exercise and RA. 
The focus groups conducted by Crowley and Kennedy (2009) similarly identified 
pain and fatigue as barriers to exercise but also identified fear of falling and the 
psychological effects of RA as other barriers to PA. Participants in the present 
study believed that once you were diagnosed with RA it was better to sit than to 
be physically active. They were also unsure about the safety of strengthening 
exercise for people with RA. 
In the present study, no injuries were reported related to walking or 
strengthening exercises. This finding is consistent with the studies of Hurkmans 
et al. (2010) Stavropoulos-Kalinoglou et al. (2013), van den Berg et al. (2006) 
and Breedland et al. (2011) where no injuries were reported related to PA or 
exercises. Thus, it seems that walking is a good form of PA for those with RA 
(Baxter et al., 2016) and that fear of injury should not be a barrier for 
undertaking PA. 
Additionally, a systematic review of chronic conditions such as osteoarthritis, RA 
and lower back pain found that pain, low PA self-efficacy, individual motivation 
and poor social support were the main barriers to participating in PA (Jack et 
al., 2010). The findings of this review are consistent with the current study in 
terms of individual motivation and low back pain. It seems that the low back 
pain affected the motivation of the individual to be physically active. 
In summary, it seems that fatigue and pain, and symptoms related to disease 
activity, are commonly reported barriers to PA in people with RA. A further 
barrier is related to the misbelief that walking and strengthening exercises will 
worsen their condition. In addition, a lack of individual motivation was identified 
in the current study and in that of Jack et al. as a barrier to PA. It is important 
to identify PA barriers so that they main be considered when designing future 
lifestyle interventions for people with RA. 
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8.2.2 Sedentary time (over 6 months) 
The UK physical activity guidelines (2011) not only recommend an increase in PA, 
but also emphasise that adults should reduce the time spent being sedentary. 
This is important as sedentary time is a risk factor for CVD independent of the 
level of PA. 
In the present study, despite no significant interaction effect, objective 
sedentary time (including sleeping time) reduced between the baseline and 6 
months by around 40 minutes/day in the intervention group, compared with the 
control group who increased their sedentary time (including sleeping time) by 20 
minutes/day. In terms of clinically significant differences half of the baseline 
standard deviation could be clinically significant for sedentary 
behaviour(Norman et al., 2003). In the present study, half of baseline standard 
deviation of sedentary behaviour was 50 minutes/day however, the sedentary 
behaviour only reduced by an average of 40 minutes/day in the intervention 
group and increased 20 minutes/day among the control group over the 6 months 
Thus, overall no clinical significant differences were noted in sedentary 
behaviour in both groups. However,14 (37%) participants in the intervention 
group had a clinically significant reduction in sedentary time were there 
sedentary time reduced more than 50 minutes/day over the 6 months.  
Similarly, in the current study, self-reported weekday and weekend sitting hours 
decreased in the intervention group, but increased in the control group. 
However, the discrepancy between the objective and subjective measures of 
sedentary behaviour in the current study could be partially explained by the fact 
that the activPALTM measured all sedentary behaviour (sitting/lying) over 24 
hours, (in this study the sleeping time was included in the sedentary behaviour) 
and the IPAQ only measured the time spent sitting. 
The self-reported findings of the current study are consistent with a physical 
activity consultation and 12-week pedometer-based walking programme among a 
healthy population carried out by Baker et al. (2008a). They found a significant 
reduction in time spent sitting during weekdays (P = 0.003), weekends (P = 
0.001) and in total (P = 0.001). However, Baker et al. investigated a healthy 
population and the present study investigated those with RA. 
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Furthermore, a systematic review and meta-analysis of Martin et al. (2015) 
found a reduction of 22 min/day in sedentary time in favour of the intervention 
group (95% CI −35 to −9 min/day, n=5868) in 34 studies out of 51, where 
sedentary behaviour was measured objectively or self-reported. Lifestyle 
interventions reduced SB by 24 min/day (95% CI −41 to −8 min/day, n=3981, 
moderate quality) and the interventions that focused only on sedentary 
behaviour reduced SB by 42 min/day (95% CI −79 to −5 min/day, n=62, low 
quality). However, there was no evidence of an effect of PA and combined 
PA/SB interventions on sedentary behaviour. Martin et al. (2015) highlighted that 
if the primary aim of a study is to change sedentary behaviour, then the 
intervention should focus on that, rather than increasing physical activity. The 
result of Martin et al. may help to understand to some extent the lack of change 
in objectively measured sedentary behaviour, as the focus of the present 
intervention was on increasing physical activity. However, self-reported 
measures showed reduced weekday and weekend sitting time. 
An RCT with a cross-over design was carried out by Mutrie et al. (2012). The 
participants were previously sedentary adults and the intervention group 
received two 30-minute individual PA consultations delivered by a trained 
practice nurse, a booklet with information about the walking programme and a 
pedometer. The programme also included a walking group twice weekly for 12 
weeks. The intervention led to an improvement in the participants’ quality of 
life and a reduction in their sedentary time. Studies generally seem to show a 
reduction in sedentary time following a PA intervention. 
Walking groups, like that in the study above, play an important role in 
motivation and also in increasing adherence to a PA programme (Helmink et al., 
2010). The current study did not include a walking group, which a few 
participants raised as a deficit in the WARA intervention. The participants 
commented, in telephone interviews, that they thought group walking would be 
a valuable addition and would provide an incentive to encourage walking. 
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8.2.3 Physical activity and sedentary time 6 months after the 
intervention (12 month) 
In the present study, only a small number of participants were followed up 6 
months after the intervention. The result showed that the step count of the 
intervention group was slightly reduced compared to 6 months, but it remained 
at a higher level than the baseline. However, the step count of the control group 
returned back to baseline levels at 12 months. In this study, there was no 
significant difference between the intervention and control groups in terms of 
weekday and weekend sitting hours at 12 months (P = 0.441 & 0.172 
respectively). Due to the time limits of the study, only 22 participants were 
followed up at 12 months, but data were available for only 18 participants thus 
the 12-month results might not accurately reflect the participants’ level of PA as 
the sample size was small. 
The overall findings suggest that an intervention based on pedometers, grounded 
in behaviour theory and incorporating behaviour change techniques (particularly 
self-monitoring, feedback and social support) can promote PA and to a lesser 
extent reduce sedentary behaviour, in people with RA who are within the first 
five years of diagnosis. This effect was seen for 6 months and, where data were 
available, the step count at 6 months’ follow-up remained higher than the 
baseline. The following sections discuss the results of the secondary outcome 
measures. 
8.3 Discussion of the secondary outcome measures (at 6 
months) 
8.3.1 Self-efficacy for physical activity 
The concept of self-efficacy, in relation to PA, concerns the level to which an 
individual has belief in their capabilities to perform exercise and to be physically 
active (Williams and French, 2011). The findings showed that the WARA 
intervention lead to a significant improvement in the self-efficacy for PA in the 
intervention group at 6 months. It increased from baseline to 3 months and 
baseline to 6 months; self-efficacy for PA reduced in the control group over the 
study time points. In addition, high self-efficacy for PA was associated with a 
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higher step count and lower sedentary time (P < 0.05) at 3 months in the 
intervention group and at 6 months in the control group. 
Similarly to a systematic review of lifestyle and physical activity interventions 
that aimed to increase physical activity and self-efficacy in healthy adults, a 
change in self-efficacy has been found to correlate with a change in PA (r = 
0.690, P < 0.001) (Williams and French, 2011). 
The results of this trial are in agreement with an RCT of a 6-week walking 
intervention, where the participants in the intervention group received a 
pedometer and instructions on a walking route to be completed 3-4 times per 
week (Baxter et al., 2016). The walking route was designed so that the RA 
participants could choose a walk of an appropriate length for them. The trial, 
which involved 33 RA patients and 22 control individuals, reported that the 
intervention group experienced greater improvement in their self-efficacy for PA 
and wellbeing, and less pain, compared with the control group (Baxter et al., 
2016). Although the trial was successful in increasing self-efficacy for PA in the 
target population, no theoretical underpinnings of the intervention were 
reported, which makes it difficult to explain the mechanism of its success 
(further details discussed in section 2.5.3). Increasing self-efficacy for PA can 
play a role in the likelihood of an individual with RA achieving their PA goals, 
which is important in improving outcomes (Knittle et al., 2011). 
In contrast a study conducted by Larkin et al. (2016b) examined self-reported PA 
levels and self-efficacy in 102 people with inflammatory arthritis with a mean 
age of 59.6 ± 13.2 years. Self-efficacy for PA was measured using the 
Rheumatoid Arthritis Self-Efficacy questionnaire. No significant relationship was 
noted between self-efficacy for PA and reported PA levels in the study 
population, while beliefs about PA correlated with self-reported PA. However, 
PA was measured subjectively and also a non-specific measurement of self-
efficacy, which measured general self-efficacy for RA as opposed to PA-specific 
self-efficacy, was used, which may have led to an underestimation of the 
participants' confidence in their ability to engage in PA. 
A study by Neuberger et al. (2007) investigated the effects of 12 weeks of 
aerobic exercise for 1 hour 3 times/week in 220 adults with RA aged between 40 
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and 70. They were randomised into class exercise, home exercise following a 
exercise video, or a control group. The exercises consisted of a warm-up, low-
impact aerobics, strengthening, and cool-down exercises. The outcome measures 
were assessed at baseline, 6 weeks and 12 weeks (end of the study). It was 
reported that self-efficacy for PA measured with the exercise self-efficacy scale 
influenced exercise participation in people with RA. Despite the positive 
outcome of the study, convenience sampling was used and therefore the sample 
may be biased towards more highly motivated participants. Also, the control 
group was in remission and fewer were treated with Disease-Modifying 
Antirheumatic Drugs (DMARDs) than in the intervention group (Neuberger et al., 
2007). 
In the qualitative interviews of the present study, the participants stated that 
after participating in the WARA intervention they were more confident in 
walking, whereas they had not been confident before the programme. The 
success of the WARA intervention may be explained by the fact that it was based 
on social cognitive theory, as the participants’ views showed that observing 
others perform the PA task and sharing the experience helped the participants 
to increase their ability to perform PA. 
8.3.2 Rheumatoid arthritis assessment 
1 Disease activity 
The simple disease activity index (SDAI) has been validated for use in clinical 
trials and practice, and the ACR/EULAR recommend using the remission criteria 
of SDAI in clinical trials (Felson et al., 2011). In the current study, there was no 
significant interaction effect between the two groups over time in the SDAI. The 
percentage of people in remission as determined by the SDAI remission score 
increased from 12.8% at baseline to 32.4% at 6 months in the intervention group. 
No real changes were noted in the control group. The MCID for RA disease 
activity have not been well-defined in real-world clinical settings, especially for 
patients early on in RA, who are experiencing low/moderate disease activity 
(Curtis et al., 2015). 
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Higher disease activity (SDAI) was associated with both lower step count (P = 
0.03) and higher sedentary time (P = 0.02), at 3 months in the intervention 
group. 
The findings of this study are in contrast with a study conducted by Prioreschi et 
al. (2013) who reported no correlation between SDAI and PA (P = 0.976). 
However, in the present study the population consisted of people with RA within 
the first five years of diagnosis and the participants in the Prioreschi study had a 
disease duration from 1.8 years to 14.6 years. However, there is a lack of RCTs 
examining the effectiveness of PA on disease activity (SDAI) in people with RA 
and further work in this area is required. 
The most appropriate PA for RA is aerobic exercise such as walking. It can 
enhance cartilage integrity and joint lubrication, and increase the range of 
motion and flexibility, increase the muscle mass and physical function of people 
suffering from RA without damaging the joints of exacerbating the disease 
(Cooney et al., 2011, Pal et al., 2009). The combination of increased PA and 
effective medication may help to inhibit disease progression, improving quality 
of life and health outcomes (Metsios et al., 2011). 
In the telephone interviews the participants stated that after engaging in the 
WARA intervention, those who increased their PA, felt much healthier and had 
less joint pain. 
The effect of regular aerobic PA on CRP is not yet fully understood, although 
regular PA is associated with a reduction in CRP levels in healthy men (Albert et 
al., 2004) as well as in people with RA (Metsios et al., 2009, Metsios et al., 
2008). SDAI is based on CRP, and in the current study CRP showed no significant 
interaction between groups, which explains the SDAI results. However, the exact 
mechanisms to explain the link between increased PA and reduced disease 
activity are not clear. Exercise-induced immune changes have been identified, in 
particular muscle contractions that regulate the expression of specific cytokines 
such as in interleukin (IL) 6-8, IL10, and IL15, and TNF-alpha; thus the effect 
may be due to the anti-inflammatory effects of exercise (Brandt and Pedersen, 
2010). Exercise has several other benefits, including improving blood and 
synovial fluid circulation in joints in the general population. However, the dose 
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response of PA in people with RA is not yet fully known (Cooney et al., 2011) and 
further study is recommended in this area. 
2 Rheumatoid arthritis quality of life (RAQoL) 
Quality of life is an important concept within health outcome appraisals, in 
general as well as in chronic disease. It is an indicator of the burden of the 
disease, in terms of both physical and mental health, and provides insight into 
the outcome of a treatment programme (Burckhardt and Anderson, 2003, Salaffi 
et al., 2009). People with RA have a low level of PA, and this has a high negative 
impact on quality of life (Arne et al., 2009). In the present study, there was no 
interaction effect between groups in terms of RAQoL; however, there was a non-
significant improvement in both groups. Based on MICD, the fact that the ability 
to detect improvement in RAQoL in clinical setting if the RAQoL score reduced 
by an average of – 0.67 to – 0.51 over 6 months (Maska et al., 2011b). In the 
present study, the RAQoL score reduced by an average of 2.8 in the intervention 
group and by 1 among the control group over the 6 months. Thus, based on 
MICD, there was an overall clinical significant difference in RAQoL in the both 
groups, the results suggest a strong trend towards an improved quality of life in 
the clinical setting among the intervention group. 
Plasqui (2008) stated that aerobic or strengthening exercises have a positive 
effect on RA disease progress, range of motion, quality of life and functional 
capacity. In a number of studies quality of life was measured with the EuroQol 
five-dimension questionnaire (EQ-5D). EQ-5D consists of the dimension’s 
mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, 
which differs from the RA specific tool used in this study and may explain the 
different results of this study from previous studies. 
In other chronic disease such as diabetes, quality of life of people is increased if 
they achieve their PA goal (Arne et al., 2009) and this may also be true of people 
with RA. However, this effect of PA, and more specifically walking, on quality of 
life in people with RA has not yet been established and further work in this area 
is required. 
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In contrast to the present study, Hurkmans et al. (2010) reported improved 
quality of life of people with RA, measured by RAQoL at 24 months following 
one-year internet-based PA intervention. This may be explained by the fact that 
the people who were motivated and physically active completed the 24 months, 
as it was reported that 26.7% were lost to follow-up. On the other hand, it may 
be related to other factors such as disease activity controlled by treatment or 
pain and fatigue; further study is needed. 
Although there was no statistically significant difference in RAQoL in the present 
study, the results suggest a strong trend towards an improved quality of life and 
possibly a larger sample is needed. Also, there may be other factors such as 
fatigue and pain that are related to quality of life, but that were not considered 
in this study. 
8.3.3 Functional capacity 
Functional capacity in this trial was assessed with the six-minute walk test 
(6MWT), hand grip strength and the Health Assessment Questionnaire (HAQ). In 
the current study, the distance walked in six minutes increased in the 
intervention group but fell in the control group. In the intervention group, a 
higher step count at 6 months was significantly associated with an improvement 
in 6MWT. 
The finding of the current study is consistent with that of Neuberger et al. 
(2007), which involved 220 adults with RA. The exercise programme consisted of 
12 weeks of warm-up, low-impact aerobics, and strengthening and cool-down 
exercises for 1 hour 3 times/week. The time to walk 50 feet was used to assess 
functional capacity. A significant interaction effect was reported between the 
intervention and the control group in walk time (P ≤ 0.005) in favour of the 
intervention group. However, walking 50 feet might be insufficient to identify 
any improvement in functional performance in people with RA. The current 
study used 6MWT, which is more reliable for assessing and evaluating functional 
capacity (Du et al., 2009). 
In the current study, 6MWt showed a significant improvement from the baseline 
to six months (361m at baseline to 417m at six months) for an average of 36.3-
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74.9m. However, based on MCID, even the smallest difference in score for some 
measurements may be beneficial to the patient (Cook, 2008). It has been 
reported that clinically meaningful change in 6MWT is approximately 15-30 
meters (Shoemaker et al., 2013). Therefore, even though there wasn’t a 
statistically significant increase in the 6MWT there may have been a clinically 
significant change.  
In terms of grip strength the finding of the current study contrasts with the study 
by Neuberger et al. (2007) (described above), which identified a significant 
interaction effect between the intervention and control group (P ≤ 0.005) in 
favour of the intervention group. The intervention in the study by Neurberger et 
al. included strengthening exercises with elastic exercise bands and for one 
group it was supervised. However, in the current study the strength exercise was 
included in just one of the education sessions and the handout instructions may 
have been insufficient to motivate participants to perform the exercise at home. 
Also, a number of participants in the interviews said that the strengthening 
exercise made them sore, therefore they stopped doing it. 
The WARA study findings were also consistent with a prospective study carried 
out by Hakkinen et al. (2001) where 70 participants with RA were randomly 
assigned to either the control group or to a dynamic strength-training group, 
who had to perform 8–12 repetitions per set of exercises twice a week, giving an 
exercise duration of 45 minutes. The training programme included exercises for 
the upper and lower extremities, with elastic bands for resistance, and exercises 
for the abdominal and back muscle exercises, using dumbbells. 
In addition, the patients were encouraged to perform PA including walking, 
cycling, skiing, and swimming 2–3 times/week for 30–45 minutes. The 
participants completed training diaries, which were emailed to the researcher 
every second month. They were assessed at 6-month intervals for 2 years. 
Functional capacity was assessed with muscle strength tests (isometric grip 
strength, trunk flexor, and knee extensor measured with a dynamometer), 
walking speed (maximum walking speed in meters/second over a distance of 30 
meters) and HAQ. The greatest increase in muscle strength was noted in the 
strength-training group, where it increased by 19–59% over 24 months. The 
corresponding change in the control group was 1–31%. HAQ and walking speed 
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also showed significant improvements in the strength-training group. The study 
concluded that combined endurance PA with regular strength training can 
improve the functional capacity of people with RA (Hakkinen et al., 2001). 
The target population was those with RA within 2 years of diagnosis, and all of 
the participants were treated with medication to achieve disease remission. The 
primary outcome measure was the improvement in muscle strength. 
Furthermore, the intervention was intensive and lasted for two years – so the 
improvement in the functional capacity of RA was unsurprising. Such an increase 
in strength is unlikely in the current study, where the main focus was on 
promoting PA. 
In contrast to the current study, an RCT carried out by Stavropoulos-Kalinoglou 
et al. (2013) on aerobic and high intensity resistance exercise in people with RA 
reported that there was a significant difference between the intervention and 
control groups in HAQ (P = 0.003). The improvement may be due to the intensity 
of the intervention. 
A study carried out by Khoja et al. (2016) reported that light, very light, and 
moderate intensity PA was significantly associated with lower functional 
disability in people with RA. Although in the present study PA intensity was not 
measured, higher physical activity (steps/day) was associated with higher 
functional capacity at baseline in the intervention group (P= 0.04). Also, higher 
functional disability was associated with higher objectively measured sedentary 
time at 6 months in the control group. 
Joints are susceptible to insufficient or excessive activities, leading to joint 
degeneration; lack of exercise is known to induce joint contracture, leading to 
impaired functional capacity in osteoarthritis (Ozkan et al., 2007). People with 
RA who develop functional limitations secondary to immobility early in the 
disease course are at risk of becoming disabled (Cooney et al., 2011). A few 
studies were able to improve functional capacity (HAQ). They were studies 
where the examined cohort was in the early stage of RA and had low disease 
activity (Hakkinen et al., 2001) or convenience sampling was used (Stavropoulos-
Kalinoglou et al., 2013) or the programme was supervised with intensive 
216 
 
intervention and the participants were young, aged between 18 and 53 years old 
(Orlova et al., 2015). 
Previous literature suggests that exercise, whether aerobic or strengthening, has 
a positive effect on RA functional capacity (Plasqui, 2008). The findings of a 
review of RCTs by Metsios et al. (2009) demonstrated that PA plays an important 
role in improving functional capacity in people with RA and the results of the 
current study add to that evidence. The present study adds to that literature by 
using the 6MWT, which does not seem to have been used before. 
The interviewed participants said that after participating in the WARA 
intervention they could do more walking and they felt much healthier. The 
improvements in walking discussed at interview would explain the improved 
distance walked in the 6MWT. 
The lack of improvement in hand grip was perhaps expected. Although the 
strength training was a component of this study, there was no supervised 
resistance training programme. In addition, the qualitative findings added 
context to these results whereby although a few participants found that the 
strengthening exercise helped them and they enjoyed performing the exercises, 
the majority of the participants mentioned that they did not do the 
strengthening exercise very often. Also, some participants experienced an 
increase in pain after the strengthening exercises. 
The findings of this study indicate that the WARA intervention improved 6MWT 
but not the HAQ or hand grip strength. This may be expected as, despite the 
strengthening component of the intervention, the strengthening programme was 
not intensive and was unsupervised. It was also not the main focus of the study. 
8.3.4 Cardiovascular risk factors 
1 Blood results 
There were no interaction effects between the two groups in blood lipids in this 
study (HDL, TG, cholesterol level CRP, glucose, GGT, insulin, ALT and AST). 
However, there was a significant association between objectively measured time 
spent being sedentary (including sleeping time) and TG, with a higher sedentary 
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time (including sleeping time) being associated with a higher level of TG at 3 
months in both the intervention and control group. Also, there was a significant 
inverse relationship between sedentary time (including sleeping time) and GGT 
(P < 0.05). Hamilton et al. (2007) showed that increased time being sedentary 
leads to suppression of the lipoprotein lipase activity of skeletal muscle (LPL) 
due to a loss of local contractile stimulation. LPL is the enzyme that is engaged 
in the uptake of free fatty acids and triglyceride and high density lipoprotein 
(HDL) in skeletal muscle (Hamilton et al., 2007). 
Thus, the increase in sedentary time may lead to a reduction in the uptake of 
triglyceride and HDL, which consequently increases levels of free fatty acids 
and triglycerides in the blood stream and reduces the protective effect of HDL 
against cardiac events, which may increase the risk of developing CVD. The 
relationship between sedentary time and cardiometabolic biomarkers, 
independent of PA, has been established (Qi et al., 2015). This emphasises the 
importance of reducing sedentary behaviour for the prevention of CVD, even in 
those who meet PA recommendations (Qi et al., 2015). 
The findings of this study contrast with an RCT conducted by Murphy et al. 
(2002), who utilised an RCT cross-over design with previously sedentary adults. 
The intervention comprised 6-week of brisk walking with short and long bouts. 
The results showed a reduction in triglyceride level and triglyceride level/ total 
cholesterol level, and increased HDL in the intervention group (P < 0.05). In 
addition, a study by Khoja et al. (2016) reported that very light, light and 
moderate intensity PA was significantly associated with improved insulin 
sensitivity and HDL as well lower functional disability, SBP, DBP, and BMI in 
people with RA. 
The evidence suggests that that there is a dose-response association between 
exercise duration and health outcomes such as lipid profile (Dalleck et al., 2009) 
and that higher intensity PA favourably affects the lipid profile (Cornelissen et 
al., 2009). The UK physical activity guidelines (2011) recommended a healthy 
lifestyle including moderate intensity/vigorous PA. 
A significant dose-response association between blood glucose and high intensity 
PA (P = 0.04) in an adult population was reported by Teh et al. (2015). Also a 
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large cohort study carried out in the United States on more than 70,000 healthy 
women aged 40-65 years reported that brisk walking and vigorous exercise were 
associated with a 25% reduction in diabetes incidence (Hu et al., 1999). In other 
studies in adults with diabetes, by Loprinzi and Cardinal (2013) and Healy et al. 
(2015) a significant association was found between light intensity PA, low 
inflammatory markers and blood glucose. In the present study PA intensity may 
not have been high enough to change lipid profiles and blood glucose. 
2 Blood pressure and 10- year CVD risk 
In the present study, there was a significant improvement in CV profile in terms 
of systolic blood pressure (SBP), which declined by a mean of 7.2 mmHg in the 
intervention group and increased in the control group by 4 mmHg at 6 months. A 
significant interaction effect was seen between groups in the ASSIGN score (P < 
0.001). A decline in the ASSIGN scores was noted within and between the 
intervention and the control group. In the intervention group the ASSIGN score 
significantly reduced between baseline and 6 months (P < 0.001). 
A reduction in SBP and DBP was observed following a PA programme with healthy 
individuals at 12 weeks and 12 months (Hunt et al., 2014). Moreau et al. (2001) 
demonstrated that SBP reduced by 11 mmHg and body mass reduced by 1.3 kg 
over the 24 weeks of a walking programme in postmenopausal women. 
This study’s findings are also in line with those by Metsios et al. (2009), which 
demonstrated a reduced risk of developing CVD and an improved functional 
capacity in RA patients who were physically active. A significant difference was 
detected among groups (physical active and inactive group) in systolic blood 
pressure (P = 0.006), cholesterol (P < 0.001), low-density lipoprotein (P = 0.01). 
Although the findings of both studies are consistent, the Metsios study calculated 
the 10-year probability of a CVD event using the Framingham risk score. In the 
current study the CVD risk was measured using the ASSIGN score. The ASSIGN 
score was developed in Scotland and it includes social deprivation and family 
history of CVD, features that are not included in the Framingham risk score. 
Stavropoulos-Kalinoglou et al. (2012) reported that CVD was reduced (P= 0.012) 
in RA patients who participated in a 6-month programme of high intensity 
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resistance exercises. The 10-year CVD event probability was assessed with the 
Heart Score programme of the European Society of Cardiology. Although the 
current study and the study by Stavropoulos-Kalinoglou et al. reduced the 10-
year CVD risk, the current study was a less intensive programme than 
Stavropoulos-Kalinoglou study and thus the WARA intervention may be more 
appropriate and more acceptable to people with RA. 
The finding of the current study is in line with a meta-analysis of prospective 
cohort studies on healthy individuals conducted by Li and Siegrist (2012) where 
the lipid profile, blood pressure, adiposity variables, endothelial function and 
coagulation factors were all evaluated following the PA intervention. There was 
a reported reduction in risk of CVD by 20-30% among women and men who 
engaged in high levels of leisure time PA, while moderate leisure time PA 
decreased the risk of CVD by 10-20%. However, the study did not distinguish 
between CHD and stroke and the overall relative risk of CVD was calculated. 
Studies reveal that sedentary behaviour is significantly associated with increased 
risk of CVD (Chomistek et al., 2013, Dunstan et al., 2010), (further discussed in 
section 2.8.3). In addition, Kaplan (2010), van Halm et al. (2009), Liao and 
Solomon (2013) reported that a low level of PA is associated with increased risk 
of CVD. On the other hand, Chiuve et al. (2011) and Greenland et al. (2010) 
stated that regular PA is associated with a low risk of sudden cardiac death. 
Consistent with the evidence, the current study found that spending more time 
sedentary was associated with high SBP at 3 months in the intervention group 
and high triglyceride at 3 months in both the intervention and control groups. 
Hypertension contributes to the increased risk of CVD in the general population 
as well as in those with RA (Liao and Solomon, 2013). Hypertension can lead to 
an increased workload on the heart (increased vascular resistance) that could 
increase/accelerate the atherosclerotic changes; it can also induce left 
ventricular hypertrophy, congestive heart failure and cerebrovascular accidents 
(Evaristi et al., 2016). There is evidence that people with RA are more likely to 
have hypertension than non-RA individuals (Siebert et al., 2016). In the current 
study, 16 participants (21.0%) had a history of hypertension. Lifestyle 
modifications have an important role to play in preventing hypertension, 
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reducing BP and lowering the risk of hypertension complications (Gupta and 
Guptha, 2010). 
Exercise has several physiological effects that affect the cardiovascular system 
through autonomic and hemodynamic adaptations (Whyte and Laughlin, 2010). 
Cardiac debt, the extra oxygen required after exercise for the oxidative energy 
process in order to convert the lactic acid to glucose and to decompose 
adenosine triphosphate and creatinine phosphates to their original state, 
increases in line with rises in SBP (Whyte and Laughlin, 2010). 
Peripheral resistance to blood flow is reduced by the vasodilatation within the 
skeletal muscle; this is compensated for by the induced vasoconstriction 
occurring in non-exercised tissues. Physical exercise causes a reduction in the 
peripheral vascular resistance due to an accumulation of muscular metabolites 
(potassium, lactate and adenosine) (Whyte and Laughlin, 2010). 
SBP increases in line with exercise intensity; however, DBP changes little during 
sub-maximal exercise, irrespective of intensity (Council et al., 2013). Blood 
pressure changes vary with the type of exercise. Aerobic exercise increases the 
heart rate and increases the pressure with which blood is pumped, thus raising 
the SBP. This is the preferred exercise for the heart. However, during 
strength/resistance training, peripheral vascular resistance increases due to 
sustained static muscle contractions, which lead to restricted blood flow through 
arterial and venous blood vessels. This can lead to an increase in SBP and DBP 
(Council et al., 2013). As this study involved a walking programme, the aerobic 
nature of the exercise many explain why SBP but not DBP declined. 
During the recovery period post-exercise, SBP decreases below the pre-exercise 
levels for up to 12 hours and the DBP can also remain low for hours afterwards. 
This may have an important application in promoting a healthy lifestyle as 
exercising regularly can reduce BP on a daily basis (Council et al., 2013). 
Education of participants regarding the condition seems to play a role in 
reducing the consequences of the disease (Glanz et al., 2002). In the present 
study during the interviews participants in the intervention group stated that the 
education sessions raised their awareness and knowledge of CVD and RA. It also 
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made them aware of the importance of people with RA being physically active to 
reduce the CVD risk and to improve functional capacity and reduce disability, 
which they said was new knowledge for them. 
This finding is consistent with a study conducted by Bartels et al. (2013), who 
interviewed 10 people with RA aged from 23 -81 years, in order to evaluate CVD 
preventive care. Almost all of the participants were unaware of the increased 
risk of CVD in RA. In addition, the majority of the participants who were 
interviewed reported receiving no consistent CVD preventive care. The study 
recommended that rheumatologists should consider interventions in order to 
overcome the CVD preventive care gap in clinics. The increased awareness 
regarding the co-morbidities associated with RA, particularly CVD, might help to 
motivate people to increase their PA and subsequently reduce their blood 
pressure and CVD risk. Knowledge and awareness regarding CVD can influence a 
patient’s choice with regard to adopting a healthy lifestyle, including PA 
(Koniak-Griffin and Brecht, 2015). 
This study supports the evidence on the role of lifestyle interventions, including 
promoting PA in order to reduce SBP and 10-year CVD risk. The decline in the 
ASSIGN score is likely to be due to changes in SBP, cholesterol levels and HDL, 
but specifically SBP. 
3 Anthropometric measurement 
In the current study, although there was a significant interaction effect in BMI in 
favour of the control group, there was no significant difference within group 
changes. There was no significant interaction between groups in adiposity 
variables (WC, HC, and WHR). This is in contrast to the RCT of Murphy et al. 
(2002), which reported no significant changes in BMI following a 6-week 
programme of brisk walking in previously sedentary adults; however, WC and HC 
were reduced in the intervention and control groups (P < 0.05). This may be not 
the case with RA, as the evidence revealed that BMI has a paradoxical 
association with RA as low BMI (<20kg/m2) is associated with increased CVD risk 
(Boyer et al., 2011, Zegkos et al., 2016). Furthermore, muscle loss due to 
systemic inflammation and reduced PA may contribute to low BMI (Stavropoulos-
Kalinoglou et al., 2007). 
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In the present study, a higher time spent being sedentary (including sleeping 
time) was associated with higher WC, HC, BMI, and WHtR in the intervention 
group at 3 months but not the control group. This result is in line with a study by 
Wijndaele et al. (2014) that assessed 171 adults with a history of DM using an 
accelerometer to measure their PA, self-reporting television viewing time and an 
assessment of their cardiometabolic risk. The results showed that increased 
sedentary time is associated with clustered cardiometabolic risk (CCMR) which 
includes greater waist circumference, dyslipidaemia, hypertension and 
hyperglycaemia (CCMR: 0.08, 95% CI 0.01, 0.15). Thus, promoting walking and 
reducing time being sedentary can help to reduce anthropometric measurements 
and thus cardiometabolic risk. 
The fact that the adiposity variables did not change in this study may be because 
the intervention did not target energy intake and energy expenditure (see 
section 8.3.5 below). It may be that an intervention of higher intensity alongside 
a dietary component is needed to improve the adiposity variables. 
8.3.5 Dietary assessment 
There were no interaction effects between the intervention and control groups 
in the scores of the DINE questionnaire in the current study in terms of the 
consumption of fatty and sugary food, and fruits and vegetables. The present 
finding contrasts with an RCT conducted by Hunt et al. (2014), which identified 
a significant difference between groups (intervention and control) in DINE score. 
However, the main aim of Hunt et al.’s study was to examine the effect of a 
healthy living programme on weight loss and the targeted population was 
football players, which could explain their success at changing their food intake. 
However, no previous studies in RA have used the DINE questionnaire, therefore 
it was difficult to fully explain the present findings. 
In the current study, changing diet was not within the main objectives of this 
study; only one education session on diet was given to the intervention group 
and advice and material about diet was provided to the control group as well. 
Findings from the interviews suggested that participants found the topic of diet 
very useful, and the information provided increased their awareness of an 
appropriate diet. Some participants stated that they changed their dietary 
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habits after the session, however these individual changes were not sufficient to 
alter the DINE scores. 
8.3.6 Charlson co-morbidity index 
There was no significant difference across the period of the study in the 
Charlson co-morbidity in either group. In particular, there was no significant 
increase in co-morbidity over the 6-month intervention period. However, a 
previous study identified a significant increase in co-morbidity over a year in 
people with RA – more so than in people with other conditions such as 
osteoarthritis, and non-arthritis patients. Additionally, people with RA did not 
show improvements in survival (Charlson co-morbidity) similar to their non-RA 
peers and more attention should be paid to mortality in people with RA (Gabriel 
et al., 1999). However, Radner et al. (2010) reported that increased co-
morbidity in RA patients is independent of disease activity and physical function. 
8.4  Strengths of the study 
The WARA intervention has many strengths; it was designed specifically for 
people with RA, and was a single blind, randomised controlled trial. It was 
grounded on the constructs of SCT and also the behavioural change techniques 
used integral to the intervention were well established. In addition, it compared 
the effectiveness of the programme with usual care in this patient group. The 
programme was piloted in the first group and subsequent changes were 
implemented according to the physiotherapist’s and the participants’ feedback. 
A mixed methodology was employed using both quantitative and qualitative 
components, in order to explore findings in more depth. 
The primary outcome, PA at 6 months, was assessed with both objective and 
subjective measures. The secondary outcomes considered many aspects of RA 
(disease activity, functional capacity, quality of life, self-efficacy for PA, co-
morbidity and CVD risk). More than two-thirds of participants in the intervention 
group increased their step count over 6 months, and 25/37 (67.6%) participants 
whose step count increase over the 6 months – 19/25 (76%) participants 
increased their step count by more than 2000 steps/day from baseline to the 
primary end point (6 months). 
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The programme also improved the participants’ self-efficacy with regard to PA 
and health outcomes including functional capacity, SBP, and 10-year-risk of CVD. 
Participant’s views on the programme were sought and participants reported 
that the programme was good for them and, as they often felt very isolated, the 
programme gave them the chance to share their experience and gain new 
knowledge. They reported the education sessions improved their knowledge such 
as the higher risk of CVD and the detrimental effects of sedentary behaviour. 
The programme was acceptable in terms of content, time, venue, group size, 
number of sessions, content, handout, method of delivery, use of the pedometer 
and physical activity diary. From the quantitative and qualitative findings, it 
seems that there was an interactive theoretical mechanism of action. Increasing 
the participants’ awareness and knowledge of their condition, and increasing 
their PA self-efficacy by using motivation methods such as group education 
sessions, self-monitoring and feedback tools (pedometer and PA diary), 
enhanced their adherence to the WARA intervention. Subsequently, PA increased 
and improved health outcomes were observed. 
8.5 Limitations of the study 
The study has offered an evaluative perspective on an important condition, and 
was conducted in a people with first five years of diagnosed of RA. The study 
had a number of limitations, which need to be considered. As with other studies, 
a high number of participants were lost to follow-up in the control group. 
Seventeen (22.4%) participants were lost to follow-up in the study, two in the 
intervention group and fifteen in the control group. This differential loss to 
follow-up in the control group may be because they have no programme, thus no 
motivation to continue attending assessments. Telephone interviews with people 
who had been lost to follow-up would have helped to explore the reasons for 
this. The loss to follow-up figures are consistent with other studies such as the 
RCT of Neuberger et al. (2007), where around 28% were lost to follow-up at 12 
weeks; however Knittle et al. (2015) lost only 14.1% participants to follow-up 
(18.4% in the intervention group and 10% in the control group). 
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In terms of generalisability, patients who participated in the exercise study 
displayed a relatively high baseline step count and had a disease duration of 
within 5 years so were not representative of the general rheumatology 
population. The step counts of those with a short disease duration, less than 12 
months, did not change or reduce in comparison with participants whose disease 
duration was more than 12 months. 
Flares or exacerbations of RA were not captured in the study. In addition, 
variables such as mood, pain, fatigue and sleep were not captured 
systematically in the study, although they are key components of RA, and may 
affect, or be affected by, exercise intervention.  
Limited physical strengthening- resistance exercises were included in the 
present study as the focus was on increasing physical activity however the effect 
of strength training on RA cachexia should be explored in future studies. 
Due to the large number of outcome measures and the focus on more clinically 
based measures the maximum volume of oxygen (VO2max), as a measures of 
cardiovascular fitness was not included.  However, it would have been 
interesting to explore any association between the change in physical activity 
and cardiovascular fitness. 
The study consisted of two primary outcome measures: step count and sedentary 
behaviour, however the study sample size was based on only one primary 
outcome measure i.e. step count. The study was powered for 68 participants, 
although the aim was to recruit 90 participants, in order to allow for people 
dropping out/missing data. Due to the time constraints of the study, only 76 
participants were recruited, which did, however, provide sufficient numbers. 
In addition, including pilot data within the data set is a weakness in the 
experiment. It would have been better to undertake a separate pilot. 
Due to a high number of ‘lost to follow up’ participants among the usual care 
(control group) the current study did not compare people who increased their 
physical activity or those who did not change or reduce PA among the usual care 
group.  
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Use of a cross-over design or incentives, such as a specific programme for the 
control group after finishing the intervention may have helped to counteract the 
high drop-out rate, particularly among the control group. 
The current study did not evaluate the intensity of PA, therefore future studies 
should aim to identify the dose-response relationship between PA and clinical 
outcomes in those with RA. 
Sedentary data included sleep, as it was not possible to separate this from other 
sedentary behaviour. Future studies should consider the addition of sleep diaries 
to better differentiate between night time sleep and day time sedentary 
behaviour. It is also possible that exercise could lead to a better/longer sleep 
but this needs to be explored in future study.  
8.6 Discussion summary 
Walking has been reported as being popular and convenient for all ages, it 
requires no specialist skills and carries little risk of injury in the general 
population (Kassavou et al., 2013, Ogilvie et al., 2007) and in people with RA 
(Baxter et al., 2016). In the present study there was no adverse effect or injury 
recorded related to walking. Participants in the WARA intervention stated that 
walking was good for their health and mood and that it did not worsen their 
condition or cause injuries as they had previously believed. 
The positive outcomes that have emerged from this trial can guide others to 
promote walking in people with RA and encourage an approach that incorporates 
patient education. Although the results highlight the ef 
fectiveness of walking for 6MWT, SBP, and CVD risk, further work to investigate 
the effect of walking on joint pain, fatigue and mood may be required. 
A high number of people were lost to follow-up in the control group (n=15), the 
majority of which were female and of a younger age, so the losses may be 
explained by work commitments or child care commitments. Telephone 
interviews with people who had dropped out of the study would have helped to 
explore the reasons for this.
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9 Summary, Conclusions and Recommendations 
of the Study 
The following chapter offers a summary and considers the implications of this 
research for future work in this area. It offers recommendations that may help in 
clinical practice and finally it presents the conclusion of the study, highlighting 
the novelty of this research. 
9.1 Summary of the study 
Although there is evidence that PA has a beneficial effect on health and that 
interventions that include behavioural change techniques can promote PA in the 
general population, there is still a lack of evidence regarding whether 
behavioural change interventions can promote PA among people with RA. There 
is also insufficient evidence regarding the role of PA, particularly walking, on 
CVD in RA. This trial was designed to address some of these unanswered 
questions in RA. 
The primary outcome of this study was assessed with an objective measure 
(activPALTM) and the subjective measure of PA. Thus, the findings are robust and 
directly relevant to people with RA. The 6-month WARA intervention was 
effective in that the intervention group increased their physical activity; it 
helped people with RA to overcome barriers to PA and it brought them benefits 
in a number of ways. The secondary outcome measures (functional capacity, 
RAQoL, disease activity, CV risk and 10-year-risk of CVD) were assessed with 
subjective and objective measures. The results demonstrated that the 
intervention had a statistically significant, positive effect on functional capacity 
(6MWT), CV risk profile and 10-year- risk of CVD.  
There were no adverse effects or injuries related to the intervention. The 
results of this study indicate that this type of intervention is suitable and 
appropriate for people with RA within the first five years of their diagnosis. The 
results from the qualitative study supported some of these findings in that the 
participants felt an improvement in mobility, had less pain and felt healthier.  
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Also, the participants’ interviews identified the fact that group-based education 
sessions and the use of a pedometer, PA diaries and a handout had a great 
influence on the participants’ increased PA. The results also highlighted the 
importance of BCTs, such as using pedometers and PA diaries for self-
monitoring, in promoting PA and the social benefits of group education sessions. 
Additionally, results underlined the fact that theoretical based intervention was 
essential in influencing lifestyle changes, such as PA and also explained the 
outcomes of the intervention. 
9.2 Recommendations  
Encouraging PA in people with RA may play a role in improving the functioning of 
individuals in terms of 6 minutes’ walk and reducing the 10-year-risk of CVD.  
9.2.1 Key recommendations for future research  
Future intervention research should include telephone interviews with people 
who drop out of the study, in order to understand the reasons for this. 
Understanding these factors would help the design of future studies.   
Future physical activity intervention trials should evaluate the intensity of 
physical activity for people with RA. This would help investigate the dose- 
response relationship between physical activity and clinical outcomes in those 
with RA.  
Further studies are needed to replicate the results of this study, which may play 
a critical role in the management of long-term RA. 
9.2.2 Key recommendations for clinical practice  
People with RA wish to know about RA, physical activity in RA, and the 
consequence of sedentary behaviour, in order to improve their understanding of 
the condition and the benefits of PA. To that effect, a specific education 
programme for people diagnosed with RA should be offered to those with early 
RA. This could be provided as an interactive online patient education package.   
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Finally, the trial could be designed to be crossover design, which may make the 
study more acceptable to patients and reduce the dropout rate.   
9.3 Conclusions  
This study found that WARA, a community-based pedometer-supported walking 
programme, along with education sessions incorporating behavioural change 
techniques, is effective at promoting walking in these patients over 6 months in 
people within the first five years of being diagnosed with RA. The WARA 
intervention improved the participants’ self-efficacy for PA and health outcomes 
in terms of functional capacity (6MWT), CV profile (systolic blood pressure) and 
the 10-year-risk of CVD. The WARA programme may be a useful adjunct to 
current clinical practice in rheumatology. 
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Appendices 
Appendix 1 Preface 
Relevant research concerning rheumatoid arthritis, physical activity and 
cardiovascular disease (CVD) risk was identified by searching the databases for 
primary research material before designing this trial. Databases were searched 
for publications from 1965 through to 2014, with key articles obtained primarily 
from PubMed, Medline, Google Scholar, Cochrane Library, Web Sciences and 
PsycINFO. Cross-sectional studies, case controls, cohort studies, literature 
reviews, systematic reviews, Meta-analyses and clinical trials were reviewed, all 
related to rheumatoid arthritis, physical activity/exercise, and CVD. The next 
step was a detailed examination of the papers in order to identify the 
limitations, gaps and inconsistencies in the body of knowledge in this area. This 
helped to determine the research objectives, hypotheses and theoretical 
frameworks of this study. 
A summary of the reviewed studies is included in the following tables. In order 
to ensure that relevant studies were not missed, the search terms remained 
broad. These were "rheumatoid arthritis and "physical activity” or “physical 
inactivity” or “exercise” or “aerobic exercise” or “walking or sedentary 
behaviour” and “CVD” or “heart disease" anywhere in the title or abstract. 
Further reviews were carried out after designing this study, while analysing the 
present data and during the writing up stages (chapter 2). This was done in order 
to compare the results of this study with previous literature, to explain the 
results in depth, and to critically evaluate the study and existing knowledge. 
This strategy also helped the researcher to understand the limitations and the 
implications of the present findings for policy and practices. 
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